data_2mdq_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2mdq _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.5 -0.884 0 N-CA-C 110.818 -0.913 . . . . 0.0 110.818 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 20.7 m -62.73 -22.25 66.4 Favored 'General case' 0 N--CA 1.432 -1.366 0 N-CA-C 115.609 1.707 . . . . 0.0 115.609 -175.429 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 24.0 m -70.19 -35.42 73.92 Favored 'General case' 0 C--N 1.283 -2.317 0 C-N-CA 120.543 -0.463 . . . . 0.0 112.194 177.103 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 20.0 m -79.18 -4.38 50.19 Favored 'General case' 0 C--N 1.295 -1.764 0 CA-C-O 121.516 0.674 . . . . 0.0 110.304 177.401 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 10.6 m-70 -104.1 103.71 39.64 Favored Pre-proline 0 C--N 1.317 -0.83 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 176.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_exo -49.57 -38.58 45.16 Favored 'Trans proline' 0 CA--C 1.544 1.025 0 C-N-CA 122.736 2.291 . . . . 0.0 113.302 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -72.46 -41.91 65.55 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 -179.097 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 10.2 t -82.78 -19.99 36.72 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-O 121.742 0.782 . . . . 0.0 109.64 -175.083 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 -58.61 -41.81 86.75 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 115.036 -0.984 . . . . 0.0 109.477 179.093 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 49.1 t -62.7 -34.35 65.01 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 CA-C-N 114.09 -1.414 . . . . 0.0 111.955 -177.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -94.25 1.92 55.94 Favored 'General case' 0 C--N 1.316 -0.888 0 C-N-CA 119.199 -1.0 . . . . 0.0 112.971 -175.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 78.6 m-70 -118.73 72.37 10.91 Favored Pre-proline 0 N--CA 1.432 -1.328 0 CA-C-N 116.677 -0.238 . . . . 0.0 110.746 174.06 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -73.49 -13.76 25.04 Favored 'Trans proline' 0 C--N 1.356 0.943 0 C-N-CA 121.795 1.664 . . . . 0.0 111.411 -177.552 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.439 ' HG3' HG12 ' A' ' 15' ' ' ILE . 10.4 pt-20 -81.72 -23.48 36.71 Favored 'General case' 0 N--CA 1.421 -1.922 0 CA-C-N 114.553 -1.203 . . . . 0.0 110.896 179.267 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.439 HG12 ' HG3' ' A' ' 14' ' ' GLU . 35.7 mm -107.54 -50.98 7.54 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.067 0 CA-C-O 121.813 0.816 . . . . 0.0 108.805 -177.606 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 31.1 m . . . . . 0 C--N 1.287 -2.136 0 CA-C-N 114.318 -1.31 . . . . 0.0 109.495 -176.864 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.501 -0.784 0 N-CA-C 110.121 -1.192 . . . . 0.0 110.121 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 9.4 m -66.69 -13.99 61.96 Favored 'General case' 0 CA--C 1.493 -1.217 0 N-CA-C 114.116 1.154 . . . . 0.0 114.116 -178.619 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 96.1 m -68.41 -35.56 77.82 Favored 'General case' 0 C--N 1.28 -2.434 0 CA-C-O 121.766 0.793 . . . . 0.0 110.971 178.111 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 19.2 m -79.72 10.9 3.55 Favored 'General case' 0 C--N 1.281 -2.408 0 CA-C-N 114.772 -1.104 . . . . 0.0 110.308 176.371 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 83.6 m-70 -130.61 95.32 26.85 Favored Pre-proline 0 N--CA 1.444 -0.736 0 C-N-CA 124.274 1.03 . . . . 0.0 109.139 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.443 ' O ' HG21 ' A' ' 10' ' ' VAL . 57.2 Cg_exo -40.87 -47.12 4.87 Favored 'Trans proline' 0 N--CA 1.484 0.969 0 C-N-CA 124.23 3.287 . . . . 0.0 114.744 -176.352 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -65.36 -40.47 93.6 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 -178.407 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 9.4 t -83.41 -20.77 33.55 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 122.143 0.973 . . . . 0.0 109.49 -174.361 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 41.2 t-20 -67.06 -41.54 86.27 Favored 'General case' 0 C--N 1.294 -1.832 0 CA-C-N 114.424 -1.262 . . . . 0.0 109.187 -178.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.443 HG21 ' O ' ' A' ' 6' ' ' PRO . 96.0 t -62.88 -41.72 93.71 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 CA-C-N 113.957 -1.474 . . . . 0.0 111.917 179.672 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -87.14 3.37 46.62 Favored 'General case' 0 C--O 1.24 0.553 0 N-CA-C 113.215 0.82 . . . . 0.0 113.215 -176.207 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 88.1 m-70 -119.09 75.1 14.38 Favored Pre-proline 0 N--CA 1.428 -1.567 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.462 171.529 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo -66.43 -24.11 50.02 Favored 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 122.472 2.115 . . . . 0.0 113.997 -174.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -93.38 -18.33 22.51 Favored 'General case' 0 N--CA 1.416 -2.145 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.449 -177.225 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 22.8 mt -100.14 -40.82 8.67 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 CA-C-O 122.013 0.911 . . . . 0.0 109.196 -178.295 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 62.5 m . . . . . 0 N--CA 1.406 -2.647 0 CA-C-N 114.527 -1.215 . . . . 0.0 110.261 -177.268 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.242 0.645 0 N-CA-C 111.117 -0.793 . . . . 0.0 111.117 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . 0.469 ' HB2' ' NE2' ' A' ' 12' ' ' HIS . 7.9 m -60.79 -18.27 54.2 Favored 'General case' 0 C--O 1.205 -1.286 0 N-CA-C 116.022 1.86 . . . . 0.0 116.022 -176.719 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 4.7 m -65.54 -28.35 69.1 Favored 'General case' 0 C--N 1.277 -2.581 0 N-CA-C 113.947 1.091 . . . . 0.0 113.947 179.021 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 50.6 m -81.6 3.83 23.74 Favored 'General case' 0 C--N 1.282 -2.367 0 CA-C-O 121.501 0.667 . . . . 0.0 110.789 174.236 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 80.1 m-70 -117.63 103.4 50.82 Favored Pre-proline 0 C--N 1.31 -1.128 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 179.01 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_exo -44.56 -43.77 14.04 Favored 'Trans proline' 0 N--CA 1.486 1.037 0 C-N-CA 123.815 3.01 . . . . 0.0 114.245 -176.343 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -72.46 -28.28 62.83 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 112.818 0.673 . . . . 0.0 112.818 -177.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 6.9 t -102.52 4.99 39.17 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-O 122.462 1.125 . . . . 0.0 108.869 -176.53 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 -77.82 -44.97 25.74 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 114.751 -1.113 . . . . 0.0 110.383 -176.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 14.6 p -62.83 -25.48 38.46 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.246 0 CA-C-N 113.823 -1.535 . . . . 0.0 112.704 -176.058 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.407 ' O ' ' HD3' ' A' ' 13' ' ' PRO . 4.8 p-10 -91.24 13.15 17.98 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 113.366 0.876 . . . . 0.0 113.366 -177.828 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . 0.469 ' NE2' ' HB2' ' A' ' 2' ' ' CYS . 36.4 m-70 -110.22 84.18 3.56 Favored Pre-proline 0 N--CA 1.444 -0.731 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 170.342 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.407 ' HD3' ' O ' ' A' ' 11' ' ' ASP . 7.8 Cg_exo -68.74 -26.67 32.54 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.468 2.112 . . . . 0.0 113.934 -173.098 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -95.16 1.62 54.85 Favored 'General case' 0 N--CA 1.409 -2.487 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.561 -177.062 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 30.9 mm -122.93 -62.64 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-O 121.778 0.799 . . . . 0.0 109.166 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 71.3 m . . . . . 0 C--N 1.29 -2.004 0 CA-C-N 115.065 -0.97 . . . . 0.0 111.404 -176.412 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.494 -1.25 0 N-CA-C 110.304 -1.119 . . . . 0.0 110.304 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 3.9 m -61.37 -20.86 63.49 Favored 'General case' 0 C--O 1.2 -1.542 0 N-CA-C 114.773 1.398 . . . . 0.0 114.773 -176.354 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 83.0 m -73.51 -42.08 62.24 Favored 'General case' 0 C--N 1.285 -2.219 0 CA-C-O 121.378 0.608 . . . . 0.0 111.543 177.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 11.8 m -73.5 -13.75 61.1 Favored 'General case' 0 C--N 1.286 -2.18 0 CA-C-N 114.726 -1.125 . . . . 0.0 109.851 -179.399 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 9.7 m-70 -96.31 103.82 15.26 Favored Pre-proline 0 N--CA 1.434 -1.267 0 CA-C-N 114.499 -1.228 . . . . 0.0 108.863 175.079 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.528 ' O ' HG23 ' A' ' 10' ' ' VAL . 73.4 Cg_exo -50.46 -38.54 53.9 Favored 'Trans proline' 0 CA--C 1.534 0.505 0 C-N-CA 123.016 2.478 . . . . 0.0 113.679 -175.809 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -70.79 -40.49 72.52 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.125 0.417 . . . . 0.0 112.125 -177.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 11.2 t -83.38 -20.02 34.97 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 121.48 0.657 . . . . 0.0 109.454 -176.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -70.12 -32.8 70.99 Favored 'General case' 0 CA--C 1.501 -0.932 0 CA-C-O 121.206 0.527 . . . . 0.0 109.616 179.418 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.528 HG23 ' O ' ' A' ' 6' ' ' PRO . 89.3 t -53.94 -40.25 44.1 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.11 0 CA-C-N 114.745 -1.116 . . . . 0.0 110.918 175.302 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.475 ' C ' ' HD3' ' A' ' 13' ' ' PRO . 3.9 p30 -94.45 1.97 55.76 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.183 0.516 . . . . 0.0 111.385 179.686 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . 0.406 ' CD2' HG13 ' A' ' 15' ' ' ILE . 6.7 m80 -119.5 67.65 10.23 Favored Pre-proline 0 C--O 1.252 1.215 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.335 173.594 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.475 ' HD3' ' C ' ' A' ' 11' ' ' ASP . 3.4 Cg_exo -84.99 -22.02 2.96 Favored 'Trans proline' 0 C--N 1.357 1.017 0 C-N-CA 121.871 1.714 . . . . 0.0 111.057 -176.605 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -84.06 -11.92 55.94 Favored 'General case' 0 N--CA 1.412 -2.363 0 CA-C-N 113.784 -1.553 . . . . 0.0 109.739 179.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.406 HG13 ' CD2' ' A' ' 12' ' ' HIS . 38.2 mm -97.31 -52.52 9.08 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.36 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 -177.79 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 69.0 m . . . . . 0 N--CA 1.419 -1.976 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.446 178.397 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.5 -0.885 0 N-CA-C 110.339 -1.104 . . . . 0.0 110.339 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 17.3 m -60.51 -17.33 44.81 Favored 'General case' 0 C--O 1.202 -1.438 0 N-CA-C 115.442 1.645 . . . . 0.0 115.442 -176.2 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 80.8 m -63.64 -38.98 93.19 Favored 'General case' 0 C--N 1.282 -2.351 0 CA-C-O 121.279 0.561 . . . . 0.0 112.105 175.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 17.5 m -79.08 -0.28 30.88 Favored 'General case' 0 C--N 1.281 -2.39 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.668 178.391 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 17.4 m-70 -109.68 105.35 57.09 Favored Pre-proline 0 C--N 1.307 -1.239 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 178.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -54.36 -42.04 71.21 Favored 'Trans proline' 0 CA--C 1.531 0.372 0 C-N-CA 122.301 2.001 . . . . 0.0 112.564 -178.212 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -72.27 -25.23 61.52 Favored 'General case' 0 C--O 1.212 -0.881 0 N-CA-C 112.249 0.463 . . . . 0.0 112.249 -178.227 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 11.2 t -104.22 9.44 36.11 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.908 0.861 . . . . 0.0 109.037 -178.042 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 20.1 t-20 -87.08 -50.69 6.47 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-O 121.355 0.597 . . . . 0.0 110.425 -175.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 8.3 p -58.26 -37.91 65.68 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.145 0 CA-C-N 114.499 -1.228 . . . . 0.0 113.508 -175.108 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -86.97 7.34 27.91 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 113.169 0.803 . . . . 0.0 113.169 -177.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 47.7 m-70 -116.8 73.98 6.44 Favored Pre-proline 0 N--CA 1.433 -1.309 0 O-C-N 122.084 -0.385 . . . . 0.0 111.398 173.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_exo -67.9 -25.34 38.95 Favored 'Trans proline' 0 C--N 1.365 1.441 0 C-N-CA 122.374 2.049 . . . . 0.0 109.881 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.439 ' HG3' HG13 ' A' ' 15' ' ' ILE . 4.9 pt-20 -61.89 -34.12 75.46 Favored 'General case' 0 N--CA 1.424 -1.746 0 CA-C-N 112.937 -1.938 . . . . 0.0 112.343 177.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.439 HG13 ' HG3' ' A' ' 14' ' ' GLU . 15.6 mt -108.12 -49.48 7.65 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 C-N-CA 119.608 -0.837 . . . . 0.0 109.777 -177.154 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 84.4 m . . . . . 0 N--CA 1.428 -1.553 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.797 -178.912 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . 0.46 ' O ' ' HD2' ' A' ' 5' ' ' HIS . . . . . . . . 0 CA--C 1.503 -0.716 0 N-CA-C 110.061 -1.216 . . . . 0.0 110.061 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 4.9 m -65.49 -19.86 66.11 Favored 'General case' 0 CA--C 1.489 -1.377 0 N-CA-C 115.49 1.663 . . . . 0.0 115.49 -177.053 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . 0.608 ' SG ' ' HB ' ' A' ' 15' ' ' ILE . 1.6 m -68.19 -25.55 65.29 Favored 'General case' 0 C--N 1.277 -2.559 0 N-CA-C 113.439 0.903 . . . . 0.0 113.439 176.84 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 14.6 m -77.19 0.02 23.37 Favored 'General case' 0 C--N 1.284 -2.241 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.099 173.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . 0.46 ' HD2' ' O ' ' A' ' 1' ' ' GLY . 76.9 m-70 -121.59 109.8 34.22 Favored Pre-proline 0 C--N 1.325 -0.492 0 C-N-CA 123.762 0.825 . . . . 0.0 108.864 -177.338 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_exo -45.74 -49.83 10.34 Favored 'Trans proline' 0 N--CA 1.491 1.333 0 C-N-CA 123.913 3.075 . . . . 0.0 115.929 -172.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -73.55 -34.21 65.06 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 113.317 0.858 . . . . 0.0 113.317 -178.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 6.6 t -83.32 -17.56 42.04 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-O 121.896 0.855 . . . . 0.0 109.365 -176.386 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 18.6 t-20 -60.72 -39.24 87.87 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 114.918 -1.037 . . . . 0.0 109.52 177.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 67.8 t -56.93 -36.06 49.1 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 CA-C-N 113.714 -1.585 . . . . 0.0 113.33 -176.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.407 ' C ' ' HD3' ' A' ' 13' ' ' PRO . 4.7 p-10 -94.43 1.72 55.78 Favored 'General case' 0 C--N 1.312 -1.065 0 C-N-CA 118.581 -1.247 . . . . 0.0 113.449 -175.714 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 91.9 m-70 -116.21 75.23 6.02 Favored Pre-proline 0 N--CA 1.429 -1.489 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 177.538 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.493 ' HA ' ' O ' ' A' ' 16' ' ' CYS . 15.6 Cg_exo -71.43 -10.45 26.95 Favored 'Trans proline' 0 C--N 1.361 1.214 0 C-N-CA 122.396 2.064 . . . . 0.0 111.276 177.905 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.416 ' HG3' HG12 ' A' ' 15' ' ' ILE . 14.8 pt-20 -63.7 -29.24 70.49 Favored 'General case' 0 N--CA 1.434 -1.265 0 C-N-CA 124.314 1.046 . . . . 0.0 110.129 177.801 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.608 ' HB ' ' SG ' ' A' ' 3' ' ' CYS . 35.4 mm -107.85 -58.93 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.169 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 177.308 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.493 ' O ' ' HA ' ' A' ' 13' ' ' PRO . 61.4 m . . . . . 0 C--N 1.288 -2.106 0 CA-C-N 114.198 -1.364 . . . . 0.0 110.392 -177.049 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.495 -1.173 0 N-CA-C 109.084 -1.607 . . . . 0.0 109.084 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 1.9 m -65.13 -24.06 67.31 Favored 'General case' 0 C--O 1.197 -1.691 0 N-CA-C 114.374 1.25 . . . . 0.0 114.374 -178.548 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 5.8 m -74.58 -32.09 62.27 Favored 'General case' 0 C--N 1.283 -2.29 0 C-N-CA 120.479 -0.488 . . . . 0.0 112.212 176.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 10.8 m -69.61 -18.67 63.63 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-O 121.857 0.837 . . . . 0.0 109.404 176.625 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 23.3 m-70 -97.51 107.51 39.61 Favored Pre-proline 0 C--N 1.318 -0.767 0 CA-C-N 114.778 -1.101 . . . . 0.0 108.85 176.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_exo -49.33 -36.81 39.08 Favored 'Trans proline' 0 CA--C 1.541 0.843 0 C-N-CA 123.429 2.752 . . . . 0.0 113.636 -178.298 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -72.1 -43.51 64.67 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 111.827 0.306 . . . . 0.0 111.827 -179.467 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 5.7 t -83.49 -10.86 58.07 Favored 'General case' 0 N--CA 1.479 0.978 0 CA-C-O 121.937 0.875 . . . . 0.0 109.815 -174.254 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 -62.31 -44.94 95.34 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 114.786 -1.097 . . . . 0.0 110.498 -179.366 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 49.1 t -61.29 -34.76 62.22 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.116 0 CA-C-N 114.037 -1.438 . . . . 0.0 112.334 -175.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -88.53 5.47 42.5 Favored 'General case' 0 C--O 1.245 0.858 0 N-CA-C 112.937 0.718 . . . . 0.0 112.937 -177.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 53.5 m-70 -119.06 72.73 12.29 Favored Pre-proline 0 N--CA 1.433 -1.288 0 C-N-CA 122.663 0.385 . . . . 0.0 110.329 172.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -75.09 -16.03 20.23 Favored 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 122.696 2.264 . . . . 0.0 112.685 -173.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -83.37 -19.55 35.87 Favored 'General case' 0 N--CA 1.419 -1.986 0 CA-C-N 115.23 -0.895 . . . . 0.0 111.219 -179.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 26.9 mt -103.14 -45.35 10.22 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.004 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 176.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 84.7 m . . . . . 0 N--CA 1.422 -1.853 0 CA-C-N 114.311 -1.313 . . . . 0.0 110.683 -179.732 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.503 -0.69 0 N-CA-C 110.611 -0.995 . . . . 0.0 110.611 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 6.6 m -65.61 -15.91 63.2 Favored 'General case' 0 CA--C 1.491 -1.309 0 N-CA-C 114.432 1.271 . . . . 0.0 114.432 -177.339 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . 0.439 ' SG ' HG21 ' A' ' 15' ' ' ILE . 86.9 m -66.06 -34.04 77.16 Favored 'General case' 0 C--N 1.276 -2.626 0 CA-C-O 121.481 0.657 . . . . 0.0 111.889 176.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 50.5 m -80.32 3.65 20.38 Favored 'General case' 0 C--N 1.279 -2.47 0 CA-C-N 115.303 -0.862 . . . . 0.0 111.069 175.197 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 49.4 m-70 -120.95 92.68 48.54 Favored Pre-proline 0 C--N 1.314 -0.949 0 C-N-CA 124.113 0.965 . . . . 0.0 108.624 179.222 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_exo -45.97 -43.19 20.22 Favored 'Trans proline' 0 N--CA 1.486 1.053 0 C-N-CA 123.482 2.788 . . . . 0.0 113.888 -176.17 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -68.03 -24.61 65.11 Favored 'General case' 0 C--O 1.219 -0.552 0 N-CA-C 112.327 0.491 . . . . 0.0 112.327 -178.478 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 18.0 t -97.12 -20.78 17.74 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-O 122.044 0.926 . . . . 0.0 109.048 -179.656 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 45.8 t-20 -77.97 -39.44 42.47 Favored 'General case' 0 C--N 1.301 -1.512 0 CA-C-N 115.125 -0.943 . . . . 0.0 109.481 -176.183 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 11.0 p -60.08 -23.08 26.14 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.157 0 CA-C-N 114.366 -1.288 . . . . 0.0 112.205 -178.158 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -109.96 3.16 20.21 Favored 'General case' 0 CA--C 1.513 -0.443 0 C-N-CA 119.313 -0.955 . . . . 0.0 112.704 178.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 76.1 m-70 -118.95 78.25 16.18 Favored Pre-proline 0 N--CA 1.428 -1.542 0 N-CA-C 112.222 0.453 . . . . 0.0 112.222 176.022 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -75.37 -12.98 20.79 Favored 'Trans proline' 0 C--N 1.353 0.774 0 C-N-CA 122.35 2.033 . . . . 0.0 110.191 179.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -71.17 -29.63 65.43 Favored 'General case' 0 N--CA 1.415 -2.194 0 CA-C-N 113.636 -1.62 . . . . 0.0 110.045 178.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.439 HG21 ' SG ' ' A' ' 3' ' ' CYS . 32.2 mm -98.82 -54.84 6.54 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.746 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 -178.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 70.5 m . . . . . 0 N--CA 1.43 -1.445 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.22 176.68 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.506 -0.473 0 N-CA-C 110.413 -1.075 . . . . 0.0 110.413 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 3.4 m -62.69 -19.33 63.78 Favored 'General case' 0 C--O 1.21 -1.0 0 N-CA-C 114.666 1.358 . . . . 0.0 114.666 -177.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . 0.451 ' SG ' HG22 ' A' ' 15' ' ' ILE . 52.6 m -70.59 -33.1 70.7 Favored 'General case' 0 C--N 1.281 -2.398 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 177.605 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 18.8 m -81.3 -2.64 49.83 Favored 'General case' 0 C--N 1.284 -2.266 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.015 175.456 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 17.4 m-70 -107.43 101.3 38.53 Favored Pre-proline 0 C--N 1.313 -1.0 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.157 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 99.1 Cg_exo -45.56 -44.65 16.96 Favored 'Trans proline' 0 N--CA 1.478 0.615 0 C-N-CA 123.927 3.085 . . . . 0.0 114.408 -175.536 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -72.48 -37.53 68.42 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 112.257 0.465 . . . . 0.0 112.257 -177.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 14.0 t -83.13 -19.97 35.67 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.736 0.779 . . . . 0.0 109.573 -174.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -64.12 -45.09 90.1 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.963 -179.515 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 57.7 t -62.06 -39.45 83.84 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.012 0 CA-C-N 114.211 -1.359 . . . . 0.0 112.542 -175.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -86.41 1.37 51.54 Favored 'General case' 0 CA--C 1.512 -0.508 0 C-N-CA 120.079 -0.649 . . . . 0.0 112.647 -177.394 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 83.3 m-70 -118.68 73.02 11.23 Favored Pre-proline 0 N--CA 1.425 -1.684 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 172.557 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_exo -71.28 -25.52 21.84 Favored 'Trans proline' 0 C--N 1.353 0.813 0 C-N-CA 122.393 2.062 . . . . 0.0 111.561 -175.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -73.8 -26.13 60.47 Favored 'General case' 0 N--CA 1.419 -2.002 0 CA-C-N 114.282 -1.326 . . . . 0.0 110.999 179.56 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.451 HG22 ' SG ' ' A' ' 3' ' ' CYS . 46.2 mt -94.22 -48.36 13.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 178.603 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 32.8 m . . . . . 0 N--CA 1.423 -1.816 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.742 179.046 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.493 -1.29 0 N-CA-C 110.249 -1.14 . . . . 0.0 110.249 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 1.7 m -61.56 -34.26 75.27 Favored 'General case' 0 CA--C 1.487 -1.473 0 N-CA-C 114.258 1.207 . . . . 0.0 114.258 -178.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . 0.425 ' SG ' ' HB ' ' A' ' 15' ' ' ILE . 1.6 m -71.0 -22.78 62.12 Favored 'General case' 0 C--N 1.28 -2.439 0 N-CA-C 113.711 1.004 . . . . 0.0 113.711 178.671 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 16.3 m -72.52 -12.45 61.08 Favored 'General case' 0 C--N 1.287 -2.146 0 CA-C-O 121.293 0.568 . . . . 0.0 110.013 173.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 40.0 m-70 -109.08 122.38 40.02 Favored Pre-proline 0 C--N 1.319 -0.72 0 C-N-CA 123.661 0.784 . . . . 0.0 109.221 178.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -55.55 -33.03 85.24 Favored 'Trans proline' 0 CA--C 1.542 0.921 0 C-N-CA 122.839 2.359 . . . . 0.0 113.825 -177.315 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -72.71 -47.19 49.23 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 112.411 0.523 . . . . 0.0 112.411 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.447 ' HA ' ' OD1' ' A' ' 11' ' ' ASP . 3.9 t -83.24 -14.5 53.11 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-O 121.664 0.745 . . . . 0.0 110.206 -173.168 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 20.1 t-20 -59.75 -42.23 92.76 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 115.334 -0.848 . . . . 0.0 109.838 178.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 47.5 t -62.72 -41.28 91.76 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.993 0 CA-C-N 113.847 -1.524 . . . . 0.0 111.684 -177.277 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.447 ' OD1' ' HA ' ' A' ' 8' ' ' CYS . 5.3 p-10 -88.84 14.74 9.66 Favored 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 113.127 0.788 . . . . 0.0 113.127 -176.672 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 18.3 m-70 -118.57 79.53 16.04 Favored Pre-proline 0 N--CA 1.432 -1.343 0 N-CA-C 111.701 0.26 . . . . 0.0 111.701 173.07 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -66.7 -27.23 45.12 Favored 'Trans proline' 0 C--N 1.359 1.107 0 C-N-CA 123.029 2.486 . . . . 0.0 110.95 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.414 ' HG3' HG12 ' A' ' 15' ' ' ILE . 11.0 pt-20 -71.45 -21.35 61.97 Favored 'General case' 0 N--CA 1.419 -2.009 0 CA-C-N 113.729 -1.578 . . . . 0.0 111.853 -178.552 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.425 ' HB ' ' SG ' ' A' ' 3' ' ' CYS . 30.9 mm -112.24 -49.94 5.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 121.462 0.648 . . . . 0.0 109.54 -178.621 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 84.1 m . . . . . 0 N--CA 1.425 -1.708 0 CA-C-N 115.093 -0.958 . . . . 0.0 111.251 -176.828 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.508 -0.377 0 N-CA-C 111.458 -0.657 . . . . 0.0 111.458 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 32.2 m -60.53 -17.82 48.22 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 116.18 1.918 . . . . 0.0 116.18 -175.678 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 79.6 m -67.05 -33.74 76.16 Favored 'General case' 0 C--N 1.273 -2.748 0 N-CA-C 112.891 0.7 . . . . 0.0 112.891 -179.218 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 24.8 p -86.28 12.6 9.6 Favored 'General case' 0 C--N 1.278 -2.53 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.873 176.399 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 33.7 m-70 -124.35 103.07 32.73 Favored Pre-proline 0 C--N 1.317 -0.822 0 C-N-CA 124.124 0.97 . . . . 0.0 109.036 -178.261 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_exo -47.46 -45.21 23.46 Favored 'Trans proline' 0 N--CA 1.474 0.349 0 C-N-CA 123.656 2.904 . . . . 0.0 114.186 -176.24 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -68.17 -41.15 81.95 Favored 'General case' 0 C--N 1.317 -0.824 0 C-N-CA 121.337 -0.145 . . . . 0.0 111.282 -177.286 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 8.4 t -83.62 -16.87 43.56 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 121.808 0.813 . . . . 0.0 110.097 -175.694 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 -66.34 -38.25 87.21 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-O 121.751 0.786 . . . . 0.0 108.965 179.526 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 97.4 t -60.62 -46.45 95.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 114.011 -1.45 . . . . 0.0 112.679 -178.087 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.418 ' C ' ' HD3' ' A' ' 13' ' ' PRO . 7.5 p-10 -87.01 1.86 51.44 Favored 'General case' 0 CA--C 1.513 -0.45 0 N-CA-C 113.485 0.92 . . . . 0.0 113.485 -173.863 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . 0.516 ' HB3' ' HB ' ' A' ' 15' ' ' ILE . 89.3 m-70 -116.39 73.0 5.3 Favored Pre-proline 0 N--CA 1.429 -1.479 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 172.318 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.418 ' HD3' ' C ' ' A' ' 11' ' ' ASP . 21.4 Cg_exo -64.95 -27.44 58.4 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 123.079 2.52 . . . . 0.0 114.17 -173.166 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -95.86 -22.06 17.7 Favored 'General case' 0 N--CA 1.408 -2.535 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.209 -178.049 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.516 ' HB ' ' HB3' ' A' ' 12' ' ' HIS . 37.2 mm -89.99 -45.2 15.11 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.665 0 CA-C-O 121.94 0.876 . . . . 0.0 108.66 -177.26 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 62.6 m . . . . . 0 N--CA 1.413 -2.316 0 CA-C-N 114.508 -1.224 . . . . 0.0 110.259 -177.7 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.496 -1.103 0 N-CA-C 110.912 -0.875 . . . . 0.0 110.912 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . 0.421 ' HA ' ' HB2' ' A' ' 5' ' ' HIS . 19.7 m -66.01 -17.08 64.45 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 115.168 1.544 . . . . 0.0 115.168 -176.334 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 58.4 m -63.15 -31.63 72.81 Favored 'General case' 0 C--N 1.281 -2.373 0 N-CA-C 113.172 0.804 . . . . 0.0 113.172 177.712 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 5.3 p -99.17 18.59 17.1 Favored 'General case' 0 C--N 1.279 -2.487 0 CA-C-O 121.848 0.832 . . . . 0.0 110.118 175.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . 0.452 ' O ' ' HB2' ' A' ' 9' ' ' ASN . 67.5 m170 -122.01 93.79 48.43 Favored Pre-proline 0 C--N 1.312 -1.038 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 178.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -49.79 -48.68 18.39 Favored 'Trans proline' 0 N--CA 1.484 0.949 0 C-N-CA 123.35 2.7 . . . . 0.0 114.447 -173.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -71.34 -19.66 62.27 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.81 -177.113 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 20.8 t -95.07 -22.41 17.92 Favored 'General case' 0 C--O 1.208 -1.128 0 C-N-CA 120.087 -0.645 . . . . 0.0 109.67 179.415 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . 0.452 ' HB2' ' O ' ' A' ' 5' ' ' HIS . 57.3 t30 -85.07 -29.38 24.95 Favored 'General case' 0 C--N 1.28 -2.441 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.93 -167.868 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 7.3 p -56.01 -31.62 31.45 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.126 0 CA-C-N 115.082 -0.963 . . . . 0.0 111.652 178.208 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -97.85 12.56 33.59 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-O 120.894 0.378 . . . . 0.0 111.569 179.425 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 48.4 m80 -116.94 71.93 5.72 Favored Pre-proline 0 N--CA 1.44 -0.935 0 C-N-CA 122.767 0.427 . . . . 0.0 110.166 174.592 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo -72.56 -32.72 9.42 Favored 'Trans proline' 0 C--N 1.356 0.944 0 C-N-CA 122.844 2.363 . . . . 0.0 113.761 -172.593 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -92.4 5.27 51.31 Favored 'General case' 0 N--CA 1.411 -2.376 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.594 -178.549 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 37.2 mm -105.33 -65.93 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.952 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 177.565 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 69.2 m . . . . . 0 C--N 1.288 -2.096 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.458 179.575 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . 0.417 ' O ' ' HD2' ' A' ' 5' ' ' HIS . . . . . . . . 0 CA--C 1.495 -1.177 0 N-CA-C 110.156 -1.178 . . . . 0.0 110.156 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 14.2 m -68.53 -22.84 64.49 Favored 'General case' 0 N--CA 1.428 -1.528 0 N-CA-C 114.041 1.126 . . . . 0.0 114.041 -177.671 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 65.0 m -75.12 -28.02 60.04 Favored 'General case' 0 C--N 1.294 -1.833 0 CA-C-O 121.697 0.761 . . . . 0.0 111.555 176.411 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 4.1 m -71.54 0.97 7.25 Favored 'General case' 0 C--N 1.297 -1.678 0 CA-C-N 114.495 -1.23 . . . . 0.0 109.781 174.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . 0.447 ' O ' ' HB2' ' A' ' 9' ' ' ASN . 30.7 m-70 -125.91 147.96 60.89 Favored Pre-proline 0 N--CA 1.438 -1.075 0 C-N-CA 124.804 1.241 . . . . 0.0 107.895 178.498 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -77.44 -41.67 0.33 Allowed 'Trans proline' 0 CA--C 1.548 1.217 0 C-N-CA 121.652 1.568 . . . . 0.0 112.865 175.679 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -72.08 -39.86 68.66 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 113.332 0.864 . . . . 0.0 113.332 -174.159 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 10.1 t -87.12 4.21 43.18 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-O 121.932 0.872 . . . . 0.0 109.787 -178.662 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . 0.447 ' HB2' ' O ' ' A' ' 5' ' ' HIS . 9.7 t-20 -79.19 -39.78 32.48 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-O 121.702 0.763 . . . . 0.0 109.364 -177.218 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 14.9 p -71.05 -30.59 41.81 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-N 114.46 -1.245 . . . . 0.0 112.752 -174.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -87.92 3.43 48.58 Favored 'General case' 0 C--N 1.317 -0.81 0 C-N-CA 119.037 -1.065 . . . . 0.0 112.457 -179.28 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 83.8 m-70 -118.67 73.12 11.27 Favored Pre-proline 0 N--CA 1.425 -1.682 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 172.208 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo -72.94 -31.22 10.22 Favored 'Trans proline' 0 C--N 1.359 1.109 0 C-N-CA 122.768 2.312 . . . . 0.0 112.257 -173.446 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -77.51 -10.16 59.33 Favored 'General case' 0 N--CA 1.419 -1.975 0 CA-C-N 114.394 -1.276 . . . . 0.0 111.391 -179.311 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 37.8 mm -104.06 -57.63 4.36 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.007 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 177.496 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 91.7 m . . . . . 0 N--CA 1.426 -1.672 0 CA-C-N 115.074 -0.966 . . . . 0.0 110.761 178.449 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.499 -0.919 0 N-CA-C 109.969 -1.253 . . . . 0.0 109.969 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 1.7 m -64.94 -23.2 67.15 Favored 'General case' 0 C--O 1.189 -2.089 0 N-CA-C 113.438 0.903 . . . . 0.0 113.438 179.375 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 19.4 m -77.0 -29.7 55.58 Favored 'General case' 0 C--N 1.277 -2.582 0 CA-C-O 121.213 0.53 . . . . 0.0 112.095 175.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 2.7 m -67.44 -28.49 67.93 Favored 'General case' 0 C--N 1.286 -2.16 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 175.016 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 32.7 m170 -91.04 113.23 57.49 Favored Pre-proline 0 C--N 1.318 -0.8 0 CA-C-N 114.877 -1.056 . . . . 0.0 110.0 -179.674 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_endo -51.62 -40.97 63.4 Favored 'Trans proline' 0 CA--C 1.539 0.73 0 C-N-CA 123.13 2.553 . . . . 0.0 113.956 -177.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -72.41 -39.98 67.52 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 -177.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 11.0 t -83.48 -19.83 35.1 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.451 0.644 . . . . 0.0 110.118 -174.506 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 18.4 t-20 -54.08 -44.34 71.09 Favored 'General case' 0 C--N 1.321 -0.673 0 C-N-CA 124.735 1.214 . . . . 0.0 111.162 -178.122 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 36.0 t -62.89 -38.32 81.57 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.184 0 CA-C-N 114.085 -1.416 . . . . 0.0 112.502 -175.072 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.405 ' O ' ' HD3' ' A' ' 13' ' ' PRO . 5.4 p-10 -90.22 13.93 13.94 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 119.795 -0.762 . . . . 0.0 112.93 -176.879 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 22.8 m-70 -114.35 79.17 5.07 Favored Pre-proline 0 N--CA 1.431 -1.425 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 171.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.405 ' HD3' ' O ' ' A' ' 11' ' ' ASP . 5.4 Cg_exo -72.31 -27.84 15.86 Favored 'Trans proline' 0 C--N 1.358 1.036 0 C-N-CA 123.36 2.706 . . . . 0.0 112.923 -172.015 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -84.05 -11.46 56.69 Favored 'General case' 0 C--N 1.291 -1.947 0 CA-C-N 115.139 -0.937 . . . . 0.0 111.505 -178.394 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 27.5 mm -107.91 -52.84 6.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 -179.344 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 97.5 m . . . . . 0 N--CA 1.426 -1.641 0 CA-C-N 114.979 -1.009 . . . . 0.0 111.433 -179.088 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.502 -0.762 0 N-CA-C 110.801 -0.92 . . . . 0.0 110.801 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 16.5 m -67.48 -16.27 64.12 Favored 'General case' 0 N--CA 1.435 -1.216 0 N-CA-C 114.765 1.394 . . . . 0.0 114.765 -176.747 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 65.0 m -67.73 -33.98 75.95 Favored 'General case' 0 C--N 1.279 -2.471 0 CA-C-O 121.193 0.521 . . . . 0.0 111.148 176.475 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 20.7 m -85.85 14.53 5.86 Favored 'General case' 0 C--N 1.294 -1.81 0 CA-C-N 115.256 -0.884 . . . . 0.0 110.301 176.037 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 25.0 m-70 -130.76 94.79 27.86 Favored Pre-proline 0 C--N 1.318 -0.785 0 C-N-CA 124.425 1.09 . . . . 0.0 109.727 -178.453 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_exo -48.88 -48.86 16.59 Favored 'Trans proline' 0 N--CA 1.481 0.77 0 C-N-CA 123.537 2.825 . . . . 0.0 113.913 -176.306 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -64.85 -32.63 74.42 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 111.847 0.314 . . . . 0.0 111.847 -178.478 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 34.1 t -84.4 -20.76 31.36 Favored 'General case' 0 C--O 1.203 -1.357 0 CA-C-O 121.601 0.715 . . . . 0.0 109.436 179.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 45.6 t-20 -82.73 -48.08 11.26 Favored 'General case' 0 C--N 1.288 -2.105 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.646 -173.321 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 11.8 p -54.04 -39.15 40.17 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.206 0 CA-C-N 114.873 -1.058 . . . . 0.0 113.775 -175.045 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -99.94 5.86 45.23 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 118.557 -1.257 . . . . 0.0 111.905 -179.224 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 31.7 m-70 -118.62 76.88 13.84 Favored Pre-proline 0 N--CA 1.438 -1.067 0 N-CA-C 112.789 0.662 . . . . 0.0 112.789 177.174 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_exo -72.56 -21.03 22.79 Favored 'Trans proline' 0 N--CA 1.462 -0.374 0 C-N-CA 121.985 1.79 . . . . 0.0 110.503 178.513 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -74.89 -22.95 58.35 Favored 'General case' 0 N--CA 1.428 -1.556 0 CA-C-N 114.371 -1.286 . . . . 0.0 110.382 179.52 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 50.3 mm -99.8 -50.01 10.96 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.805 0 N-CA-C 108.644 -0.872 . . . . 0.0 108.644 -179.421 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 63.6 m . . . . . 0 N--CA 1.417 -2.101 0 CA-C-N 114.896 -1.047 . . . . 0.0 110.319 -179.848 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.807 0 N-CA-C 111.51 -0.636 . . . . 0.0 111.51 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 6.1 m -65.76 -17.97 65.0 Favored 'General case' 0 CA--C 1.491 -1.292 0 N-CA-C 114.747 1.388 . . . . 0.0 114.747 -177.403 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 30.2 m -65.64 -32.86 74.66 Favored 'General case' 0 C--N 1.283 -2.293 0 CA-C-O 121.021 0.439 . . . . 0.0 111.912 177.026 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 19.1 m -82.28 11.61 5.25 Favored 'General case' 0 C--N 1.287 -2.134 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.374 176.06 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 45.2 m-70 -124.56 111.45 27.85 Favored Pre-proline 0 C--N 1.313 -0.983 0 C-N-CA 123.817 0.847 . . . . 0.0 109.361 179.533 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -49.21 -49.31 15.75 Favored 'Trans proline' 0 CA--C 1.539 0.741 0 C-N-CA 123.462 2.774 . . . . 0.0 114.691 -174.485 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -72.75 -37.21 67.75 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 112.621 0.6 . . . . 0.0 112.621 -177.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.485 ' O ' ' HD2' ' A' ' 12' ' ' HIS . 7.3 t -81.65 -19.9 40.76 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 122.019 0.914 . . . . 0.0 108.833 -174.784 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -62.09 -44.19 97.2 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-N 114.837 -1.074 . . . . 0.0 109.704 177.682 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 49.5 t -65.28 -41.96 92.7 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 CA-C-N 113.953 -1.476 . . . . 0.0 111.796 -176.038 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.417 ' OD1' ' HA ' ' A' ' 8' ' ' CYS . 4.5 p-10 -84.9 3.92 35.85 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 113.316 0.858 . . . . 0.0 113.316 -175.283 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . 0.485 ' HD2' ' O ' ' A' ' 8' ' ' CYS . 66.3 m-70 -113.72 77.34 3.41 Favored Pre-proline 0 N--CA 1.434 -1.245 0 N-CA-C 109.924 -0.399 . . . . 0.0 109.924 172.462 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_exo -66.54 -32.33 39.52 Favored 'Trans proline' 0 C--N 1.355 0.899 0 C-N-CA 122.728 2.286 . . . . 0.0 112.47 -174.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -79.69 -22.69 43.09 Favored 'General case' 0 C--N 1.289 -2.057 0 CA-C-N 114.53 -1.214 . . . . 0.0 111.845 -178.1 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.409 ' HB ' ' HB3' ' A' ' 12' ' ' HIS . 41.2 mm -100.92 -58.71 3.72 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 CA-C-O 121.813 0.816 . . . . 0.0 109.337 -176.757 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 36.8 m . . . . . 0 C--N 1.281 -2.403 0 CA-C-N 114.707 -1.133 . . . . 0.0 110.319 -175.975 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.573 0 N-CA-C 111.958 -0.457 . . . . 0.0 111.958 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 31.1 m -60.84 -22.04 63.81 Favored 'General case' 0 N--CA 1.438 -1.061 0 N-CA-C 116.358 1.985 . . . . 0.0 116.358 -174.041 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 67.2 m -71.95 -35.91 69.71 Favored 'General case' 0 C--N 1.278 -2.53 0 C-N-CA 120.542 -0.463 . . . . 0.0 112.149 179.247 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 38.4 t -83.64 1.26 43.24 Favored 'General case' 0 C--N 1.281 -2.386 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.931 177.225 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 39.9 m170 -110.32 111.19 57.85 Favored Pre-proline 0 C--N 1.311 -1.092 0 C-N-CA 123.504 0.721 . . . . 0.0 109.901 -177.788 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.482 ' O ' HG21 ' A' ' 10' ' ' VAL . 52.9 Cg_exo -51.5 -49.62 16.59 Favored 'Trans proline' 0 CA--C 1.542 0.915 0 C-N-CA 123.16 2.573 . . . . 0.0 115.033 -172.587 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -73.09 -33.12 65.42 Favored 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 112.6 0.593 . . . . 0.0 112.6 -176.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.514 ' HA ' ' OD2' ' A' ' 11' ' ' ASP . 8.9 t -82.75 -20.33 36.14 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 122.07 0.938 . . . . 0.0 108.906 -177.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 -66.21 -40.93 90.71 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 115.057 -0.974 . . . . 0.0 108.484 177.23 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.482 HG21 ' O ' ' A' ' 6' ' ' PRO . 84.3 t -62.34 -36.24 73.62 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 CA-C-N 114.458 -1.247 . . . . 0.0 111.417 -179.921 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.514 ' OD2' ' HA ' ' A' ' 8' ' ' CYS . 3.3 p30 -87.84 0.74 55.42 Favored 'General case' 0 C--N 1.321 -0.664 0 C-N-CA 119.518 -0.873 . . . . 0.0 111.196 179.625 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . 0.492 ' HB3' ' HB ' ' A' ' 15' ' ' ILE . 1.0 OUTLIER -118.58 70.59 9.26 Favored Pre-proline 0 C--N 1.312 -1.038 0 C-N-CA 123.071 0.548 . . . . 0.0 110.248 175.378 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -79.19 -17.98 11.43 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 121.696 1.597 . . . . 0.0 111.799 -176.337 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -100.92 0.15 37.84 Favored 'General case' 0 N--CA 1.41 -2.441 0 CA-C-N 114.721 -1.127 . . . . 0.0 111.182 -178.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.492 ' HB ' ' HB3' ' A' ' 12' ' ' HIS . 25.3 mm -114.65 -54.95 4.52 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.949 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 -179.797 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 21.6 m . . . . . 0 C--N 1.284 -2.261 0 CA-C-N 114.089 -1.414 . . . . 0.0 110.077 -174.095 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.946 0 N-CA-C 112.209 -0.357 . . . . 0.0 112.209 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 4.0 m -64.99 -19.95 66.25 Favored 'General case' 0 N--CA 1.433 -1.305 0 N-CA-C 114.158 1.17 . . . . 0.0 114.158 -179.218 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 20.0 m -68.06 -30.81 70.1 Favored 'General case' 0 C--N 1.28 -2.415 0 N-CA-C 112.98 0.733 . . . . 0.0 112.98 178.819 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 16.6 m -72.84 -0.53 13.7 Favored 'General case' 0 C--N 1.291 -1.951 0 CA-C-O 121.369 0.604 . . . . 0.0 110.533 175.742 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 67.7 m-70 -125.98 104.21 26.56 Favored Pre-proline 0 C--O 1.216 -0.676 0 C-N-CA 124.322 1.049 . . . . 0.0 108.952 -178.25 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -50.21 -35.19 42.34 Favored 'Trans proline' 0 N--CA 1.483 0.89 0 C-N-CA 123.229 2.619 . . . . 0.0 113.83 -177.217 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -68.98 -32.93 72.85 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 111.577 0.214 . . . . 0.0 111.577 -179.015 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.426 ' HA ' ' OD1' ' A' ' 11' ' ' ASP . 6.4 t -97.11 -18.62 19.22 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.933 0.873 . . . . 0.0 109.593 -177.78 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 19.9 t-20 -60.13 -45.16 93.96 Favored 'General case' 0 C--N 1.314 -0.948 0 C-N-CA 124.21 1.004 . . . . 0.0 110.481 -178.808 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 12.3 p -66.66 -30.56 50.1 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.003 0 CA-C-N 114.156 -1.384 . . . . 0.0 112.322 -176.823 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.426 ' OD1' ' HA ' ' A' ' 8' ' ' CYS 0.252 7.0 p-10 -90.8 5.21 49.32 Favored 'General case' 0 C--O 1.24 0.557 0 C-N-CA 119.649 -0.82 . . . . 0.0 112.137 -179.871 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 57.3 m-70 -119.38 72.01 13.45 Favored Pre-proline 0 N--CA 1.431 -1.42 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.702 168.719 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -77.77 -12.02 16.63 Favored 'Trans proline' 0 C--N 1.354 0.856 0 C-N-CA 122.522 2.148 . . . . 0.0 111.955 -176.437 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -80.01 -20.85 44.44 Favored 'General case' 0 N--CA 1.416 -2.125 0 CA-C-N 114.907 -1.042 . . . . 0.0 110.393 177.528 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 38.5 mt -103.37 -54.41 6.58 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.04 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 177.257 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 91.1 m . . . . . 0 N--CA 1.415 -2.212 0 CA-C-N 114.702 -1.136 . . . . 0.0 110.522 178.437 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.503 -0.666 0 N-CA-C 110.358 -1.097 . . . . 0.0 110.358 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . 0.437 ' HB3' ' O ' ' A' ' 8' ' ' CYS . 8.0 m -72.1 -22.91 61.28 Favored 'General case' 0 N--CA 1.428 -1.536 0 N-CA-C 113.265 0.839 . . . . 0.0 113.265 -178.745 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 1.8 m -74.55 -24.56 58.95 Favored 'General case' 0 C--N 1.294 -1.841 0 CA-C-O 121.205 0.526 . . . . 0.0 111.148 173.792 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 4.0 m -69.77 -26.28 64.21 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 173.638 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . 0.541 ' O ' ' HB2' ' A' ' 9' ' ' ASN . 30.5 m80 -90.38 156.2 45.91 Favored Pre-proline 0 N--CA 1.446 -0.666 0 CA-C-N 114.703 -1.135 . . . . 0.0 109.957 178.946 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -84.47 -49.49 0.04 OUTLIER 'Trans proline' 0 CA--C 1.549 1.231 0 C-N-CA 122.03 1.82 . . . . 0.0 114.196 178.59 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -73.26 -38.03 66.11 Favored 'General case' 0 C--N 1.32 -0.706 0 O-C-N 121.703 -0.623 . . . . 0.0 112.299 -177.25 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.437 ' O ' ' HB3' ' A' ' 2' ' ' CYS . 5.9 t -83.3 0.67 44.69 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 122.098 0.951 . . . . 0.0 109.45 -176.837 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . 0.541 ' HB2' ' O ' ' A' ' 5' ' ' HIS . 19.6 t-20 -74.39 -41.19 61.37 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 114.962 -1.017 . . . . 0.0 108.739 -179.73 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 62.1 t -58.82 -35.24 55.05 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-N 113.279 -1.782 . . . . 0.0 112.679 -176.381 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.513 ' O ' ' HD3' ' A' ' 13' ' ' PRO 0.276 7.1 p-10 -82.62 6.35 18.03 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 113.863 1.06 . . . . 0.0 113.863 -177.865 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 23.5 m-70 -109.75 74.18 0.72 Allowed Pre-proline 0 N--CA 1.441 -0.886 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 168.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.513 ' HD3' ' O ' ' A' ' 11' ' ' ASP . 13.6 Cg_exo -66.82 -35.99 25.37 Favored 'Trans proline' 0 CA--C 1.501 -1.14 0 C-N-CA 122.756 2.304 . . . . 0.0 113.439 -168.489 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -86.85 -1.03 57.47 Favored 'General case' 0 C--N 1.282 -2.334 0 CA-C-N 114.926 -1.033 . . . . 0.0 111.946 -177.127 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 30.7 mm -114.37 -52.44 5.02 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 -179.661 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 73.5 m . . . . . 0 C--N 1.288 -2.1 0 CA-C-N 114.625 -1.171 . . . . 0.0 109.945 -179.518 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.13 0 N-CA-C 112.492 -0.243 . . . . 0.0 112.492 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 1.6 m -62.36 -21.65 65.49 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-O 120.963 0.411 . . . . 0.0 111.514 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 3.4 m -65.3 -37.34 86.84 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.155 -179.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 50.6 m -64.6 -11.8 38.69 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.37 178.792 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . 0.486 ' O ' ' HB2' ' A' ' 9' ' ' ASN . 87.5 m-70 -105.37 150.14 38.58 Favored Pre-proline 0 N--CA 1.452 -0.326 0 CA-C-N 114.922 -1.036 . . . . 0.0 110.273 179.524 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -84.49 -38.51 0.12 Allowed 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.464 2.11 . . . . 0.0 112.928 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -72.29 -44.99 61.94 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 -179.06 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 6.9 t -83.59 12.21 6.06 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.664 0.269 . . . . 0.0 111.567 -178.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . 0.486 ' HB2' ' O ' ' A' ' 5' ' ' HIS . 3.3 t-20 -90.74 -51.45 5.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.192 0.52 . . . . 0.0 111.458 -179.799 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 22.5 t -54.94 -41.69 59.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.201 -0.909 . . . . 0.0 112.598 -178.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -75.87 1.72 14.33 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 -179.042 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 15.3 m-70 -119.34 71.76 12.97 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.188 179.461 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -76.91 -10.16 18.15 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.321 2.014 . . . . 0.0 112.356 -179.855 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -93.98 -2.77 52.63 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.113 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 25.7 mm -111.8 -71.16 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-O 120.929 0.395 . . . . 0.0 111.098 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.443 ' HB2' HD22 ' A' ' 9' ' ' ASN . 33.6 m . . . . . 0 C--N 1.323 -0.559 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.041 179.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.5 -0.884 0 N-CA-C 110.818 -0.913 . . . . 0.0 110.818 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 20.7 m -62.73 -22.25 66.4 Favored 'General case' 0 N--CA 1.432 -1.366 0 N-CA-C 115.609 1.707 . . . . 0.0 115.609 -175.429 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 24.0 m -70.19 -35.42 73.92 Favored 'General case' 0 C--N 1.283 -2.317 0 C-N-CA 120.543 -0.463 . . . . 0.0 112.194 177.103 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 20.0 m -79.18 -4.38 50.19 Favored 'General case' 0 C--N 1.295 -1.764 0 CA-C-O 121.516 0.674 . . . . 0.0 110.304 177.401 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 10.6 m-70 -104.1 103.71 39.64 Favored Pre-proline 0 C--N 1.317 -0.83 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 176.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_exo -49.57 -38.58 45.16 Favored 'Trans proline' 0 CA--C 1.544 1.025 0 C-N-CA 122.736 2.291 . . . . 0.0 113.302 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -72.46 -41.91 65.55 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 -179.097 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 10.2 t -82.78 -19.99 36.72 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-O 121.742 0.782 . . . . 0.0 109.64 -175.083 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 -58.61 -41.81 86.75 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 115.036 -0.984 . . . . 0.0 109.477 179.093 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 49.1 t -62.7 -34.35 65.01 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 CA-C-N 114.09 -1.414 . . . . 0.0 111.955 -177.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -94.25 1.92 55.94 Favored 'General case' 0 C--N 1.316 -0.888 0 C-N-CA 119.199 -1.0 . . . . 0.0 112.971 -175.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 78.6 m-70 -118.73 72.37 10.91 Favored Pre-proline 0 N--CA 1.432 -1.328 0 CA-C-N 116.677 -0.238 . . . . 0.0 110.746 174.06 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -73.49 -13.76 25.04 Favored 'Trans proline' 0 C--N 1.356 0.943 0 C-N-CA 121.795 1.664 . . . . 0.0 111.411 -177.552 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.439 ' HG3' HG12 ' A' ' 15' ' ' ILE . 10.4 pt-20 -81.72 -23.48 36.71 Favored 'General case' 0 N--CA 1.421 -1.922 0 CA-C-N 114.553 -1.203 . . . . 0.0 110.896 179.267 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.439 HG12 ' HG3' ' A' ' 14' ' ' GLU . 35.7 mm -107.54 -50.98 7.54 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.067 0 CA-C-O 121.813 0.816 . . . . 0.0 108.805 -177.606 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 31.1 m -98.74 95.41 7.21 Favored 'General case' 0 C--N 1.287 -2.136 0 CA-C-N 114.318 -1.31 . . . . 0.0 109.495 -176.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.306 -1.293 0 CA-C-N 116.463 -0.335 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.501 -0.784 0 N-CA-C 110.121 -1.192 . . . . 0.0 110.121 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 9.4 m -66.69 -13.99 61.96 Favored 'General case' 0 CA--C 1.493 -1.217 0 N-CA-C 114.116 1.154 . . . . 0.0 114.116 -178.619 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 96.1 m -68.41 -35.56 77.82 Favored 'General case' 0 C--N 1.28 -2.434 0 CA-C-O 121.766 0.793 . . . . 0.0 110.971 178.111 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 19.2 m -79.72 10.9 3.55 Favored 'General case' 0 C--N 1.281 -2.408 0 CA-C-N 114.772 -1.104 . . . . 0.0 110.308 176.371 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 83.6 m-70 -130.61 95.32 26.85 Favored Pre-proline 0 N--CA 1.444 -0.736 0 C-N-CA 124.274 1.03 . . . . 0.0 109.139 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.443 ' O ' HG21 ' A' ' 10' ' ' VAL . 57.2 Cg_exo -40.87 -47.12 4.87 Favored 'Trans proline' 0 N--CA 1.484 0.969 0 C-N-CA 124.23 3.287 . . . . 0.0 114.744 -176.352 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -65.36 -40.47 93.6 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 -178.407 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 9.4 t -83.41 -20.77 33.55 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 122.143 0.973 . . . . 0.0 109.49 -174.361 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 41.2 t-20 -67.06 -41.54 86.27 Favored 'General case' 0 C--N 1.294 -1.832 0 CA-C-N 114.424 -1.262 . . . . 0.0 109.187 -178.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.443 HG21 ' O ' ' A' ' 6' ' ' PRO . 96.0 t -62.88 -41.72 93.71 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 CA-C-N 113.957 -1.474 . . . . 0.0 111.917 179.672 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -87.14 3.37 46.62 Favored 'General case' 0 C--O 1.24 0.553 0 N-CA-C 113.215 0.82 . . . . 0.0 113.215 -176.207 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 88.1 m-70 -119.09 75.1 14.38 Favored Pre-proline 0 N--CA 1.428 -1.567 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.462 171.529 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo -66.43 -24.11 50.02 Favored 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 122.472 2.115 . . . . 0.0 113.997 -174.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -93.38 -18.33 22.51 Favored 'General case' 0 N--CA 1.416 -2.145 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.449 -177.225 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 22.8 mt -100.14 -40.82 8.67 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 CA-C-O 122.013 0.911 . . . . 0.0 109.196 -178.295 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 62.5 m -125.16 -75.31 0.59 Allowed 'General case' 0 N--CA 1.406 -2.647 0 CA-C-N 114.527 -1.215 . . . . 0.0 110.261 -177.268 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.314 -0.942 0 O-C-N 122.014 -0.429 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.242 0.645 0 N-CA-C 111.117 -0.793 . . . . 0.0 111.117 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . 0.469 ' HB2' ' NE2' ' A' ' 12' ' ' HIS . 7.9 m -60.79 -18.27 54.2 Favored 'General case' 0 C--O 1.205 -1.286 0 N-CA-C 116.022 1.86 . . . . 0.0 116.022 -176.719 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 4.7 m -65.54 -28.35 69.1 Favored 'General case' 0 C--N 1.277 -2.581 0 N-CA-C 113.947 1.091 . . . . 0.0 113.947 179.021 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 50.6 m -81.6 3.83 23.74 Favored 'General case' 0 C--N 1.282 -2.367 0 CA-C-O 121.501 0.667 . . . . 0.0 110.789 174.236 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 80.1 m-70 -117.63 103.4 50.82 Favored Pre-proline 0 C--N 1.31 -1.128 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 179.01 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_exo -44.56 -43.77 14.04 Favored 'Trans proline' 0 N--CA 1.486 1.037 0 C-N-CA 123.815 3.01 . . . . 0.0 114.245 -176.343 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -72.46 -28.28 62.83 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 112.818 0.673 . . . . 0.0 112.818 -177.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 6.9 t -102.52 4.99 39.17 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-O 122.462 1.125 . . . . 0.0 108.869 -176.53 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 -77.82 -44.97 25.74 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 114.751 -1.113 . . . . 0.0 110.383 -176.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 14.6 p -62.83 -25.48 38.46 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.246 0 CA-C-N 113.823 -1.535 . . . . 0.0 112.704 -176.058 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.407 ' O ' ' HD3' ' A' ' 13' ' ' PRO . 4.8 p-10 -91.24 13.15 17.98 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 113.366 0.876 . . . . 0.0 113.366 -177.828 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . 0.469 ' NE2' ' HB2' ' A' ' 2' ' ' CYS . 36.4 m-70 -110.22 84.18 3.56 Favored Pre-proline 0 N--CA 1.444 -0.731 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 170.342 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.407 ' HD3' ' O ' ' A' ' 11' ' ' ASP . 7.8 Cg_exo -68.74 -26.67 32.54 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.468 2.112 . . . . 0.0 113.934 -173.098 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -95.16 1.62 54.85 Favored 'General case' 0 N--CA 1.409 -2.487 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.561 -177.062 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 30.9 mm -122.93 -62.64 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-O 121.778 0.799 . . . . 0.0 109.166 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 71.3 m -119.71 -88.0 0.63 Allowed 'General case' 0 C--N 1.29 -2.004 0 CA-C-N 115.065 -0.97 . . . . 0.0 111.404 -176.412 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.538 0 O-C-N 121.94 -0.475 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.494 -1.25 0 N-CA-C 110.304 -1.119 . . . . 0.0 110.304 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 3.9 m -61.37 -20.86 63.49 Favored 'General case' 0 C--O 1.2 -1.542 0 N-CA-C 114.773 1.398 . . . . 0.0 114.773 -176.354 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 83.0 m -73.51 -42.08 62.24 Favored 'General case' 0 C--N 1.285 -2.219 0 CA-C-O 121.378 0.608 . . . . 0.0 111.543 177.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 11.8 m -73.5 -13.75 61.1 Favored 'General case' 0 C--N 1.286 -2.18 0 CA-C-N 114.726 -1.125 . . . . 0.0 109.851 -179.399 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 9.7 m-70 -96.31 103.82 15.26 Favored Pre-proline 0 N--CA 1.434 -1.267 0 CA-C-N 114.499 -1.228 . . . . 0.0 108.863 175.079 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.528 ' O ' HG23 ' A' ' 10' ' ' VAL . 73.4 Cg_exo -50.46 -38.54 53.9 Favored 'Trans proline' 0 CA--C 1.534 0.505 0 C-N-CA 123.016 2.478 . . . . 0.0 113.679 -175.809 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -70.79 -40.49 72.52 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.125 0.417 . . . . 0.0 112.125 -177.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 11.2 t -83.38 -20.02 34.97 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 121.48 0.657 . . . . 0.0 109.454 -176.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -70.12 -32.8 70.99 Favored 'General case' 0 CA--C 1.501 -0.932 0 CA-C-O 121.206 0.527 . . . . 0.0 109.616 179.418 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.528 HG23 ' O ' ' A' ' 6' ' ' PRO . 89.3 t -53.94 -40.25 44.1 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.11 0 CA-C-N 114.745 -1.116 . . . . 0.0 110.918 175.302 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.475 ' C ' ' HD3' ' A' ' 13' ' ' PRO . 3.9 p30 -94.45 1.97 55.76 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.183 0.516 . . . . 0.0 111.385 179.686 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . 0.406 ' CD2' HG13 ' A' ' 15' ' ' ILE . 6.7 m80 -119.5 67.65 10.23 Favored Pre-proline 0 C--O 1.252 1.215 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.335 173.594 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.475 ' HD3' ' C ' ' A' ' 11' ' ' ASP . 3.4 Cg_exo -84.99 -22.02 2.96 Favored 'Trans proline' 0 C--N 1.357 1.017 0 C-N-CA 121.871 1.714 . . . . 0.0 111.057 -176.605 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -84.06 -11.92 55.94 Favored 'General case' 0 N--CA 1.412 -2.363 0 CA-C-N 113.784 -1.553 . . . . 0.0 109.739 179.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.406 HG13 ' CD2' ' A' ' 12' ' ' HIS . 38.2 mm -97.31 -52.52 9.08 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.36 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 -177.79 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 69.0 m -140.94 89.4 2.25 Favored 'General case' 0 N--CA 1.419 -1.976 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.446 178.397 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.307 -1.272 0 CA-C-N 116.441 -0.345 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.5 -0.885 0 N-CA-C 110.339 -1.104 . . . . 0.0 110.339 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 17.3 m -60.51 -17.33 44.81 Favored 'General case' 0 C--O 1.202 -1.438 0 N-CA-C 115.442 1.645 . . . . 0.0 115.442 -176.2 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 80.8 m -63.64 -38.98 93.19 Favored 'General case' 0 C--N 1.282 -2.351 0 CA-C-O 121.279 0.561 . . . . 0.0 112.105 175.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 17.5 m -79.08 -0.28 30.88 Favored 'General case' 0 C--N 1.281 -2.39 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.668 178.391 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 17.4 m-70 -109.68 105.35 57.09 Favored Pre-proline 0 C--N 1.307 -1.239 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 178.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -54.36 -42.04 71.21 Favored 'Trans proline' 0 CA--C 1.531 0.372 0 C-N-CA 122.301 2.001 . . . . 0.0 112.564 -178.212 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -72.27 -25.23 61.52 Favored 'General case' 0 C--O 1.212 -0.881 0 N-CA-C 112.249 0.463 . . . . 0.0 112.249 -178.227 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 11.2 t -104.22 9.44 36.11 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.908 0.861 . . . . 0.0 109.037 -178.042 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 20.1 t-20 -87.08 -50.69 6.47 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-O 121.355 0.597 . . . . 0.0 110.425 -175.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 8.3 p -58.26 -37.91 65.68 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.145 0 CA-C-N 114.499 -1.228 . . . . 0.0 113.508 -175.108 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -86.97 7.34 27.91 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 113.169 0.803 . . . . 0.0 113.169 -177.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 47.7 m-70 -116.8 73.98 6.44 Favored Pre-proline 0 N--CA 1.433 -1.309 0 O-C-N 122.084 -0.385 . . . . 0.0 111.398 173.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_exo -67.9 -25.34 38.95 Favored 'Trans proline' 0 C--N 1.365 1.441 0 C-N-CA 122.374 2.049 . . . . 0.0 109.881 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.439 ' HG3' HG13 ' A' ' 15' ' ' ILE . 4.9 pt-20 -61.89 -34.12 75.46 Favored 'General case' 0 N--CA 1.424 -1.746 0 CA-C-N 112.937 -1.938 . . . . 0.0 112.343 177.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.439 HG13 ' HG3' ' A' ' 14' ' ' GLU . 15.6 mt -108.12 -49.48 7.65 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 C-N-CA 119.608 -0.837 . . . . 0.0 109.777 -177.154 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 84.4 m -143.88 -89.72 0.12 Allowed 'General case' 0 N--CA 1.428 -1.553 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.797 -178.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.318 -0.798 0 O-C-N 121.663 -0.648 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.46 ' O ' ' HD2' ' A' ' 5' ' ' HIS . . . . . . . . 0 CA--C 1.503 -0.716 0 N-CA-C 110.061 -1.216 . . . . 0.0 110.061 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 4.9 m -65.49 -19.86 66.11 Favored 'General case' 0 CA--C 1.489 -1.377 0 N-CA-C 115.49 1.663 . . . . 0.0 115.49 -177.053 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . 0.608 ' SG ' ' HB ' ' A' ' 15' ' ' ILE . 1.6 m -68.19 -25.55 65.29 Favored 'General case' 0 C--N 1.277 -2.559 0 N-CA-C 113.439 0.903 . . . . 0.0 113.439 176.84 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 14.6 m -77.19 0.02 23.37 Favored 'General case' 0 C--N 1.284 -2.241 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.099 173.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . 0.46 ' HD2' ' O ' ' A' ' 1' ' ' GLY . 76.9 m-70 -121.59 109.8 34.22 Favored Pre-proline 0 C--N 1.325 -0.492 0 C-N-CA 123.762 0.825 . . . . 0.0 108.864 -177.338 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_exo -45.74 -49.83 10.34 Favored 'Trans proline' 0 N--CA 1.491 1.333 0 C-N-CA 123.913 3.075 . . . . 0.0 115.929 -172.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -73.55 -34.21 65.06 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 113.317 0.858 . . . . 0.0 113.317 -178.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 6.6 t -83.32 -17.56 42.04 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-O 121.896 0.855 . . . . 0.0 109.365 -176.386 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 18.6 t-20 -60.72 -39.24 87.87 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 114.918 -1.037 . . . . 0.0 109.52 177.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 67.8 t -56.93 -36.06 49.1 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 CA-C-N 113.714 -1.585 . . . . 0.0 113.33 -176.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.407 ' C ' ' HD3' ' A' ' 13' ' ' PRO . 4.7 p-10 -94.43 1.72 55.78 Favored 'General case' 0 C--N 1.312 -1.065 0 C-N-CA 118.581 -1.247 . . . . 0.0 113.449 -175.714 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 91.9 m-70 -116.21 75.23 6.02 Favored Pre-proline 0 N--CA 1.429 -1.489 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 177.538 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.493 ' HA ' ' O ' ' A' ' 16' ' ' CYS . 15.6 Cg_exo -71.43 -10.45 26.95 Favored 'Trans proline' 0 C--N 1.361 1.214 0 C-N-CA 122.396 2.064 . . . . 0.0 111.276 177.905 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.416 ' HG3' HG12 ' A' ' 15' ' ' ILE . 14.8 pt-20 -63.7 -29.24 70.49 Favored 'General case' 0 N--CA 1.434 -1.265 0 C-N-CA 124.314 1.046 . . . . 0.0 110.129 177.801 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.608 ' HB ' ' SG ' ' A' ' 3' ' ' CYS . 35.4 mm -107.85 -58.93 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.169 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 177.308 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.493 ' O ' ' HA ' ' A' ' 13' ' ' PRO . 61.4 m -107.21 92.67 4.17 Favored 'General case' 0 C--N 1.288 -2.106 0 CA-C-N 114.198 -1.364 . . . . 0.0 110.392 -177.049 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.307 -1.27 0 CA-C-N 116.336 -0.393 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.495 -1.173 0 N-CA-C 109.084 -1.607 . . . . 0.0 109.084 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 1.9 m -65.13 -24.06 67.31 Favored 'General case' 0 C--O 1.197 -1.691 0 N-CA-C 114.374 1.25 . . . . 0.0 114.374 -178.548 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 5.8 m -74.58 -32.09 62.27 Favored 'General case' 0 C--N 1.283 -2.29 0 C-N-CA 120.479 -0.488 . . . . 0.0 112.212 176.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 10.8 m -69.61 -18.67 63.63 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-O 121.857 0.837 . . . . 0.0 109.404 176.625 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 23.3 m-70 -97.51 107.51 39.61 Favored Pre-proline 0 C--N 1.318 -0.767 0 CA-C-N 114.778 -1.101 . . . . 0.0 108.85 176.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_exo -49.33 -36.81 39.08 Favored 'Trans proline' 0 CA--C 1.541 0.843 0 C-N-CA 123.429 2.752 . . . . 0.0 113.636 -178.298 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -72.1 -43.51 64.67 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 111.827 0.306 . . . . 0.0 111.827 -179.467 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 5.7 t -83.49 -10.86 58.07 Favored 'General case' 0 N--CA 1.479 0.978 0 CA-C-O 121.937 0.875 . . . . 0.0 109.815 -174.254 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 -62.31 -44.94 95.34 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 114.786 -1.097 . . . . 0.0 110.498 -179.366 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 49.1 t -61.29 -34.76 62.22 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.116 0 CA-C-N 114.037 -1.438 . . . . 0.0 112.334 -175.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -88.53 5.47 42.5 Favored 'General case' 0 C--O 1.245 0.858 0 N-CA-C 112.937 0.718 . . . . 0.0 112.937 -177.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 53.5 m-70 -119.06 72.73 12.29 Favored Pre-proline 0 N--CA 1.433 -1.288 0 C-N-CA 122.663 0.385 . . . . 0.0 110.329 172.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -75.09 -16.03 20.23 Favored 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 122.696 2.264 . . . . 0.0 112.685 -173.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -83.37 -19.55 35.87 Favored 'General case' 0 N--CA 1.419 -1.986 0 CA-C-N 115.23 -0.895 . . . . 0.0 111.219 -179.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 26.9 mt -103.14 -45.35 10.22 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.004 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 176.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 84.7 m -132.97 87.81 2.44 Favored 'General case' 0 N--CA 1.422 -1.853 0 CA-C-N 114.311 -1.313 . . . . 0.0 110.683 -179.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.3 -1.561 0 CA-C-N 116.548 -0.297 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.503 -0.69 0 N-CA-C 110.611 -0.995 . . . . 0.0 110.611 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 6.6 m -65.61 -15.91 63.2 Favored 'General case' 0 CA--C 1.491 -1.309 0 N-CA-C 114.432 1.271 . . . . 0.0 114.432 -177.339 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . 0.439 ' SG ' HG21 ' A' ' 15' ' ' ILE . 86.9 m -66.06 -34.04 77.16 Favored 'General case' 0 C--N 1.276 -2.626 0 CA-C-O 121.481 0.657 . . . . 0.0 111.889 176.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 50.5 m -80.32 3.65 20.38 Favored 'General case' 0 C--N 1.279 -2.47 0 CA-C-N 115.303 -0.862 . . . . 0.0 111.069 175.197 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 49.4 m-70 -120.95 92.68 48.54 Favored Pre-proline 0 C--N 1.314 -0.949 0 C-N-CA 124.113 0.965 . . . . 0.0 108.624 179.222 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_exo -45.97 -43.19 20.22 Favored 'Trans proline' 0 N--CA 1.486 1.053 0 C-N-CA 123.482 2.788 . . . . 0.0 113.888 -176.17 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -68.03 -24.61 65.11 Favored 'General case' 0 C--O 1.219 -0.552 0 N-CA-C 112.327 0.491 . . . . 0.0 112.327 -178.478 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 18.0 t -97.12 -20.78 17.74 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-O 122.044 0.926 . . . . 0.0 109.048 -179.656 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 45.8 t-20 -77.97 -39.44 42.47 Favored 'General case' 0 C--N 1.301 -1.512 0 CA-C-N 115.125 -0.943 . . . . 0.0 109.481 -176.183 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 11.0 p -60.08 -23.08 26.14 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.157 0 CA-C-N 114.366 -1.288 . . . . 0.0 112.205 -178.158 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -109.96 3.16 20.21 Favored 'General case' 0 CA--C 1.513 -0.443 0 C-N-CA 119.313 -0.955 . . . . 0.0 112.704 178.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 76.1 m-70 -118.95 78.25 16.18 Favored Pre-proline 0 N--CA 1.428 -1.542 0 N-CA-C 112.222 0.453 . . . . 0.0 112.222 176.022 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -75.37 -12.98 20.79 Favored 'Trans proline' 0 C--N 1.353 0.774 0 C-N-CA 122.35 2.033 . . . . 0.0 110.191 179.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -71.17 -29.63 65.43 Favored 'General case' 0 N--CA 1.415 -2.194 0 CA-C-N 113.636 -1.62 . . . . 0.0 110.045 178.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.439 HG21 ' SG ' ' A' ' 3' ' ' CYS . 32.2 mm -98.82 -54.84 6.54 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.746 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 -178.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 70.5 m -132.47 -84.7 0.48 Allowed 'General case' 0 N--CA 1.43 -1.445 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.22 176.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.311 -1.09 0 O-C-N 121.721 -0.612 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.506 -0.473 0 N-CA-C 110.413 -1.075 . . . . 0.0 110.413 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 3.4 m -62.69 -19.33 63.78 Favored 'General case' 0 C--O 1.21 -1.0 0 N-CA-C 114.666 1.358 . . . . 0.0 114.666 -177.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . 0.451 ' SG ' HG22 ' A' ' 15' ' ' ILE . 52.6 m -70.59 -33.1 70.7 Favored 'General case' 0 C--N 1.281 -2.398 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 177.605 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 18.8 m -81.3 -2.64 49.83 Favored 'General case' 0 C--N 1.284 -2.266 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.015 175.456 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 17.4 m-70 -107.43 101.3 38.53 Favored Pre-proline 0 C--N 1.313 -1.0 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.157 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 99.1 Cg_exo -45.56 -44.65 16.96 Favored 'Trans proline' 0 N--CA 1.478 0.615 0 C-N-CA 123.927 3.085 . . . . 0.0 114.408 -175.536 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -72.48 -37.53 68.42 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 112.257 0.465 . . . . 0.0 112.257 -177.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 14.0 t -83.13 -19.97 35.67 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.736 0.779 . . . . 0.0 109.573 -174.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -64.12 -45.09 90.1 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.963 -179.515 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 57.7 t -62.06 -39.45 83.84 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.012 0 CA-C-N 114.211 -1.359 . . . . 0.0 112.542 -175.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -86.41 1.37 51.54 Favored 'General case' 0 CA--C 1.512 -0.508 0 C-N-CA 120.079 -0.649 . . . . 0.0 112.647 -177.394 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 83.3 m-70 -118.68 73.02 11.23 Favored Pre-proline 0 N--CA 1.425 -1.684 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 172.557 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_exo -71.28 -25.52 21.84 Favored 'Trans proline' 0 C--N 1.353 0.813 0 C-N-CA 122.393 2.062 . . . . 0.0 111.561 -175.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -73.8 -26.13 60.47 Favored 'General case' 0 N--CA 1.419 -2.002 0 CA-C-N 114.282 -1.326 . . . . 0.0 110.999 179.56 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.451 HG22 ' SG ' ' A' ' 3' ' ' CYS . 46.2 mt -94.22 -48.36 13.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 178.603 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 32.8 m -138.54 -74.93 0.39 Allowed 'General case' 0 N--CA 1.423 -1.816 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.742 179.046 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.315 -0.934 0 O-C-N 122.206 -0.309 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.493 -1.29 0 N-CA-C 110.249 -1.14 . . . . 0.0 110.249 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 1.7 m -61.56 -34.26 75.27 Favored 'General case' 0 CA--C 1.487 -1.473 0 N-CA-C 114.258 1.207 . . . . 0.0 114.258 -178.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . 0.425 ' SG ' ' HB ' ' A' ' 15' ' ' ILE . 1.6 m -71.0 -22.78 62.12 Favored 'General case' 0 C--N 1.28 -2.439 0 N-CA-C 113.711 1.004 . . . . 0.0 113.711 178.671 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 16.3 m -72.52 -12.45 61.08 Favored 'General case' 0 C--N 1.287 -2.146 0 CA-C-O 121.293 0.568 . . . . 0.0 110.013 173.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 40.0 m-70 -109.08 122.38 40.02 Favored Pre-proline 0 C--N 1.319 -0.72 0 C-N-CA 123.661 0.784 . . . . 0.0 109.221 178.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -55.55 -33.03 85.24 Favored 'Trans proline' 0 CA--C 1.542 0.921 0 C-N-CA 122.839 2.359 . . . . 0.0 113.825 -177.315 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -72.71 -47.19 49.23 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 112.411 0.523 . . . . 0.0 112.411 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.447 ' HA ' ' OD1' ' A' ' 11' ' ' ASP . 3.9 t -83.24 -14.5 53.11 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-O 121.664 0.745 . . . . 0.0 110.206 -173.168 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 20.1 t-20 -59.75 -42.23 92.76 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 115.334 -0.848 . . . . 0.0 109.838 178.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 47.5 t -62.72 -41.28 91.76 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.993 0 CA-C-N 113.847 -1.524 . . . . 0.0 111.684 -177.277 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.447 ' OD1' ' HA ' ' A' ' 8' ' ' CYS . 5.3 p-10 -88.84 14.74 9.66 Favored 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 113.127 0.788 . . . . 0.0 113.127 -176.672 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 18.3 m-70 -118.57 79.53 16.04 Favored Pre-proline 0 N--CA 1.432 -1.343 0 N-CA-C 111.701 0.26 . . . . 0.0 111.701 173.07 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -66.7 -27.23 45.12 Favored 'Trans proline' 0 C--N 1.359 1.107 0 C-N-CA 123.029 2.486 . . . . 0.0 110.95 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.414 ' HG3' HG12 ' A' ' 15' ' ' ILE . 11.0 pt-20 -71.45 -21.35 61.97 Favored 'General case' 0 N--CA 1.419 -2.009 0 CA-C-N 113.729 -1.578 . . . . 0.0 111.853 -178.552 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.425 ' HB ' ' SG ' ' A' ' 3' ' ' CYS . 30.9 mm -112.24 -49.94 5.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 121.462 0.648 . . . . 0.0 109.54 -178.621 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 84.1 m -124.58 -79.4 0.61 Allowed 'General case' 0 N--CA 1.425 -1.708 0 CA-C-N 115.093 -0.958 . . . . 0.0 111.251 -176.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.499 0 O-C-N 122.055 -0.403 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.508 -0.377 0 N-CA-C 111.458 -0.657 . . . . 0.0 111.458 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 32.2 m -60.53 -17.82 48.22 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 116.18 1.918 . . . . 0.0 116.18 -175.678 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 79.6 m -67.05 -33.74 76.16 Favored 'General case' 0 C--N 1.273 -2.748 0 N-CA-C 112.891 0.7 . . . . 0.0 112.891 -179.218 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 24.8 p -86.28 12.6 9.6 Favored 'General case' 0 C--N 1.278 -2.53 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.873 176.399 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 33.7 m-70 -124.35 103.07 32.73 Favored Pre-proline 0 C--N 1.317 -0.822 0 C-N-CA 124.124 0.97 . . . . 0.0 109.036 -178.261 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_exo -47.46 -45.21 23.46 Favored 'Trans proline' 0 N--CA 1.474 0.349 0 C-N-CA 123.656 2.904 . . . . 0.0 114.186 -176.24 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -68.17 -41.15 81.95 Favored 'General case' 0 C--N 1.317 -0.824 0 C-N-CA 121.337 -0.145 . . . . 0.0 111.282 -177.286 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 8.4 t -83.62 -16.87 43.56 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 121.808 0.813 . . . . 0.0 110.097 -175.694 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 -66.34 -38.25 87.21 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-O 121.751 0.786 . . . . 0.0 108.965 179.526 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 97.4 t -60.62 -46.45 95.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 114.011 -1.45 . . . . 0.0 112.679 -178.087 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.418 ' C ' ' HD3' ' A' ' 13' ' ' PRO . 7.5 p-10 -87.01 1.86 51.44 Favored 'General case' 0 CA--C 1.513 -0.45 0 N-CA-C 113.485 0.92 . . . . 0.0 113.485 -173.863 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . 0.516 ' HB3' ' HB ' ' A' ' 15' ' ' ILE . 89.3 m-70 -116.39 73.0 5.3 Favored Pre-proline 0 N--CA 1.429 -1.479 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 172.318 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.418 ' HD3' ' C ' ' A' ' 11' ' ' ASP . 21.4 Cg_exo -64.95 -27.44 58.4 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 123.079 2.52 . . . . 0.0 114.17 -173.166 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -95.86 -22.06 17.7 Favored 'General case' 0 N--CA 1.408 -2.535 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.209 -178.049 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.516 ' HB ' ' HB3' ' A' ' 12' ' ' HIS . 37.2 mm -89.99 -45.2 15.11 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.665 0 CA-C-O 121.94 0.876 . . . . 0.0 108.66 -177.26 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 62.6 m -116.65 -77.82 0.57 Allowed 'General case' 0 N--CA 1.413 -2.316 0 CA-C-N 114.508 -1.224 . . . . 0.0 110.259 -177.7 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.326 -0.449 0 O-C-N 122.004 -0.435 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.496 -1.103 0 N-CA-C 110.912 -0.875 . . . . 0.0 110.912 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . 0.421 ' HA ' ' HB2' ' A' ' 5' ' ' HIS . 19.7 m -66.01 -17.08 64.45 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 115.168 1.544 . . . . 0.0 115.168 -176.334 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 58.4 m -63.15 -31.63 72.81 Favored 'General case' 0 C--N 1.281 -2.373 0 N-CA-C 113.172 0.804 . . . . 0.0 113.172 177.712 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 5.3 p -99.17 18.59 17.1 Favored 'General case' 0 C--N 1.279 -2.487 0 CA-C-O 121.848 0.832 . . . . 0.0 110.118 175.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . 0.452 ' O ' ' HB2' ' A' ' 9' ' ' ASN . 67.5 m170 -122.01 93.79 48.43 Favored Pre-proline 0 C--N 1.312 -1.038 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 178.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -49.79 -48.68 18.39 Favored 'Trans proline' 0 N--CA 1.484 0.949 0 C-N-CA 123.35 2.7 . . . . 0.0 114.447 -173.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -71.34 -19.66 62.27 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.81 -177.113 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 20.8 t -95.07 -22.41 17.92 Favored 'General case' 0 C--O 1.208 -1.128 0 C-N-CA 120.087 -0.645 . . . . 0.0 109.67 179.415 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.452 ' HB2' ' O ' ' A' ' 5' ' ' HIS . 57.3 t30 -85.07 -29.38 24.95 Favored 'General case' 0 C--N 1.28 -2.441 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.93 -167.868 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 7.3 p -56.01 -31.62 31.45 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.126 0 CA-C-N 115.082 -0.963 . . . . 0.0 111.652 178.208 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -97.85 12.56 33.59 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-O 120.894 0.378 . . . . 0.0 111.569 179.425 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 48.4 m80 -116.94 71.93 5.72 Favored Pre-proline 0 N--CA 1.44 -0.935 0 C-N-CA 122.767 0.427 . . . . 0.0 110.166 174.592 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo -72.56 -32.72 9.42 Favored 'Trans proline' 0 C--N 1.356 0.944 0 C-N-CA 122.844 2.363 . . . . 0.0 113.761 -172.593 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -92.4 5.27 51.31 Favored 'General case' 0 N--CA 1.411 -2.376 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.594 -178.549 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 37.2 mm -105.33 -65.93 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.952 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 177.565 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 69.2 m -135.56 88.65 2.43 Favored 'General case' 0 C--N 1.288 -2.096 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.458 179.575 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.31 -1.15 0 CA-C-N 116.245 -0.434 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.417 ' O ' ' HD2' ' A' ' 5' ' ' HIS . . . . . . . . 0 CA--C 1.495 -1.177 0 N-CA-C 110.156 -1.178 . . . . 0.0 110.156 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 14.2 m -68.53 -22.84 64.49 Favored 'General case' 0 N--CA 1.428 -1.528 0 N-CA-C 114.041 1.126 . . . . 0.0 114.041 -177.671 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 65.0 m -75.12 -28.02 60.04 Favored 'General case' 0 C--N 1.294 -1.833 0 CA-C-O 121.697 0.761 . . . . 0.0 111.555 176.411 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 4.1 m -71.54 0.97 7.25 Favored 'General case' 0 C--N 1.297 -1.678 0 CA-C-N 114.495 -1.23 . . . . 0.0 109.781 174.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . 0.447 ' O ' ' HB2' ' A' ' 9' ' ' ASN . 30.7 m-70 -125.91 147.96 60.89 Favored Pre-proline 0 N--CA 1.438 -1.075 0 C-N-CA 124.804 1.241 . . . . 0.0 107.895 178.498 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -77.44 -41.67 0.33 Allowed 'Trans proline' 0 CA--C 1.548 1.217 0 C-N-CA 121.652 1.568 . . . . 0.0 112.865 175.679 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -72.08 -39.86 68.66 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 113.332 0.864 . . . . 0.0 113.332 -174.159 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 10.1 t -87.12 4.21 43.18 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-O 121.932 0.872 . . . . 0.0 109.787 -178.662 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.447 ' HB2' ' O ' ' A' ' 5' ' ' HIS . 9.7 t-20 -79.19 -39.78 32.48 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-O 121.702 0.763 . . . . 0.0 109.364 -177.218 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 14.9 p -71.05 -30.59 41.81 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-N 114.46 -1.245 . . . . 0.0 112.752 -174.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -87.92 3.43 48.58 Favored 'General case' 0 C--N 1.317 -0.81 0 C-N-CA 119.037 -1.065 . . . . 0.0 112.457 -179.28 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 83.8 m-70 -118.67 73.12 11.27 Favored Pre-proline 0 N--CA 1.425 -1.682 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 172.208 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo -72.94 -31.22 10.22 Favored 'Trans proline' 0 C--N 1.359 1.109 0 C-N-CA 122.768 2.312 . . . . 0.0 112.257 -173.446 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -77.51 -10.16 59.33 Favored 'General case' 0 N--CA 1.419 -1.975 0 CA-C-N 114.394 -1.276 . . . . 0.0 111.391 -179.311 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 37.8 mm -104.06 -57.63 4.36 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.007 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 177.496 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 91.7 m -131.4 -83.26 0.52 Allowed 'General case' 0 N--CA 1.426 -1.672 0 CA-C-N 115.074 -0.966 . . . . 0.0 110.761 178.449 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.323 -0.559 0 O-C-N 121.723 -0.611 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.499 -0.919 0 N-CA-C 109.969 -1.253 . . . . 0.0 109.969 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 1.7 m -64.94 -23.2 67.15 Favored 'General case' 0 C--O 1.189 -2.089 0 N-CA-C 113.438 0.903 . . . . 0.0 113.438 179.375 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 19.4 m -77.0 -29.7 55.58 Favored 'General case' 0 C--N 1.277 -2.582 0 CA-C-O 121.213 0.53 . . . . 0.0 112.095 175.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 2.7 m -67.44 -28.49 67.93 Favored 'General case' 0 C--N 1.286 -2.16 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 175.016 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 32.7 m170 -91.04 113.23 57.49 Favored Pre-proline 0 C--N 1.318 -0.8 0 CA-C-N 114.877 -1.056 . . . . 0.0 110.0 -179.674 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_endo -51.62 -40.97 63.4 Favored 'Trans proline' 0 CA--C 1.539 0.73 0 C-N-CA 123.13 2.553 . . . . 0.0 113.956 -177.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -72.41 -39.98 67.52 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 -177.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 11.0 t -83.48 -19.83 35.1 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.451 0.644 . . . . 0.0 110.118 -174.506 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 18.4 t-20 -54.08 -44.34 71.09 Favored 'General case' 0 C--N 1.321 -0.673 0 C-N-CA 124.735 1.214 . . . . 0.0 111.162 -178.122 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 36.0 t -62.89 -38.32 81.57 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.184 0 CA-C-N 114.085 -1.416 . . . . 0.0 112.502 -175.072 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.405 ' O ' ' HD3' ' A' ' 13' ' ' PRO . 5.4 p-10 -90.22 13.93 13.94 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 119.795 -0.762 . . . . 0.0 112.93 -176.879 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 22.8 m-70 -114.35 79.17 5.07 Favored Pre-proline 0 N--CA 1.431 -1.425 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 171.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.405 ' HD3' ' O ' ' A' ' 11' ' ' ASP . 5.4 Cg_exo -72.31 -27.84 15.86 Favored 'Trans proline' 0 C--N 1.358 1.036 0 C-N-CA 123.36 2.706 . . . . 0.0 112.923 -172.015 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -84.05 -11.46 56.69 Favored 'General case' 0 C--N 1.291 -1.947 0 CA-C-N 115.139 -0.937 . . . . 0.0 111.505 -178.394 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 27.5 mm -107.91 -52.84 6.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 -179.344 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 97.5 m -129.04 -81.69 0.57 Allowed 'General case' 0 N--CA 1.426 -1.641 0 CA-C-N 114.979 -1.009 . . . . 0.0 111.433 -179.088 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.323 -0.571 0 O-C-N 121.809 -0.557 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.502 -0.762 0 N-CA-C 110.801 -0.92 . . . . 0.0 110.801 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 16.5 m -67.48 -16.27 64.12 Favored 'General case' 0 N--CA 1.435 -1.216 0 N-CA-C 114.765 1.394 . . . . 0.0 114.765 -176.747 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 65.0 m -67.73 -33.98 75.95 Favored 'General case' 0 C--N 1.279 -2.471 0 CA-C-O 121.193 0.521 . . . . 0.0 111.148 176.475 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 20.7 m -85.85 14.53 5.86 Favored 'General case' 0 C--N 1.294 -1.81 0 CA-C-N 115.256 -0.884 . . . . 0.0 110.301 176.037 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 25.0 m-70 -130.76 94.79 27.86 Favored Pre-proline 0 C--N 1.318 -0.785 0 C-N-CA 124.425 1.09 . . . . 0.0 109.727 -178.453 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_exo -48.88 -48.86 16.59 Favored 'Trans proline' 0 N--CA 1.481 0.77 0 C-N-CA 123.537 2.825 . . . . 0.0 113.913 -176.306 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -64.85 -32.63 74.42 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 111.847 0.314 . . . . 0.0 111.847 -178.478 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 34.1 t -84.4 -20.76 31.36 Favored 'General case' 0 C--O 1.203 -1.357 0 CA-C-O 121.601 0.715 . . . . 0.0 109.436 179.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 45.6 t-20 -82.73 -48.08 11.26 Favored 'General case' 0 C--N 1.288 -2.105 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.646 -173.321 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 11.8 p -54.04 -39.15 40.17 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.206 0 CA-C-N 114.873 -1.058 . . . . 0.0 113.775 -175.045 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -99.94 5.86 45.23 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 118.557 -1.257 . . . . 0.0 111.905 -179.224 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 31.7 m-70 -118.62 76.88 13.84 Favored Pre-proline 0 N--CA 1.438 -1.067 0 N-CA-C 112.789 0.662 . . . . 0.0 112.789 177.174 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_exo -72.56 -21.03 22.79 Favored 'Trans proline' 0 N--CA 1.462 -0.374 0 C-N-CA 121.985 1.79 . . . . 0.0 110.503 178.513 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -74.89 -22.95 58.35 Favored 'General case' 0 N--CA 1.428 -1.556 0 CA-C-N 114.371 -1.286 . . . . 0.0 110.382 179.52 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 50.3 mm -99.8 -50.01 10.96 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.805 0 N-CA-C 108.644 -0.872 . . . . 0.0 108.644 -179.421 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 63.6 m -129.52 -86.58 0.54 Allowed 'General case' 0 N--CA 1.417 -2.101 0 CA-C-N 114.896 -1.047 . . . . 0.0 110.319 -179.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.321 -0.655 0 O-C-N 121.665 -0.647 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.807 0 N-CA-C 111.51 -0.636 . . . . 0.0 111.51 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 6.1 m -65.76 -17.97 65.0 Favored 'General case' 0 CA--C 1.491 -1.292 0 N-CA-C 114.747 1.388 . . . . 0.0 114.747 -177.403 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 30.2 m -65.64 -32.86 74.66 Favored 'General case' 0 C--N 1.283 -2.293 0 CA-C-O 121.021 0.439 . . . . 0.0 111.912 177.026 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 19.1 m -82.28 11.61 5.25 Favored 'General case' 0 C--N 1.287 -2.134 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.374 176.06 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 45.2 m-70 -124.56 111.45 27.85 Favored Pre-proline 0 C--N 1.313 -0.983 0 C-N-CA 123.817 0.847 . . . . 0.0 109.361 179.533 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -49.21 -49.31 15.75 Favored 'Trans proline' 0 CA--C 1.539 0.741 0 C-N-CA 123.462 2.774 . . . . 0.0 114.691 -174.485 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -72.75 -37.21 67.75 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 112.621 0.6 . . . . 0.0 112.621 -177.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.485 ' O ' ' HD2' ' A' ' 12' ' ' HIS . 7.3 t -81.65 -19.9 40.76 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 122.019 0.914 . . . . 0.0 108.833 -174.784 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -62.09 -44.19 97.2 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-N 114.837 -1.074 . . . . 0.0 109.704 177.682 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 49.5 t -65.28 -41.96 92.7 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 CA-C-N 113.953 -1.476 . . . . 0.0 111.796 -176.038 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.417 ' OD1' ' HA ' ' A' ' 8' ' ' CYS . 4.5 p-10 -84.9 3.92 35.85 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 113.316 0.858 . . . . 0.0 113.316 -175.283 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . 0.485 ' HD2' ' O ' ' A' ' 8' ' ' CYS . 66.3 m-70 -113.72 77.34 3.41 Favored Pre-proline 0 N--CA 1.434 -1.245 0 N-CA-C 109.924 -0.399 . . . . 0.0 109.924 172.462 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_exo -66.54 -32.33 39.52 Favored 'Trans proline' 0 C--N 1.355 0.899 0 C-N-CA 122.728 2.286 . . . . 0.0 112.47 -174.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -79.69 -22.69 43.09 Favored 'General case' 0 C--N 1.289 -2.057 0 CA-C-N 114.53 -1.214 . . . . 0.0 111.845 -178.1 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.409 ' HB ' ' HB3' ' A' ' 12' ' ' HIS . 41.2 mm -100.92 -58.71 3.72 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 CA-C-O 121.813 0.816 . . . . 0.0 109.337 -176.757 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 36.8 m -97.78 -71.92 0.67 Allowed 'General case' 0 C--N 1.281 -2.403 0 CA-C-N 114.707 -1.133 . . . . 0.0 110.319 -175.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.321 -0.673 0 O-C-N 122.311 -0.243 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.573 0 N-CA-C 111.958 -0.457 . . . . 0.0 111.958 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 31.1 m -60.84 -22.04 63.81 Favored 'General case' 0 N--CA 1.438 -1.061 0 N-CA-C 116.358 1.985 . . . . 0.0 116.358 -174.041 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 67.2 m -71.95 -35.91 69.71 Favored 'General case' 0 C--N 1.278 -2.53 0 C-N-CA 120.542 -0.463 . . . . 0.0 112.149 179.247 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 38.4 t -83.64 1.26 43.24 Favored 'General case' 0 C--N 1.281 -2.386 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.931 177.225 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 39.9 m170 -110.32 111.19 57.85 Favored Pre-proline 0 C--N 1.311 -1.092 0 C-N-CA 123.504 0.721 . . . . 0.0 109.901 -177.788 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.482 ' O ' HG21 ' A' ' 10' ' ' VAL . 52.9 Cg_exo -51.5 -49.62 16.59 Favored 'Trans proline' 0 CA--C 1.542 0.915 0 C-N-CA 123.16 2.573 . . . . 0.0 115.033 -172.587 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -73.09 -33.12 65.42 Favored 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 112.6 0.593 . . . . 0.0 112.6 -176.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.514 ' HA ' ' OD2' ' A' ' 11' ' ' ASP . 8.9 t -82.75 -20.33 36.14 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 122.07 0.938 . . . . 0.0 108.906 -177.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 -66.21 -40.93 90.71 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 115.057 -0.974 . . . . 0.0 108.484 177.23 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.482 HG21 ' O ' ' A' ' 6' ' ' PRO . 84.3 t -62.34 -36.24 73.62 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 CA-C-N 114.458 -1.247 . . . . 0.0 111.417 -179.921 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.514 ' OD2' ' HA ' ' A' ' 8' ' ' CYS . 3.3 p30 -87.84 0.74 55.42 Favored 'General case' 0 C--N 1.321 -0.664 0 C-N-CA 119.518 -0.873 . . . . 0.0 111.196 179.625 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . 0.492 ' HB3' ' HB ' ' A' ' 15' ' ' ILE . 1.0 OUTLIER -118.58 70.59 9.26 Favored Pre-proline 0 C--N 1.312 -1.038 0 C-N-CA 123.071 0.548 . . . . 0.0 110.248 175.378 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -79.19 -17.98 11.43 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 121.696 1.597 . . . . 0.0 111.799 -176.337 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -100.92 0.15 37.84 Favored 'General case' 0 N--CA 1.41 -2.441 0 CA-C-N 114.721 -1.127 . . . . 0.0 111.182 -178.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.492 ' HB ' ' HB3' ' A' ' 12' ' ' HIS . 25.3 mm -114.65 -54.95 4.52 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.949 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 -179.797 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 21.6 m -103.9 93.41 4.86 Favored 'General case' 0 C--N 1.284 -2.261 0 CA-C-N 114.089 -1.414 . . . . 0.0 110.077 -174.095 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.31 -1.15 0 CA-C-N 116.39 -0.368 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.946 0 N-CA-C 112.209 -0.357 . . . . 0.0 112.209 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 4.0 m -64.99 -19.95 66.25 Favored 'General case' 0 N--CA 1.433 -1.305 0 N-CA-C 114.158 1.17 . . . . 0.0 114.158 -179.218 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 20.0 m -68.06 -30.81 70.1 Favored 'General case' 0 C--N 1.28 -2.415 0 N-CA-C 112.98 0.733 . . . . 0.0 112.98 178.819 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 16.6 m -72.84 -0.53 13.7 Favored 'General case' 0 C--N 1.291 -1.951 0 CA-C-O 121.369 0.604 . . . . 0.0 110.533 175.742 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 67.7 m-70 -125.98 104.21 26.56 Favored Pre-proline 0 C--O 1.216 -0.676 0 C-N-CA 124.322 1.049 . . . . 0.0 108.952 -178.25 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -50.21 -35.19 42.34 Favored 'Trans proline' 0 N--CA 1.483 0.89 0 C-N-CA 123.229 2.619 . . . . 0.0 113.83 -177.217 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -68.98 -32.93 72.85 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 111.577 0.214 . . . . 0.0 111.577 -179.015 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.426 ' HA ' ' OD1' ' A' ' 11' ' ' ASP . 6.4 t -97.11 -18.62 19.22 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.933 0.873 . . . . 0.0 109.593 -177.78 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 19.9 t-20 -60.13 -45.16 93.96 Favored 'General case' 0 C--N 1.314 -0.948 0 C-N-CA 124.21 1.004 . . . . 0.0 110.481 -178.808 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 12.3 p -66.66 -30.56 50.1 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.003 0 CA-C-N 114.156 -1.384 . . . . 0.0 112.322 -176.823 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.426 ' OD1' ' HA ' ' A' ' 8' ' ' CYS 0.252 7.0 p-10 -90.8 5.21 49.32 Favored 'General case' 0 C--O 1.24 0.557 0 C-N-CA 119.649 -0.82 . . . . 0.0 112.137 -179.871 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 57.3 m-70 -119.38 72.01 13.45 Favored Pre-proline 0 N--CA 1.431 -1.42 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.702 168.719 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -77.77 -12.02 16.63 Favored 'Trans proline' 0 C--N 1.354 0.856 0 C-N-CA 122.522 2.148 . . . . 0.0 111.955 -176.437 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -80.01 -20.85 44.44 Favored 'General case' 0 N--CA 1.416 -2.125 0 CA-C-N 114.907 -1.042 . . . . 0.0 110.393 177.528 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 38.5 mt -103.37 -54.41 6.58 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.04 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 177.257 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 91.1 m -122.16 -94.65 0.49 Allowed 'General case' 0 N--CA 1.415 -2.212 0 CA-C-N 114.702 -1.136 . . . . 0.0 110.522 178.437 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.322 -0.612 0 O-C-N 121.912 -0.492 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.503 -0.666 0 N-CA-C 110.358 -1.097 . . . . 0.0 110.358 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . 0.437 ' HB3' ' O ' ' A' ' 8' ' ' CYS . 8.0 m -72.1 -22.91 61.28 Favored 'General case' 0 N--CA 1.428 -1.536 0 N-CA-C 113.265 0.839 . . . . 0.0 113.265 -178.745 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 1.8 m -74.55 -24.56 58.95 Favored 'General case' 0 C--N 1.294 -1.841 0 CA-C-O 121.205 0.526 . . . . 0.0 111.148 173.792 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 4.0 m -69.77 -26.28 64.21 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 173.638 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . 0.541 ' O ' ' HB2' ' A' ' 9' ' ' ASN . 30.5 m80 -90.38 156.2 45.91 Favored Pre-proline 0 N--CA 1.446 -0.666 0 CA-C-N 114.703 -1.135 . . . . 0.0 109.957 178.946 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -84.47 -49.49 0.04 OUTLIER 'Trans proline' 0 CA--C 1.549 1.231 0 C-N-CA 122.03 1.82 . . . . 0.0 114.196 178.59 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -73.26 -38.03 66.11 Favored 'General case' 0 C--N 1.32 -0.706 0 O-C-N 121.703 -0.623 . . . . 0.0 112.299 -177.25 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.437 ' O ' ' HB3' ' A' ' 2' ' ' CYS . 5.9 t -83.3 0.67 44.69 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 122.098 0.951 . . . . 0.0 109.45 -176.837 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.541 ' HB2' ' O ' ' A' ' 5' ' ' HIS . 19.6 t-20 -74.39 -41.19 61.37 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 114.962 -1.017 . . . . 0.0 108.739 -179.73 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 62.1 t -58.82 -35.24 55.05 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-N 113.279 -1.782 . . . . 0.0 112.679 -176.381 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.513 ' O ' ' HD3' ' A' ' 13' ' ' PRO 0.276 7.1 p-10 -82.62 6.35 18.03 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 113.863 1.06 . . . . 0.0 113.863 -177.865 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 23.5 m-70 -109.75 74.18 0.72 Allowed Pre-proline 0 N--CA 1.441 -0.886 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 168.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.513 ' HD3' ' O ' ' A' ' 11' ' ' ASP . 13.6 Cg_exo -66.82 -35.99 25.37 Favored 'Trans proline' 0 CA--C 1.501 -1.14 0 C-N-CA 122.756 2.304 . . . . 0.0 113.439 -168.489 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -86.85 -1.03 57.47 Favored 'General case' 0 C--N 1.282 -2.334 0 CA-C-N 114.926 -1.033 . . . . 0.0 111.946 -177.127 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 30.7 mm -114.37 -52.44 5.02 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 -179.661 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 73.5 m -128.24 87.52 2.61 Favored 'General case' 0 C--N 1.288 -2.1 0 CA-C-N 114.625 -1.171 . . . . 0.0 109.945 -179.518 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.304 -1.389 0 CA-C-N 116.223 -0.444 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.13 0 N-CA-C 112.492 -0.243 . . . . 0.0 112.492 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 1.6 m -62.36 -21.65 65.49 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-O 120.963 0.411 . . . . 0.0 111.514 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 3.4 m -65.3 -37.34 86.84 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.155 -179.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 50.6 m -64.6 -11.8 38.69 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.37 178.792 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . 0.486 ' O ' ' HB2' ' A' ' 9' ' ' ASN . 87.5 m-70 -105.37 150.14 38.58 Favored Pre-proline 0 N--CA 1.452 -0.326 0 CA-C-N 114.922 -1.036 . . . . 0.0 110.273 179.524 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -84.49 -38.51 0.12 Allowed 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.464 2.11 . . . . 0.0 112.928 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -72.29 -44.99 61.94 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 -179.06 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 6.9 t -83.59 12.21 6.06 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.664 0.269 . . . . 0.0 111.567 -178.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.486 ' HB2' ' O ' ' A' ' 5' ' ' HIS . 3.3 t-20 -90.74 -51.45 5.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.192 0.52 . . . . 0.0 111.458 -179.799 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 22.5 t -54.94 -41.69 59.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.201 -0.909 . . . . 0.0 112.598 -178.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -75.87 1.72 14.33 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 -179.042 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 15.3 m-70 -119.34 71.76 12.97 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.188 179.461 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -76.91 -10.16 18.15 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.321 2.014 . . . . 0.0 112.356 -179.855 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -93.98 -2.77 52.63 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.113 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 25.7 mm -111.8 -71.16 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-O 120.929 0.395 . . . . 0.0 111.098 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.443 ' HB2' HD22 ' A' ' 9' ' ' ASN . 33.6 m -105.23 -77.7 0.58 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.041 179.769 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 116.526 -0.306 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.5 -0.884 0 N-CA-C 110.818 -0.913 . . . . 0.0 110.818 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 20.7 m -62.73 -22.25 66.4 Favored 'General case' 0 N--CA 1.432 -1.366 0 N-CA-C 115.609 1.707 . . . . 0.0 115.609 -175.429 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 24.0 m -70.19 -35.42 73.92 Favored 'General case' 0 C--N 1.283 -2.317 0 C-N-CA 120.543 -0.463 . . . . 0.0 112.194 177.103 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 20.0 m -79.18 -4.38 50.19 Favored 'General case' 0 C--N 1.295 -1.764 0 CA-C-O 121.516 0.674 . . . . 0.0 110.304 177.401 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 10.6 m-70 -104.1 103.71 39.64 Favored Pre-proline 0 C--N 1.317 -0.83 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 176.786 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_exo -49.57 -38.58 45.16 Favored 'Trans proline' 0 CA--C 1.544 1.025 0 C-N-CA 122.736 2.291 . . . . 0.0 113.302 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -72.46 -41.91 65.55 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 -179.097 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 10.2 t -82.78 -19.99 36.72 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-O 121.742 0.782 . . . . 0.0 109.64 -175.083 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -58.61 -41.81 86.75 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 115.036 -0.984 . . . . 0.0 109.477 179.093 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 49.1 t -62.7 -34.35 65.01 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 CA-C-N 114.09 -1.414 . . . . 0.0 111.955 -177.724 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -94.25 1.92 55.94 Favored 'General case' 0 C--N 1.316 -0.888 0 C-N-CA 119.199 -1.0 . . . . 0.0 112.971 -175.686 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 66.4 m80 -118.73 72.37 10.91 Favored Pre-proline 0 N--CA 1.432 -1.328 0 CA-C-N 116.677 -0.238 . . . . 0.0 110.746 174.06 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -73.49 -13.76 25.04 Favored 'Trans proline' 0 C--N 1.356 0.943 0 C-N-CA 121.795 1.664 . . . . 0.0 111.411 -177.552 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.493 ' HG3' HG12 ' A' ' 15' ' ' ILE . 10.4 pt-20 -81.72 -23.48 36.71 Favored 'General case' 0 N--CA 1.421 -1.922 0 CA-C-N 114.553 -1.203 . . . . 0.0 110.896 179.267 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.493 HG12 ' HG3' ' A' ' 14' ' ' GLU . 35.7 mm -107.54 -50.98 7.54 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.067 0 CA-C-O 121.813 0.816 . . . . 0.0 108.805 -177.606 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 31.1 m . . . . . 0 C--N 1.287 -2.136 0 CA-C-N 114.318 -1.31 . . . . 0.0 109.495 -176.864 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.501 -0.784 0 N-CA-C 110.121 -1.192 . . . . 0.0 110.121 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 9.4 m -66.69 -13.99 61.96 Favored 'General case' 0 CA--C 1.493 -1.217 0 N-CA-C 114.116 1.154 . . . . 0.0 114.116 -178.619 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 96.1 m -68.41 -35.56 77.82 Favored 'General case' 0 C--N 1.28 -2.434 0 CA-C-O 121.766 0.793 . . . . 0.0 110.971 178.111 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 19.2 m -79.72 10.9 3.55 Favored 'General case' 0 C--N 1.281 -2.408 0 CA-C-N 114.772 -1.104 . . . . 0.0 110.308 176.371 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 72.0 m80 -130.61 95.32 26.85 Favored Pre-proline 0 N--CA 1.444 -0.736 0 C-N-CA 124.274 1.03 . . . . 0.0 109.139 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.454 ' O ' HG23 ' A' ' 10' ' ' VAL . 57.2 Cg_exo -40.87 -47.12 4.87 Favored 'Trans proline' 0 N--CA 1.484 0.969 0 C-N-CA 124.23 3.287 . . . . 0.0 114.744 -176.352 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -65.36 -40.47 93.6 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 -178.407 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 9.4 t -83.41 -20.77 33.55 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 122.143 0.973 . . . . 0.0 109.49 -174.361 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 41.2 t-20 -67.06 -41.54 86.27 Favored 'General case' 0 C--N 1.294 -1.832 0 CA-C-N 114.424 -1.262 . . . . 0.0 109.187 -178.967 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.454 HG23 ' O ' ' A' ' 6' ' ' PRO . 96.0 t -62.88 -41.72 93.71 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 CA-C-N 113.957 -1.474 . . . . 0.0 111.917 179.672 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -87.14 3.37 46.62 Favored 'General case' 0 C--O 1.24 0.553 0 N-CA-C 113.215 0.82 . . . . 0.0 113.215 -176.207 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' HIS . . . . . 0.446 ' HB3' ' HB ' ' A' ' 15' ' ' ILE . 88.1 m-70 -119.09 75.1 14.38 Favored Pre-proline 0 N--CA 1.428 -1.567 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.462 171.529 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo -66.43 -24.11 50.02 Favored 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 122.472 2.115 . . . . 0.0 113.997 -174.59 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -93.38 -18.33 22.51 Favored 'General case' 0 N--CA 1.416 -2.145 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.449 -177.225 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.446 ' HB ' ' HB3' ' A' ' 12' ' ' HIS . 22.8 mt -100.14 -40.82 8.67 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 CA-C-O 122.013 0.911 . . . . 0.0 109.196 -178.295 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 62.5 m . . . . . 0 N--CA 1.406 -2.647 0 CA-C-N 114.527 -1.215 . . . . 0.0 110.261 -177.268 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.242 0.645 0 N-CA-C 111.117 -0.793 . . . . 0.0 111.117 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' CYS . . . . . 0.553 ' HB2' ' NE2' ' A' ' 12' ' ' HIS . 7.9 m -60.79 -18.27 54.2 Favored 'General case' 0 C--O 1.205 -1.286 0 N-CA-C 116.022 1.86 . . . . 0.0 116.022 -176.719 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 4.7 m -65.54 -28.35 69.1 Favored 'General case' 0 C--N 1.277 -2.581 0 N-CA-C 113.947 1.091 . . . . 0.0 113.947 179.021 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 50.6 m -81.6 3.83 23.74 Favored 'General case' 0 C--N 1.282 -2.367 0 CA-C-O 121.501 0.667 . . . . 0.0 110.789 174.236 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 80.1 m-70 -117.63 103.4 50.82 Favored Pre-proline 0 C--N 1.31 -1.128 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 179.01 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_exo -44.56 -43.77 14.04 Favored 'Trans proline' 0 N--CA 1.486 1.037 0 C-N-CA 123.815 3.01 . . . . 0.0 114.245 -176.343 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -72.46 -28.28 62.83 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 112.818 0.673 . . . . 0.0 112.818 -177.808 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 6.9 t -102.52 4.99 39.17 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-O 122.462 1.125 . . . . 0.0 108.869 -176.53 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 -77.82 -44.97 25.74 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 114.751 -1.113 . . . . 0.0 110.383 -176.528 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 14.6 p -62.83 -25.48 38.46 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.246 0 CA-C-N 113.823 -1.535 . . . . 0.0 112.704 -176.058 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.419 ' O ' ' HD3' ' A' ' 13' ' ' PRO . 4.8 p-10 -91.24 13.15 17.98 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 113.366 0.876 . . . . 0.0 113.366 -177.828 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' HIS . . . . . 0.553 ' NE2' ' HB2' ' A' ' 2' ' ' CYS . 36.4 m-70 -110.22 84.18 3.56 Favored Pre-proline 0 N--CA 1.444 -0.731 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 170.342 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.419 ' HD3' ' O ' ' A' ' 11' ' ' ASP . 7.8 Cg_exo -68.74 -26.67 32.54 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.468 2.112 . . . . 0.0 113.934 -173.098 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.402 ' H ' ' CD ' ' A' ' 14' ' ' GLU . 0.2 OUTLIER -95.16 1.62 54.85 Favored 'General case' 0 N--CA 1.409 -2.487 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.561 -177.062 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 30.9 mm -122.93 -62.64 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-O 121.778 0.799 . . . . 0.0 109.166 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 71.3 m . . . . . 0 C--N 1.29 -2.004 0 CA-C-N 115.065 -0.97 . . . . 0.0 111.404 -176.412 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.494 -1.25 0 N-CA-C 110.304 -1.119 . . . . 0.0 110.304 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 3.9 m -61.37 -20.86 63.49 Favored 'General case' 0 C--O 1.2 -1.542 0 N-CA-C 114.773 1.398 . . . . 0.0 114.773 -176.354 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 83.0 m -73.51 -42.08 62.24 Favored 'General case' 0 C--N 1.285 -2.219 0 CA-C-O 121.378 0.608 . . . . 0.0 111.543 177.533 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 11.8 m -73.5 -13.75 61.1 Favored 'General case' 0 C--N 1.286 -2.18 0 CA-C-N 114.726 -1.125 . . . . 0.0 109.851 -179.399 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 9.7 m-70 -96.31 103.82 15.26 Favored Pre-proline 0 N--CA 1.434 -1.267 0 CA-C-N 114.499 -1.228 . . . . 0.0 108.863 175.079 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.537 ' O ' HG23 ' A' ' 10' ' ' VAL . 73.4 Cg_exo -50.46 -38.54 53.9 Favored 'Trans proline' 0 CA--C 1.534 0.505 0 C-N-CA 123.016 2.478 . . . . 0.0 113.679 -175.809 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -70.79 -40.49 72.52 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.125 0.417 . . . . 0.0 112.125 -177.255 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 11.2 t -83.38 -20.02 34.97 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 121.48 0.657 . . . . 0.0 109.454 -176.701 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 63.7 t30 -70.12 -32.8 70.99 Favored 'General case' 0 CA--C 1.501 -0.932 0 CA-C-O 121.206 0.527 . . . . 0.0 109.616 179.418 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.537 HG23 ' O ' ' A' ' 6' ' ' PRO . 89.3 t -53.94 -40.25 44.1 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.11 0 CA-C-N 114.745 -1.116 . . . . 0.0 110.918 175.302 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.476 ' C ' ' HD3' ' A' ' 13' ' ' PRO . 3.9 p30 -94.45 1.97 55.76 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.183 0.516 . . . . 0.0 111.385 179.686 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' HIS . . . . . 0.426 ' CD2' HG13 ' A' ' 15' ' ' ILE . 6.7 m80 -119.5 67.65 10.23 Favored Pre-proline 0 C--O 1.252 1.215 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.335 173.594 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.476 ' HD3' ' C ' ' A' ' 11' ' ' ASP . 3.4 Cg_exo -84.99 -22.02 2.96 Favored 'Trans proline' 0 C--N 1.357 1.017 0 C-N-CA 121.871 1.714 . . . . 0.0 111.057 -176.605 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.405 ' HG2' ' H ' ' A' ' 14' ' ' GLU . 9.3 pt-20 -84.06 -11.92 55.94 Favored 'General case' 0 N--CA 1.412 -2.363 0 CA-C-N 113.784 -1.553 . . . . 0.0 109.739 179.471 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.426 HG13 ' CD2' ' A' ' 12' ' ' HIS . 38.2 mm -97.31 -52.52 9.08 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.36 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 -177.79 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 69.0 m . . . . . 0 N--CA 1.419 -1.976 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.446 178.397 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.5 -0.885 0 N-CA-C 110.339 -1.104 . . . . 0.0 110.339 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 17.3 m -60.51 -17.33 44.81 Favored 'General case' 0 C--O 1.202 -1.438 0 N-CA-C 115.442 1.645 . . . . 0.0 115.442 -176.2 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 80.8 m -63.64 -38.98 93.19 Favored 'General case' 0 C--N 1.282 -2.351 0 CA-C-O 121.279 0.561 . . . . 0.0 112.105 175.796 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 17.5 m -79.08 -0.28 30.88 Favored 'General case' 0 C--N 1.281 -2.39 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.668 178.391 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 21.8 m80 -109.68 105.35 57.09 Favored Pre-proline 0 C--N 1.307 -1.239 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 178.995 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -54.36 -42.04 71.21 Favored 'Trans proline' 0 CA--C 1.531 0.372 0 C-N-CA 122.301 2.001 . . . . 0.0 112.564 -178.212 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -72.27 -25.23 61.52 Favored 'General case' 0 C--O 1.212 -0.881 0 N-CA-C 112.249 0.463 . . . . 0.0 112.249 -178.227 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 11.2 t -104.22 9.44 36.11 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.908 0.861 . . . . 0.0 109.037 -178.042 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -87.08 -50.69 6.47 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-O 121.355 0.597 . . . . 0.0 110.425 -175.771 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 8.3 p -58.26 -37.91 65.68 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.145 0 CA-C-N 114.499 -1.228 . . . . 0.0 113.508 -175.108 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -86.97 7.34 27.91 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 113.169 0.803 . . . . 0.0 113.169 -177.888 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 47.7 m-70 -116.8 73.98 6.44 Favored Pre-proline 0 N--CA 1.433 -1.309 0 O-C-N 122.084 -0.385 . . . . 0.0 111.398 173.705 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_exo -67.9 -25.34 38.95 Favored 'Trans proline' 0 C--N 1.365 1.441 0 C-N-CA 122.374 2.049 . . . . 0.0 109.881 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.471 ' HG3' HG13 ' A' ' 15' ' ' ILE . 4.9 pt-20 -61.89 -34.12 75.46 Favored 'General case' 0 N--CA 1.424 -1.746 0 CA-C-N 112.937 -1.938 . . . . 0.0 112.343 177.937 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.471 HG13 ' HG3' ' A' ' 14' ' ' GLU . 15.6 mt -108.12 -49.48 7.65 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 C-N-CA 119.608 -0.837 . . . . 0.0 109.777 -177.154 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 84.4 m . . . . . 0 N--CA 1.428 -1.553 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.797 -178.912 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.503 -0.716 0 N-CA-C 110.061 -1.216 . . . . 0.0 110.061 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 4.9 m -65.49 -19.86 66.11 Favored 'General case' 0 CA--C 1.489 -1.377 0 N-CA-C 115.49 1.663 . . . . 0.0 115.49 -177.053 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.595 ' SG ' ' HB ' ' A' ' 15' ' ' ILE . 1.6 m -68.19 -25.55 65.29 Favored 'General case' 0 C--N 1.277 -2.559 0 N-CA-C 113.439 0.903 . . . . 0.0 113.439 176.84 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 14.6 m -77.19 0.02 23.37 Favored 'General case' 0 C--N 1.284 -2.241 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.099 173.794 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 78.6 m80 -121.59 109.8 34.22 Favored Pre-proline 0 C--N 1.325 -0.492 0 C-N-CA 123.762 0.825 . . . . 0.0 108.864 -177.338 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_exo -45.74 -49.83 10.34 Favored 'Trans proline' 0 N--CA 1.491 1.333 0 C-N-CA 123.913 3.075 . . . . 0.0 115.929 -172.932 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -73.55 -34.21 65.06 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 113.317 0.858 . . . . 0.0 113.317 -178.647 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 6.6 t -83.32 -17.56 42.04 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-O 121.896 0.855 . . . . 0.0 109.365 -176.386 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 18.6 t-20 -60.72 -39.24 87.87 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 114.918 -1.037 . . . . 0.0 109.52 177.822 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 67.8 t -56.93 -36.06 49.1 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 CA-C-N 113.714 -1.585 . . . . 0.0 113.33 -176.671 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.415 ' C ' ' HD3' ' A' ' 13' ' ' PRO . 4.7 p-10 -94.43 1.72 55.78 Favored 'General case' 0 C--N 1.312 -1.065 0 C-N-CA 118.581 -1.247 . . . . 0.0 113.449 -175.714 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 91.9 m-70 -116.21 75.23 6.02 Favored Pre-proline 0 N--CA 1.429 -1.489 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 177.538 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.504 ' HA ' ' O ' ' A' ' 16' ' ' CYS . 15.6 Cg_exo -71.43 -10.45 26.95 Favored 'Trans proline' 0 C--N 1.361 1.214 0 C-N-CA 122.396 2.064 . . . . 0.0 111.276 177.905 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.469 ' HG3' HG12 ' A' ' 15' ' ' ILE . 14.8 pt-20 -63.7 -29.24 70.49 Favored 'General case' 0 N--CA 1.434 -1.265 0 C-N-CA 124.314 1.046 . . . . 0.0 110.129 177.801 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.595 ' HB ' ' SG ' ' A' ' 3' ' ' CYS . 35.4 mm -107.85 -58.93 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.169 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 177.308 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.504 ' O ' ' HA ' ' A' ' 13' ' ' PRO . 61.4 m . . . . . 0 C--N 1.288 -2.106 0 CA-C-N 114.198 -1.364 . . . . 0.0 110.392 -177.049 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.495 -1.173 0 N-CA-C 109.084 -1.607 . . . . 0.0 109.084 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 1.9 m -65.13 -24.06 67.31 Favored 'General case' 0 C--O 1.197 -1.691 0 N-CA-C 114.374 1.25 . . . . 0.0 114.374 -178.548 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 5.8 m -74.58 -32.09 62.27 Favored 'General case' 0 C--N 1.283 -2.29 0 C-N-CA 120.479 -0.488 . . . . 0.0 112.212 176.565 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 10.8 m -69.61 -18.67 63.63 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-O 121.857 0.837 . . . . 0.0 109.404 176.625 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 40.6 m80 -97.51 107.51 39.61 Favored Pre-proline 0 C--N 1.318 -0.767 0 CA-C-N 114.778 -1.101 . . . . 0.0 108.85 176.96 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_exo -49.33 -36.81 39.08 Favored 'Trans proline' 0 CA--C 1.541 0.843 0 C-N-CA 123.429 2.752 . . . . 0.0 113.636 -178.298 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -72.1 -43.51 64.67 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 111.827 0.306 . . . . 0.0 111.827 -179.467 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 5.7 t -83.49 -10.86 58.07 Favored 'General case' 0 N--CA 1.479 0.978 0 CA-C-O 121.937 0.875 . . . . 0.0 109.815 -174.254 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 -62.31 -44.94 95.34 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 114.786 -1.097 . . . . 0.0 110.498 -179.366 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 49.1 t -61.29 -34.76 62.22 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.116 0 CA-C-N 114.037 -1.438 . . . . 0.0 112.334 -175.875 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -88.53 5.47 42.5 Favored 'General case' 0 C--O 1.245 0.858 0 N-CA-C 112.937 0.718 . . . . 0.0 112.937 -177.773 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 68.9 m80 -119.06 72.73 12.29 Favored Pre-proline 0 N--CA 1.433 -1.288 0 C-N-CA 122.663 0.385 . . . . 0.0 110.329 172.542 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -75.09 -16.03 20.23 Favored 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 122.696 2.264 . . . . 0.0 112.685 -173.554 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -83.37 -19.55 35.87 Favored 'General case' 0 N--CA 1.419 -1.986 0 CA-C-N 115.23 -0.895 . . . . 0.0 111.219 -179.734 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 26.9 mt -103.14 -45.35 10.22 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.004 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 176.943 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 84.7 m . . . . . 0 N--CA 1.422 -1.853 0 CA-C-N 114.311 -1.313 . . . . 0.0 110.683 -179.732 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.503 -0.69 0 N-CA-C 110.611 -0.995 . . . . 0.0 110.611 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 6.6 m -65.61 -15.91 63.2 Favored 'General case' 0 CA--C 1.491 -1.309 0 N-CA-C 114.432 1.271 . . . . 0.0 114.432 -177.339 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.441 ' SG ' HG22 ' A' ' 15' ' ' ILE . 86.9 m -66.06 -34.04 77.16 Favored 'General case' 0 C--N 1.276 -2.626 0 CA-C-O 121.481 0.657 . . . . 0.0 111.889 176.975 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 50.5 m -80.32 3.65 20.38 Favored 'General case' 0 C--N 1.279 -2.47 0 CA-C-N 115.303 -0.862 . . . . 0.0 111.069 175.197 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 68.5 m80 -120.95 92.68 48.54 Favored Pre-proline 0 C--N 1.314 -0.949 0 C-N-CA 124.113 0.965 . . . . 0.0 108.624 179.222 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_exo -45.97 -43.19 20.22 Favored 'Trans proline' 0 N--CA 1.486 1.053 0 C-N-CA 123.482 2.788 . . . . 0.0 113.888 -176.17 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -68.03 -24.61 65.11 Favored 'General case' 0 C--O 1.219 -0.552 0 N-CA-C 112.327 0.491 . . . . 0.0 112.327 -178.478 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 18.0 t -97.12 -20.78 17.74 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-O 122.044 0.926 . . . . 0.0 109.048 -179.656 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 45.8 t-20 -77.97 -39.44 42.47 Favored 'General case' 0 C--N 1.301 -1.512 0 CA-C-N 115.125 -0.943 . . . . 0.0 109.481 -176.183 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 11.0 p -60.08 -23.08 26.14 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.157 0 CA-C-N 114.366 -1.288 . . . . 0.0 112.205 -178.158 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -109.96 3.16 20.21 Favored 'General case' 0 CA--C 1.513 -0.443 0 C-N-CA 119.313 -0.955 . . . . 0.0 112.704 178.79 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 76.1 m-70 -118.95 78.25 16.18 Favored Pre-proline 0 N--CA 1.428 -1.542 0 N-CA-C 112.222 0.453 . . . . 0.0 112.222 176.022 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -75.37 -12.98 20.79 Favored 'Trans proline' 0 C--N 1.353 0.774 0 C-N-CA 122.35 2.033 . . . . 0.0 110.191 179.617 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.423 ' HG3' HG12 ' A' ' 15' ' ' ILE . 15.5 pt-20 -71.17 -29.63 65.43 Favored 'General case' 0 N--CA 1.415 -2.194 0 CA-C-N 113.636 -1.62 . . . . 0.0 110.045 178.728 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.441 HG22 ' SG ' ' A' ' 3' ' ' CYS . 32.2 mm -98.82 -54.84 6.54 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.746 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 -178.911 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 70.5 m . . . . . 0 N--CA 1.43 -1.445 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.22 176.68 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.506 -0.473 0 N-CA-C 110.413 -1.075 . . . . 0.0 110.413 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 3.4 m -62.69 -19.33 63.78 Favored 'General case' 0 C--O 1.21 -1.0 0 N-CA-C 114.666 1.358 . . . . 0.0 114.666 -177.791 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.468 ' SG ' HG22 ' A' ' 15' ' ' ILE . 52.6 m -70.59 -33.1 70.7 Favored 'General case' 0 C--N 1.281 -2.398 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 177.605 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 18.8 m -81.3 -2.64 49.83 Favored 'General case' 0 C--N 1.284 -2.266 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.015 175.456 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 26.5 m80 -107.43 101.3 38.53 Favored Pre-proline 0 C--N 1.313 -1.0 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.157 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 99.1 Cg_exo -45.56 -44.65 16.96 Favored 'Trans proline' 0 N--CA 1.478 0.615 0 C-N-CA 123.927 3.085 . . . . 0.0 114.408 -175.536 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -72.48 -37.53 68.42 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 112.257 0.465 . . . . 0.0 112.257 -177.962 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 14.0 t -83.13 -19.97 35.67 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.736 0.779 . . . . 0.0 109.573 -174.837 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -64.12 -45.09 90.1 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.963 -179.515 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 57.7 t -62.06 -39.45 83.84 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.012 0 CA-C-N 114.211 -1.359 . . . . 0.0 112.542 -175.976 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -86.41 1.37 51.54 Favored 'General case' 0 CA--C 1.512 -0.508 0 C-N-CA 120.079 -0.649 . . . . 0.0 112.647 -177.394 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 49.7 m80 -118.68 73.02 11.23 Favored Pre-proline 0 N--CA 1.425 -1.684 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 172.557 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_exo -71.28 -25.52 21.84 Favored 'Trans proline' 0 C--N 1.353 0.813 0 C-N-CA 122.393 2.062 . . . . 0.0 111.561 -175.898 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -73.8 -26.13 60.47 Favored 'General case' 0 N--CA 1.419 -2.002 0 CA-C-N 114.282 -1.326 . . . . 0.0 110.999 179.56 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.468 HG22 ' SG ' ' A' ' 3' ' ' CYS . 46.2 mt -94.22 -48.36 13.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 178.603 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 32.8 m . . . . . 0 N--CA 1.423 -1.816 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.742 179.046 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.493 -1.29 0 N-CA-C 110.249 -1.14 . . . . 0.0 110.249 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 1.7 m -61.56 -34.26 75.27 Favored 'General case' 0 CA--C 1.487 -1.473 0 N-CA-C 114.258 1.207 . . . . 0.0 114.258 -178.737 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 1.6 m -71.0 -22.78 62.12 Favored 'General case' 0 C--N 1.28 -2.439 0 N-CA-C 113.711 1.004 . . . . 0.0 113.711 178.671 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 16.3 m -72.52 -12.45 61.08 Favored 'General case' 0 C--N 1.287 -2.146 0 CA-C-O 121.293 0.568 . . . . 0.0 110.013 173.58 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 62.3 m80 -109.08 122.38 40.02 Favored Pre-proline 0 C--N 1.319 -0.72 0 C-N-CA 123.661 0.784 . . . . 0.0 109.221 178.943 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -55.55 -33.03 85.24 Favored 'Trans proline' 0 CA--C 1.542 0.921 0 C-N-CA 122.839 2.359 . . . . 0.0 113.825 -177.315 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -72.71 -47.19 49.23 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 112.411 0.523 . . . . 0.0 112.411 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.457 ' HA ' ' OD1' ' A' ' 11' ' ' ASP . 3.9 t -83.24 -14.5 53.11 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-O 121.664 0.745 . . . . 0.0 110.206 -173.168 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 20.1 t-20 -59.75 -42.23 92.76 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 115.334 -0.848 . . . . 0.0 109.838 178.672 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 47.5 t -62.72 -41.28 91.76 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.993 0 CA-C-N 113.847 -1.524 . . . . 0.0 111.684 -177.277 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.457 ' OD1' ' HA ' ' A' ' 8' ' ' CYS . 5.3 p-10 -88.84 14.74 9.66 Favored 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 113.127 0.788 . . . . 0.0 113.127 -176.672 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 18.3 m-70 -118.57 79.53 16.04 Favored Pre-proline 0 N--CA 1.432 -1.343 0 N-CA-C 111.701 0.26 . . . . 0.0 111.701 173.07 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -66.7 -27.23 45.12 Favored 'Trans proline' 0 C--N 1.359 1.107 0 C-N-CA 123.029 2.486 . . . . 0.0 110.95 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.449 ' HG3' HG12 ' A' ' 15' ' ' ILE . 11.0 pt-20 -71.45 -21.35 61.97 Favored 'General case' 0 N--CA 1.419 -2.009 0 CA-C-N 113.729 -1.578 . . . . 0.0 111.853 -178.552 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.449 HG12 ' HG3' ' A' ' 14' ' ' GLU . 30.9 mm -112.24 -49.94 5.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 121.462 0.648 . . . . 0.0 109.54 -178.621 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 84.1 m . . . . . 0 N--CA 1.425 -1.708 0 CA-C-N 115.093 -0.958 . . . . 0.0 111.251 -176.828 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.508 -0.377 0 N-CA-C 111.458 -0.657 . . . . 0.0 111.458 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 32.2 m -60.53 -17.82 48.22 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 116.18 1.918 . . . . 0.0 116.18 -175.678 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 79.6 m -67.05 -33.74 76.16 Favored 'General case' 0 C--N 1.273 -2.748 0 N-CA-C 112.891 0.7 . . . . 0.0 112.891 -179.218 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 24.8 p -86.28 12.6 9.6 Favored 'General case' 0 C--N 1.278 -2.53 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.873 176.399 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 33.7 m-70 -124.35 103.07 32.73 Favored Pre-proline 0 C--N 1.317 -0.822 0 C-N-CA 124.124 0.97 . . . . 0.0 109.036 -178.261 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.408 ' O ' HG23 ' A' ' 10' ' ' VAL . 90.9 Cg_exo -47.46 -45.21 23.46 Favored 'Trans proline' 0 N--CA 1.474 0.349 0 C-N-CA 123.656 2.904 . . . . 0.0 114.186 -176.24 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -68.17 -41.15 81.95 Favored 'General case' 0 C--N 1.317 -0.824 0 C-N-CA 121.337 -0.145 . . . . 0.0 111.282 -177.286 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 8.4 t -83.62 -16.87 43.56 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 121.808 0.813 . . . . 0.0 110.097 -175.694 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 -66.34 -38.25 87.21 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-O 121.751 0.786 . . . . 0.0 108.965 179.526 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.408 HG23 ' O ' ' A' ' 6' ' ' PRO . 97.4 t -60.62 -46.45 95.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 114.011 -1.45 . . . . 0.0 112.679 -178.087 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.412 ' C ' ' HD3' ' A' ' 13' ' ' PRO . 7.5 p-10 -87.01 1.86 51.44 Favored 'General case' 0 CA--C 1.513 -0.45 0 N-CA-C 113.485 0.92 . . . . 0.0 113.485 -173.863 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' HIS . . . . . 0.6 ' HB3' ' HB ' ' A' ' 15' ' ' ILE . 47.3 m80 -116.39 73.0 5.3 Favored Pre-proline 0 N--CA 1.429 -1.479 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 172.318 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.412 ' HD3' ' C ' ' A' ' 11' ' ' ASP . 21.4 Cg_exo -64.95 -27.44 58.4 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 123.079 2.52 . . . . 0.0 114.17 -173.166 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.448 ' H ' ' CD ' ' A' ' 14' ' ' GLU . 0.0 OUTLIER -95.86 -22.06 17.7 Favored 'General case' 0 N--CA 1.408 -2.535 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.209 -178.049 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.6 ' HB ' ' HB3' ' A' ' 12' ' ' HIS . 37.2 mm -89.99 -45.2 15.11 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.665 0 CA-C-O 121.94 0.876 . . . . 0.0 108.66 -177.26 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 62.6 m . . . . . 0 N--CA 1.413 -2.316 0 CA-C-N 114.508 -1.224 . . . . 0.0 110.259 -177.7 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.496 -1.103 0 N-CA-C 110.912 -0.875 . . . . 0.0 110.912 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' CYS . . . . . 0.47 ' HA ' ' HB2' ' A' ' 5' ' ' HIS . 19.7 m -66.01 -17.08 64.45 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 115.168 1.544 . . . . 0.0 115.168 -176.334 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.401 ' SG ' HG22 ' A' ' 15' ' ' ILE . 58.4 m -63.15 -31.63 72.81 Favored 'General case' 0 C--N 1.281 -2.373 0 N-CA-C 113.172 0.804 . . . . 0.0 113.172 177.712 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 5.3 p -99.17 18.59 17.1 Favored 'General case' 0 C--N 1.279 -2.487 0 CA-C-O 121.848 0.832 . . . . 0.0 110.118 175.681 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' HIS . . . . . 0.47 ' HB2' ' HA ' ' A' ' 2' ' ' CYS . 67.5 m170 -122.01 93.79 48.43 Favored Pre-proline 0 C--N 1.312 -1.038 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 178.991 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -49.79 -48.68 18.39 Favored 'Trans proline' 0 N--CA 1.484 0.949 0 C-N-CA 123.35 2.7 . . . . 0.0 114.447 -173.958 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -71.34 -19.66 62.27 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.81 -177.113 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 20.8 t -95.07 -22.41 17.92 Favored 'General case' 0 C--O 1.208 -1.128 0 C-N-CA 120.087 -0.645 . . . . 0.0 109.67 179.415 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ASN . . . . . 0.412 ' HB2' ' O ' ' A' ' 5' ' ' HIS . 57.3 t30 -85.07 -29.38 24.95 Favored 'General case' 0 C--N 1.28 -2.441 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.93 -167.868 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 7.3 p -56.01 -31.62 31.45 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.126 0 CA-C-N 115.082 -0.963 . . . . 0.0 111.652 178.208 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.407 ' O ' ' HD3' ' A' ' 13' ' ' PRO . 4.3 p30 -97.85 12.56 33.59 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-O 120.894 0.378 . . . . 0.0 111.569 179.425 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' HIS . . . . . 0.407 ' HB3' ' HB ' ' A' ' 15' ' ' ILE . 48.4 m80 -116.94 71.93 5.72 Favored Pre-proline 0 N--CA 1.44 -0.935 0 C-N-CA 122.767 0.427 . . . . 0.0 110.166 174.592 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.407 ' HD3' ' O ' ' A' ' 11' ' ' ASP . 7.5 Cg_exo -72.56 -32.72 9.42 Favored 'Trans proline' 0 C--N 1.356 0.944 0 C-N-CA 122.844 2.363 . . . . 0.0 113.761 -172.593 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -92.4 5.27 51.31 Favored 'General case' 0 N--CA 1.411 -2.376 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.594 -178.549 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.407 ' HB ' ' HB3' ' A' ' 12' ' ' HIS . 37.2 mm -105.33 -65.93 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.952 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 177.565 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 69.2 m . . . . . 0 C--N 1.288 -2.096 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.458 179.575 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.495 -1.177 0 N-CA-C 110.156 -1.178 . . . . 0.0 110.156 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 14.2 m -68.53 -22.84 64.49 Favored 'General case' 0 N--CA 1.428 -1.528 0 N-CA-C 114.041 1.126 . . . . 0.0 114.041 -177.671 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 65.0 m -75.12 -28.02 60.04 Favored 'General case' 0 C--N 1.294 -1.833 0 CA-C-O 121.697 0.761 . . . . 0.0 111.555 176.411 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 4.1 m -71.54 0.97 7.25 Favored 'General case' 0 C--N 1.297 -1.678 0 CA-C-N 114.495 -1.23 . . . . 0.0 109.781 174.95 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' HIS . . . . . 0.464 ' O ' ' HB2' ' A' ' 9' ' ' ASN . 57.4 m80 -125.91 147.96 60.89 Favored Pre-proline 0 N--CA 1.438 -1.075 0 C-N-CA 124.804 1.241 . . . . 0.0 107.895 178.498 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -77.44 -41.67 0.33 Allowed 'Trans proline' 0 CA--C 1.548 1.217 0 C-N-CA 121.652 1.568 . . . . 0.0 112.865 175.679 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -72.08 -39.86 68.66 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 113.332 0.864 . . . . 0.0 113.332 -174.159 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 10.1 t -87.12 4.21 43.18 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-O 121.932 0.872 . . . . 0.0 109.787 -178.662 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ASN . . . . . 0.464 ' HB2' ' O ' ' A' ' 5' ' ' HIS . 1.3 t30 -79.19 -39.78 32.48 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-O 121.702 0.763 . . . . 0.0 109.364 -177.218 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 14.9 p -71.05 -30.59 41.81 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-N 114.46 -1.245 . . . . 0.0 112.752 -174.923 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -87.92 3.43 48.58 Favored 'General case' 0 C--N 1.317 -0.81 0 C-N-CA 119.037 -1.065 . . . . 0.0 112.457 -179.28 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 68.3 m80 -118.67 73.12 11.27 Favored Pre-proline 0 N--CA 1.425 -1.682 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 172.208 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo -72.94 -31.22 10.22 Favored 'Trans proline' 0 C--N 1.359 1.109 0 C-N-CA 122.768 2.312 . . . . 0.0 112.257 -173.446 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -77.51 -10.16 59.33 Favored 'General case' 0 N--CA 1.419 -1.975 0 CA-C-N 114.394 -1.276 . . . . 0.0 111.391 -179.311 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 37.8 mm -104.06 -57.63 4.36 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.007 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 177.496 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 91.7 m . . . . . 0 N--CA 1.426 -1.672 0 CA-C-N 115.074 -0.966 . . . . 0.0 110.761 178.449 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.499 -0.919 0 N-CA-C 109.969 -1.253 . . . . 0.0 109.969 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 1.7 m -64.94 -23.2 67.15 Favored 'General case' 0 C--O 1.189 -2.089 0 N-CA-C 113.438 0.903 . . . . 0.0 113.438 179.375 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 19.4 m -77.0 -29.7 55.58 Favored 'General case' 0 C--N 1.277 -2.582 0 CA-C-O 121.213 0.53 . . . . 0.0 112.095 175.974 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 2.7 m -67.44 -28.49 67.93 Favored 'General case' 0 C--N 1.286 -2.16 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 175.016 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' HIS . . . . . 0.4 ' HA ' ' HD2' ' A' ' 6' ' ' PRO . 32.7 m170 -91.04 113.23 57.49 Favored Pre-proline 0 C--N 1.318 -0.8 0 CA-C-N 114.877 -1.056 . . . . 0.0 110.0 -179.674 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.4 ' HD2' ' HA ' ' A' ' 5' ' ' HIS . 7.0 Cg_endo -51.62 -40.97 63.4 Favored 'Trans proline' 0 CA--C 1.539 0.73 0 C-N-CA 123.13 2.553 . . . . 0.0 113.956 -177.901 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -72.41 -39.98 67.52 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 -177.0 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 11.0 t -83.48 -19.83 35.1 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.451 0.644 . . . . 0.0 110.118 -174.506 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 18.4 t-20 -54.08 -44.34 71.09 Favored 'General case' 0 C--N 1.321 -0.673 0 C-N-CA 124.735 1.214 . . . . 0.0 111.162 -178.122 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 36.0 t -62.89 -38.32 81.57 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.184 0 CA-C-N 114.085 -1.416 . . . . 0.0 112.502 -175.072 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.42 ' O ' ' HD3' ' A' ' 13' ' ' PRO . 5.4 p-10 -90.22 13.93 13.94 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 119.795 -0.762 . . . . 0.0 112.93 -176.879 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 22.8 m-70 -114.35 79.17 5.07 Favored Pre-proline 0 N--CA 1.431 -1.425 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 171.809 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.42 ' HD3' ' O ' ' A' ' 11' ' ' ASP . 5.4 Cg_exo -72.31 -27.84 15.86 Favored 'Trans proline' 0 C--N 1.358 1.036 0 C-N-CA 123.36 2.706 . . . . 0.0 112.923 -172.015 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -84.05 -11.46 56.69 Favored 'General case' 0 C--N 1.291 -1.947 0 CA-C-N 115.139 -0.937 . . . . 0.0 111.505 -178.394 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 27.5 mm -107.91 -52.84 6.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 -179.344 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 97.5 m . . . . . 0 N--CA 1.426 -1.641 0 CA-C-N 114.979 -1.009 . . . . 0.0 111.433 -179.088 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.502 -0.762 0 N-CA-C 110.801 -0.92 . . . . 0.0 110.801 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' CYS . . . . . 0.476 ' HA ' ' HB2' ' A' ' 5' ' ' HIS . 16.5 m -67.48 -16.27 64.12 Favored 'General case' 0 N--CA 1.435 -1.216 0 N-CA-C 114.765 1.394 . . . . 0.0 114.765 -176.747 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 65.0 m -67.73 -33.98 75.95 Favored 'General case' 0 C--N 1.279 -2.471 0 CA-C-O 121.193 0.521 . . . . 0.0 111.148 176.475 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 20.7 m -85.85 14.53 5.86 Favored 'General case' 0 C--N 1.294 -1.81 0 CA-C-N 115.256 -0.884 . . . . 0.0 110.301 176.037 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' HIS . . . . . 0.476 ' HB2' ' HA ' ' A' ' 2' ' ' CYS . 42.4 m80 -130.76 94.79 27.86 Favored Pre-proline 0 C--N 1.318 -0.785 0 C-N-CA 124.425 1.09 . . . . 0.0 109.727 -178.453 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_exo -48.88 -48.86 16.59 Favored 'Trans proline' 0 N--CA 1.481 0.77 0 C-N-CA 123.537 2.825 . . . . 0.0 113.913 -176.306 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -64.85 -32.63 74.42 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 111.847 0.314 . . . . 0.0 111.847 -178.478 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 34.1 t -84.4 -20.76 31.36 Favored 'General case' 0 C--O 1.203 -1.357 0 CA-C-O 121.601 0.715 . . . . 0.0 109.436 179.838 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 45.6 t-20 -82.73 -48.08 11.26 Favored 'General case' 0 C--N 1.288 -2.105 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.646 -173.321 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 11.8 p -54.04 -39.15 40.17 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.206 0 CA-C-N 114.873 -1.058 . . . . 0.0 113.775 -175.045 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -99.94 5.86 45.23 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 118.557 -1.257 . . . . 0.0 111.905 -179.224 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 20.2 m170 -118.62 76.88 13.84 Favored Pre-proline 0 N--CA 1.438 -1.067 0 N-CA-C 112.789 0.662 . . . . 0.0 112.789 177.174 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_exo -72.56 -21.03 22.79 Favored 'Trans proline' 0 N--CA 1.462 -0.374 0 C-N-CA 121.985 1.79 . . . . 0.0 110.503 178.513 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -74.89 -22.95 58.35 Favored 'General case' 0 N--CA 1.428 -1.556 0 CA-C-N 114.371 -1.286 . . . . 0.0 110.382 179.52 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 50.3 mm -99.8 -50.01 10.96 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.805 0 N-CA-C 108.644 -0.872 . . . . 0.0 108.644 -179.421 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 63.6 m . . . . . 0 N--CA 1.417 -2.101 0 CA-C-N 114.896 -1.047 . . . . 0.0 110.319 -179.848 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.807 0 N-CA-C 111.51 -0.636 . . . . 0.0 111.51 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 6.1 m -65.76 -17.97 65.0 Favored 'General case' 0 CA--C 1.491 -1.292 0 N-CA-C 114.747 1.388 . . . . 0.0 114.747 -177.403 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 30.2 m -65.64 -32.86 74.66 Favored 'General case' 0 C--N 1.283 -2.293 0 CA-C-O 121.021 0.439 . . . . 0.0 111.912 177.026 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 19.1 m -82.28 11.61 5.25 Favored 'General case' 0 C--N 1.287 -2.134 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.374 176.06 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 45.2 m-70 -124.56 111.45 27.85 Favored Pre-proline 0 C--N 1.313 -0.983 0 C-N-CA 123.817 0.847 . . . . 0.0 109.361 179.533 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -49.21 -49.31 15.75 Favored 'Trans proline' 0 CA--C 1.539 0.741 0 C-N-CA 123.462 2.774 . . . . 0.0 114.691 -174.485 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -72.75 -37.21 67.75 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 112.621 0.6 . . . . 0.0 112.621 -177.826 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.424 ' HA ' ' OD1' ' A' ' 11' ' ' ASP . 7.3 t -81.65 -19.9 40.76 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 122.019 0.914 . . . . 0.0 108.833 -174.784 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -62.09 -44.19 97.2 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-N 114.837 -1.074 . . . . 0.0 109.704 177.682 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 49.5 t -65.28 -41.96 92.7 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 CA-C-N 113.953 -1.476 . . . . 0.0 111.796 -176.038 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.424 ' OD1' ' HA ' ' A' ' 8' ' ' CYS . 4.5 p-10 -84.9 3.92 35.85 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 113.316 0.858 . . . . 0.0 113.316 -175.283 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' HIS . . . . . 0.459 ' HB3' ' HB ' ' A' ' 15' ' ' ILE . 61.2 m80 -113.72 77.34 3.41 Favored Pre-proline 0 N--CA 1.434 -1.245 0 N-CA-C 109.924 -0.399 . . . . 0.0 109.924 172.462 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_exo -66.54 -32.33 39.52 Favored 'Trans proline' 0 C--N 1.355 0.899 0 C-N-CA 122.728 2.286 . . . . 0.0 112.47 -174.803 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -79.69 -22.69 43.09 Favored 'General case' 0 C--N 1.289 -2.057 0 CA-C-N 114.53 -1.214 . . . . 0.0 111.845 -178.1 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.459 ' HB ' ' HB3' ' A' ' 12' ' ' HIS . 41.2 mm -100.92 -58.71 3.72 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 CA-C-O 121.813 0.816 . . . . 0.0 109.337 -176.757 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 36.8 m . . . . . 0 C--N 1.281 -2.403 0 CA-C-N 114.707 -1.133 . . . . 0.0 110.319 -175.975 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.573 0 N-CA-C 111.958 -0.457 . . . . 0.0 111.958 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 2' ' ' CYS . . . . . 0.464 ' HA ' ' HB2' ' A' ' 5' ' ' HIS . 31.1 m -60.84 -22.04 63.81 Favored 'General case' 0 N--CA 1.438 -1.061 0 N-CA-C 116.358 1.985 . . . . 0.0 116.358 -174.041 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 67.2 m -71.95 -35.91 69.71 Favored 'General case' 0 C--N 1.278 -2.53 0 C-N-CA 120.542 -0.463 . . . . 0.0 112.149 179.247 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 38.4 t -83.64 1.26 43.24 Favored 'General case' 0 C--N 1.281 -2.386 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.931 177.225 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' HIS . . . . . 0.464 ' HB2' ' HA ' ' A' ' 2' ' ' CYS . 39.9 m170 -110.32 111.19 57.85 Favored Pre-proline 0 C--N 1.311 -1.092 0 C-N-CA 123.504 0.721 . . . . 0.0 109.901 -177.788 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.493 ' O ' HG23 ' A' ' 10' ' ' VAL . 52.9 Cg_exo -51.5 -49.62 16.59 Favored 'Trans proline' 0 CA--C 1.542 0.915 0 C-N-CA 123.16 2.573 . . . . 0.0 115.033 -172.587 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -73.09 -33.12 65.42 Favored 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 112.6 0.593 . . . . 0.0 112.6 -176.949 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.523 ' HA ' ' OD2' ' A' ' 11' ' ' ASP . 8.9 t -82.75 -20.33 36.14 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 122.07 0.938 . . . . 0.0 108.906 -177.984 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 -66.21 -40.93 90.71 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 115.057 -0.974 . . . . 0.0 108.484 177.23 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.493 HG23 ' O ' ' A' ' 6' ' ' PRO . 84.3 t -62.34 -36.24 73.62 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 CA-C-N 114.458 -1.247 . . . . 0.0 111.417 -179.921 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.523 ' OD2' ' HA ' ' A' ' 8' ' ' CYS . 3.3 p30 -87.84 0.74 55.42 Favored 'General case' 0 C--N 1.321 -0.664 0 C-N-CA 119.518 -0.873 . . . . 0.0 111.196 179.625 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' HIS . . . . . 0.564 ' HB3' ' HB ' ' A' ' 15' ' ' ILE . 1.0 OUTLIER -118.58 70.59 9.26 Favored Pre-proline 0 C--N 1.312 -1.038 0 C-N-CA 123.071 0.548 . . . . 0.0 110.248 175.378 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -79.19 -17.98 11.43 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 121.696 1.597 . . . . 0.0 111.799 -176.337 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -100.92 0.15 37.84 Favored 'General case' 0 N--CA 1.41 -2.441 0 CA-C-N 114.721 -1.127 . . . . 0.0 111.182 -178.935 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.564 ' HB ' ' HB3' ' A' ' 12' ' ' HIS . 25.3 mm -114.65 -54.95 4.52 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.949 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 -179.797 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 21.6 m . . . . . 0 C--N 1.284 -2.261 0 CA-C-N 114.089 -1.414 . . . . 0.0 110.077 -174.095 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.946 0 N-CA-C 112.209 -0.357 . . . . 0.0 112.209 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 4.0 m -64.99 -19.95 66.25 Favored 'General case' 0 N--CA 1.433 -1.305 0 N-CA-C 114.158 1.17 . . . . 0.0 114.158 -179.218 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 20.0 m -68.06 -30.81 70.1 Favored 'General case' 0 C--N 1.28 -2.415 0 N-CA-C 112.98 0.733 . . . . 0.0 112.98 178.819 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 16.6 m -72.84 -0.53 13.7 Favored 'General case' 0 C--N 1.291 -1.951 0 CA-C-O 121.369 0.604 . . . . 0.0 110.533 175.742 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 76.6 m80 -125.98 104.21 26.56 Favored Pre-proline 0 C--O 1.216 -0.676 0 C-N-CA 124.322 1.049 . . . . 0.0 108.952 -178.25 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -50.21 -35.19 42.34 Favored 'Trans proline' 0 N--CA 1.483 0.89 0 C-N-CA 123.229 2.619 . . . . 0.0 113.83 -177.217 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -68.98 -32.93 72.85 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 111.577 0.214 . . . . 0.0 111.577 -179.015 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.428 ' HA ' ' OD1' ' A' ' 11' ' ' ASP . 6.4 t -97.11 -18.62 19.22 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.933 0.873 . . . . 0.0 109.593 -177.78 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 19.9 t-20 -60.13 -45.16 93.96 Favored 'General case' 0 C--N 1.314 -0.948 0 C-N-CA 124.21 1.004 . . . . 0.0 110.481 -178.808 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 12.3 p -66.66 -30.56 50.1 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.003 0 CA-C-N 114.156 -1.384 . . . . 0.0 112.322 -176.823 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.428 ' OD1' ' HA ' ' A' ' 8' ' ' CYS 0.252 7.0 p-10 -90.8 5.21 49.32 Favored 'General case' 0 C--O 1.24 0.557 0 C-N-CA 119.649 -0.82 . . . . 0.0 112.137 -179.871 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 69.2 m80 -119.38 72.01 13.45 Favored Pre-proline 0 N--CA 1.431 -1.42 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.702 168.719 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -77.77 -12.02 16.63 Favored 'Trans proline' 0 C--N 1.354 0.856 0 C-N-CA 122.522 2.148 . . . . 0.0 111.955 -176.437 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -80.01 -20.85 44.44 Favored 'General case' 0 N--CA 1.416 -2.125 0 CA-C-N 114.907 -1.042 . . . . 0.0 110.393 177.528 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 38.5 mt -103.37 -54.41 6.58 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.04 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 177.257 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 91.1 m . . . . . 0 N--CA 1.415 -2.212 0 CA-C-N 114.702 -1.136 . . . . 0.0 110.522 178.437 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.503 -0.666 0 N-CA-C 110.358 -1.097 . . . . 0.0 110.358 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 2' ' ' CYS . . . . . 0.45 ' HB3' ' O ' ' A' ' 8' ' ' CYS . 8.0 m -72.1 -22.91 61.28 Favored 'General case' 0 N--CA 1.428 -1.536 0 N-CA-C 113.265 0.839 . . . . 0.0 113.265 -178.745 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 1.8 m -74.55 -24.56 58.95 Favored 'General case' 0 C--N 1.294 -1.841 0 CA-C-O 121.205 0.526 . . . . 0.0 111.148 173.792 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 4.0 m -69.77 -26.28 64.21 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 173.638 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' HIS . . . . . 0.555 ' O ' ' HB2' ' A' ' 9' ' ' ASN . 30.5 m80 -90.38 156.2 45.91 Favored Pre-proline 0 N--CA 1.446 -0.666 0 CA-C-N 114.703 -1.135 . . . . 0.0 109.957 178.946 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -84.47 -49.49 0.04 OUTLIER 'Trans proline' 0 CA--C 1.549 1.231 0 C-N-CA 122.03 1.82 . . . . 0.0 114.196 178.59 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -73.26 -38.03 66.11 Favored 'General case' 0 C--N 1.32 -0.706 0 O-C-N 121.703 -0.623 . . . . 0.0 112.299 -177.25 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.45 ' O ' ' HB3' ' A' ' 2' ' ' CYS . 5.9 t -83.3 0.67 44.69 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 122.098 0.951 . . . . 0.0 109.45 -176.837 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' ASN . . . . . 0.555 ' HB2' ' O ' ' A' ' 5' ' ' HIS . 19.6 t-20 -74.39 -41.19 61.37 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 114.962 -1.017 . . . . 0.0 108.739 -179.73 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 62.1 t -58.82 -35.24 55.05 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-N 113.279 -1.782 . . . . 0.0 112.679 -176.381 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.522 ' O ' ' HD3' ' A' ' 13' ' ' PRO 0.276 7.1 p-10 -82.62 6.35 18.03 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 113.863 1.06 . . . . 0.0 113.863 -177.865 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 12' ' ' HIS . . . . . 0.431 ' HB3' ' HB ' ' A' ' 15' ' ' ILE . 23.5 m-70 -109.75 74.18 0.72 Allowed Pre-proline 0 N--CA 1.441 -0.886 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 168.881 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.522 ' HD3' ' O ' ' A' ' 11' ' ' ASP . 13.6 Cg_exo -66.82 -35.99 25.37 Favored 'Trans proline' 0 CA--C 1.501 -1.14 0 C-N-CA 122.756 2.304 . . . . 0.0 113.439 -168.489 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -86.85 -1.03 57.47 Favored 'General case' 0 C--N 1.282 -2.334 0 CA-C-N 114.926 -1.033 . . . . 0.0 111.946 -177.127 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.431 ' HB ' ' HB3' ' A' ' 12' ' ' HIS . 30.7 mm -114.37 -52.44 5.02 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 -179.661 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 73.5 m . . . . . 0 C--N 1.288 -2.1 0 CA-C-N 114.625 -1.171 . . . . 0.0 109.945 -179.518 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.13 0 N-CA-C 112.492 -0.243 . . . . 0.0 112.492 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 1.6 m -62.36 -21.65 65.49 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-O 120.963 0.411 . . . . 0.0 111.514 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 3.4 m -65.3 -37.34 86.84 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.155 -179.869 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 50.6 m -64.6 -11.8 38.69 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.37 178.792 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' HIS . . . . . 0.499 ' O ' ' HB2' ' A' ' 9' ' ' ASN . 87.5 m-70 -105.37 150.14 38.58 Favored Pre-proline 0 N--CA 1.452 -0.326 0 CA-C-N 114.922 -1.036 . . . . 0.0 110.273 179.524 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -84.49 -38.51 0.12 Allowed 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.464 2.11 . . . . 0.0 112.928 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -72.29 -44.99 61.94 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 -179.06 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.412 ' HA ' ' OD1' ' A' ' 11' ' ' ASP . 6.9 t -83.59 12.21 6.06 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.664 0.269 . . . . 0.0 111.567 -178.941 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' ASN . . . . . 0.499 ' HB2' ' O ' ' A' ' 5' ' ' HIS . 54.8 t30 -90.74 -51.45 5.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.192 0.52 . . . . 0.0 111.458 -179.799 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 22.5 t -54.94 -41.69 59.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.201 -0.909 . . . . 0.0 112.598 -178.94 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.412 ' OD1' ' HA ' ' A' ' 8' ' ' CYS . 5.2 p-10 -75.87 1.72 14.33 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 -179.042 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 15.3 m-70 -119.34 71.76 12.97 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.188 179.461 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -76.91 -10.16 18.15 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.321 2.014 . . . . 0.0 112.356 -179.855 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -93.98 -2.77 52.63 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.113 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 25.7 mm -111.8 -71.16 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-O 120.929 0.395 . . . . 0.0 111.098 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 33.6 m . . . . . 0 C--N 1.323 -0.559 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.041 179.769 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.5 -0.884 0 N-CA-C 110.818 -0.913 . . . . 0.0 110.818 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 20.7 m -62.73 -22.25 66.4 Favored 'General case' 0 N--CA 1.432 -1.366 0 N-CA-C 115.609 1.707 . . . . 0.0 115.609 -175.429 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 24.0 m -70.19 -35.42 73.92 Favored 'General case' 0 C--N 1.283 -2.317 0 C-N-CA 120.543 -0.463 . . . . 0.0 112.194 177.103 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 20.0 m -79.18 -4.38 50.19 Favored 'General case' 0 C--N 1.295 -1.764 0 CA-C-O 121.516 0.674 . . . . 0.0 110.304 177.401 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 10.6 m-70 -104.1 103.71 39.64 Favored Pre-proline 0 C--N 1.317 -0.83 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 176.786 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_exo -49.57 -38.58 45.16 Favored 'Trans proline' 0 CA--C 1.544 1.025 0 C-N-CA 122.736 2.291 . . . . 0.0 113.302 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -72.46 -41.91 65.55 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 -179.097 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 10.2 t -82.78 -19.99 36.72 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-O 121.742 0.782 . . . . 0.0 109.64 -175.083 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -58.61 -41.81 86.75 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 115.036 -0.984 . . . . 0.0 109.477 179.093 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 49.1 t -62.7 -34.35 65.01 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 CA-C-N 114.09 -1.414 . . . . 0.0 111.955 -177.724 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -94.25 1.92 55.94 Favored 'General case' 0 C--N 1.316 -0.888 0 C-N-CA 119.199 -1.0 . . . . 0.0 112.971 -175.686 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 66.4 m80 -118.73 72.37 10.91 Favored Pre-proline 0 N--CA 1.432 -1.328 0 CA-C-N 116.677 -0.238 . . . . 0.0 110.746 174.06 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -73.49 -13.76 25.04 Favored 'Trans proline' 0 C--N 1.356 0.943 0 C-N-CA 121.795 1.664 . . . . 0.0 111.411 -177.552 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.493 ' HG3' HG12 ' A' ' 15' ' ' ILE . 10.4 pt-20 -81.72 -23.48 36.71 Favored 'General case' 0 N--CA 1.421 -1.922 0 CA-C-N 114.553 -1.203 . . . . 0.0 110.896 179.267 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.493 HG12 ' HG3' ' A' ' 14' ' ' GLU . 35.7 mm -107.54 -50.98 7.54 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.067 0 CA-C-O 121.813 0.816 . . . . 0.0 108.805 -177.606 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 31.1 m -98.74 95.41 7.21 Favored 'General case' 0 C--N 1.287 -2.136 0 CA-C-N 114.318 -1.31 . . . . 0.0 109.495 -176.864 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.306 -1.293 0 CA-C-N 116.463 -0.335 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.501 -0.784 0 N-CA-C 110.121 -1.192 . . . . 0.0 110.121 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 9.4 m -66.69 -13.99 61.96 Favored 'General case' 0 CA--C 1.493 -1.217 0 N-CA-C 114.116 1.154 . . . . 0.0 114.116 -178.619 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 96.1 m -68.41 -35.56 77.82 Favored 'General case' 0 C--N 1.28 -2.434 0 CA-C-O 121.766 0.793 . . . . 0.0 110.971 178.111 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 19.2 m -79.72 10.9 3.55 Favored 'General case' 0 C--N 1.281 -2.408 0 CA-C-N 114.772 -1.104 . . . . 0.0 110.308 176.371 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 72.0 m80 -130.61 95.32 26.85 Favored Pre-proline 0 N--CA 1.444 -0.736 0 C-N-CA 124.274 1.03 . . . . 0.0 109.139 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.454 ' O ' HG23 ' A' ' 10' ' ' VAL . 57.2 Cg_exo -40.87 -47.12 4.87 Favored 'Trans proline' 0 N--CA 1.484 0.969 0 C-N-CA 124.23 3.287 . . . . 0.0 114.744 -176.352 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -65.36 -40.47 93.6 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 -178.407 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 9.4 t -83.41 -20.77 33.55 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 122.143 0.973 . . . . 0.0 109.49 -174.361 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 41.2 t-20 -67.06 -41.54 86.27 Favored 'General case' 0 C--N 1.294 -1.832 0 CA-C-N 114.424 -1.262 . . . . 0.0 109.187 -178.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.454 HG23 ' O ' ' A' ' 6' ' ' PRO . 96.0 t -62.88 -41.72 93.71 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 CA-C-N 113.957 -1.474 . . . . 0.0 111.917 179.672 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -87.14 3.37 46.62 Favored 'General case' 0 C--O 1.24 0.553 0 N-CA-C 113.215 0.82 . . . . 0.0 113.215 -176.207 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' HIS . . . . . 0.446 ' HB3' ' HB ' ' A' ' 15' ' ' ILE . 88.1 m-70 -119.09 75.1 14.38 Favored Pre-proline 0 N--CA 1.428 -1.567 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.462 171.529 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo -66.43 -24.11 50.02 Favored 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 122.472 2.115 . . . . 0.0 113.997 -174.59 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -93.38 -18.33 22.51 Favored 'General case' 0 N--CA 1.416 -2.145 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.449 -177.225 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.446 ' HB ' ' HB3' ' A' ' 12' ' ' HIS . 22.8 mt -100.14 -40.82 8.67 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 CA-C-O 122.013 0.911 . . . . 0.0 109.196 -178.295 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 62.5 m -125.16 -75.31 0.59 Allowed 'General case' 0 N--CA 1.406 -2.647 0 CA-C-N 114.527 -1.215 . . . . 0.0 110.261 -177.268 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.314 -0.942 0 O-C-N 122.014 -0.429 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.242 0.645 0 N-CA-C 111.117 -0.793 . . . . 0.0 111.117 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' CYS . . . . . 0.553 ' HB2' ' NE2' ' A' ' 12' ' ' HIS . 7.9 m -60.79 -18.27 54.2 Favored 'General case' 0 C--O 1.205 -1.286 0 N-CA-C 116.022 1.86 . . . . 0.0 116.022 -176.719 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 4.7 m -65.54 -28.35 69.1 Favored 'General case' 0 C--N 1.277 -2.581 0 N-CA-C 113.947 1.091 . . . . 0.0 113.947 179.021 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 50.6 m -81.6 3.83 23.74 Favored 'General case' 0 C--N 1.282 -2.367 0 CA-C-O 121.501 0.667 . . . . 0.0 110.789 174.236 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 80.1 m-70 -117.63 103.4 50.82 Favored Pre-proline 0 C--N 1.31 -1.128 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 179.01 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_exo -44.56 -43.77 14.04 Favored 'Trans proline' 0 N--CA 1.486 1.037 0 C-N-CA 123.815 3.01 . . . . 0.0 114.245 -176.343 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -72.46 -28.28 62.83 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 112.818 0.673 . . . . 0.0 112.818 -177.808 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 6.9 t -102.52 4.99 39.17 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-O 122.462 1.125 . . . . 0.0 108.869 -176.53 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 -77.82 -44.97 25.74 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 114.751 -1.113 . . . . 0.0 110.383 -176.528 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 14.6 p -62.83 -25.48 38.46 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.246 0 CA-C-N 113.823 -1.535 . . . . 0.0 112.704 -176.058 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.419 ' O ' ' HD3' ' A' ' 13' ' ' PRO . 4.8 p-10 -91.24 13.15 17.98 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 113.366 0.876 . . . . 0.0 113.366 -177.828 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' HIS . . . . . 0.553 ' NE2' ' HB2' ' A' ' 2' ' ' CYS . 36.4 m-70 -110.22 84.18 3.56 Favored Pre-proline 0 N--CA 1.444 -0.731 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 170.342 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.419 ' HD3' ' O ' ' A' ' 11' ' ' ASP . 7.8 Cg_exo -68.74 -26.67 32.54 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.468 2.112 . . . . 0.0 113.934 -173.098 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.402 ' H ' ' CD ' ' A' ' 14' ' ' GLU . 0.2 OUTLIER -95.16 1.62 54.85 Favored 'General case' 0 N--CA 1.409 -2.487 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.561 -177.062 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 30.9 mm -122.93 -62.64 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-O 121.778 0.799 . . . . 0.0 109.166 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 71.3 m -119.71 -88.0 0.63 Allowed 'General case' 0 C--N 1.29 -2.004 0 CA-C-N 115.065 -0.97 . . . . 0.0 111.404 -176.412 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.538 0 O-C-N 121.94 -0.475 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.494 -1.25 0 N-CA-C 110.304 -1.119 . . . . 0.0 110.304 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 3.9 m -61.37 -20.86 63.49 Favored 'General case' 0 C--O 1.2 -1.542 0 N-CA-C 114.773 1.398 . . . . 0.0 114.773 -176.354 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 83.0 m -73.51 -42.08 62.24 Favored 'General case' 0 C--N 1.285 -2.219 0 CA-C-O 121.378 0.608 . . . . 0.0 111.543 177.533 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 11.8 m -73.5 -13.75 61.1 Favored 'General case' 0 C--N 1.286 -2.18 0 CA-C-N 114.726 -1.125 . . . . 0.0 109.851 -179.399 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 9.7 m-70 -96.31 103.82 15.26 Favored Pre-proline 0 N--CA 1.434 -1.267 0 CA-C-N 114.499 -1.228 . . . . 0.0 108.863 175.079 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.537 ' O ' HG23 ' A' ' 10' ' ' VAL . 73.4 Cg_exo -50.46 -38.54 53.9 Favored 'Trans proline' 0 CA--C 1.534 0.505 0 C-N-CA 123.016 2.478 . . . . 0.0 113.679 -175.809 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -70.79 -40.49 72.52 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.125 0.417 . . . . 0.0 112.125 -177.255 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 11.2 t -83.38 -20.02 34.97 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 121.48 0.657 . . . . 0.0 109.454 -176.701 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 63.7 t30 -70.12 -32.8 70.99 Favored 'General case' 0 CA--C 1.501 -0.932 0 CA-C-O 121.206 0.527 . . . . 0.0 109.616 179.418 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.537 HG23 ' O ' ' A' ' 6' ' ' PRO . 89.3 t -53.94 -40.25 44.1 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.11 0 CA-C-N 114.745 -1.116 . . . . 0.0 110.918 175.302 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.476 ' C ' ' HD3' ' A' ' 13' ' ' PRO . 3.9 p30 -94.45 1.97 55.76 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.183 0.516 . . . . 0.0 111.385 179.686 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' HIS . . . . . 0.426 ' CD2' HG13 ' A' ' 15' ' ' ILE . 6.7 m80 -119.5 67.65 10.23 Favored Pre-proline 0 C--O 1.252 1.215 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.335 173.594 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.476 ' HD3' ' C ' ' A' ' 11' ' ' ASP . 3.4 Cg_exo -84.99 -22.02 2.96 Favored 'Trans proline' 0 C--N 1.357 1.017 0 C-N-CA 121.871 1.714 . . . . 0.0 111.057 -176.605 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.405 ' HG2' ' H ' ' A' ' 14' ' ' GLU . 9.3 pt-20 -84.06 -11.92 55.94 Favored 'General case' 0 N--CA 1.412 -2.363 0 CA-C-N 113.784 -1.553 . . . . 0.0 109.739 179.471 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.426 HG13 ' CD2' ' A' ' 12' ' ' HIS . 38.2 mm -97.31 -52.52 9.08 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.36 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 -177.79 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 69.0 m -140.94 89.4 2.25 Favored 'General case' 0 N--CA 1.419 -1.976 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.446 178.397 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.307 -1.272 0 CA-C-N 116.441 -0.345 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.5 -0.885 0 N-CA-C 110.339 -1.104 . . . . 0.0 110.339 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 17.3 m -60.51 -17.33 44.81 Favored 'General case' 0 C--O 1.202 -1.438 0 N-CA-C 115.442 1.645 . . . . 0.0 115.442 -176.2 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 80.8 m -63.64 -38.98 93.19 Favored 'General case' 0 C--N 1.282 -2.351 0 CA-C-O 121.279 0.561 . . . . 0.0 112.105 175.796 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 17.5 m -79.08 -0.28 30.88 Favored 'General case' 0 C--N 1.281 -2.39 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.668 178.391 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 21.8 m80 -109.68 105.35 57.09 Favored Pre-proline 0 C--N 1.307 -1.239 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 178.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -54.36 -42.04 71.21 Favored 'Trans proline' 0 CA--C 1.531 0.372 0 C-N-CA 122.301 2.001 . . . . 0.0 112.564 -178.212 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -72.27 -25.23 61.52 Favored 'General case' 0 C--O 1.212 -0.881 0 N-CA-C 112.249 0.463 . . . . 0.0 112.249 -178.227 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 11.2 t -104.22 9.44 36.11 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.908 0.861 . . . . 0.0 109.037 -178.042 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -87.08 -50.69 6.47 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-O 121.355 0.597 . . . . 0.0 110.425 -175.771 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 8.3 p -58.26 -37.91 65.68 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.145 0 CA-C-N 114.499 -1.228 . . . . 0.0 113.508 -175.108 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -86.97 7.34 27.91 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 113.169 0.803 . . . . 0.0 113.169 -177.888 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 47.7 m-70 -116.8 73.98 6.44 Favored Pre-proline 0 N--CA 1.433 -1.309 0 O-C-N 122.084 -0.385 . . . . 0.0 111.398 173.705 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_exo -67.9 -25.34 38.95 Favored 'Trans proline' 0 C--N 1.365 1.441 0 C-N-CA 122.374 2.049 . . . . 0.0 109.881 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.471 ' HG3' HG13 ' A' ' 15' ' ' ILE . 4.9 pt-20 -61.89 -34.12 75.46 Favored 'General case' 0 N--CA 1.424 -1.746 0 CA-C-N 112.937 -1.938 . . . . 0.0 112.343 177.937 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.471 HG13 ' HG3' ' A' ' 14' ' ' GLU . 15.6 mt -108.12 -49.48 7.65 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 C-N-CA 119.608 -0.837 . . . . 0.0 109.777 -177.154 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 84.4 m -143.88 -89.72 0.12 Allowed 'General case' 0 N--CA 1.428 -1.553 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.797 -178.912 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.318 -0.798 0 O-C-N 121.663 -0.648 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.503 -0.716 0 N-CA-C 110.061 -1.216 . . . . 0.0 110.061 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 4.9 m -65.49 -19.86 66.11 Favored 'General case' 0 CA--C 1.489 -1.377 0 N-CA-C 115.49 1.663 . . . . 0.0 115.49 -177.053 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.595 ' SG ' ' HB ' ' A' ' 15' ' ' ILE . 1.6 m -68.19 -25.55 65.29 Favored 'General case' 0 C--N 1.277 -2.559 0 N-CA-C 113.439 0.903 . . . . 0.0 113.439 176.84 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 14.6 m -77.19 0.02 23.37 Favored 'General case' 0 C--N 1.284 -2.241 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.099 173.794 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 78.6 m80 -121.59 109.8 34.22 Favored Pre-proline 0 C--N 1.325 -0.492 0 C-N-CA 123.762 0.825 . . . . 0.0 108.864 -177.338 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_exo -45.74 -49.83 10.34 Favored 'Trans proline' 0 N--CA 1.491 1.333 0 C-N-CA 123.913 3.075 . . . . 0.0 115.929 -172.932 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -73.55 -34.21 65.06 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 113.317 0.858 . . . . 0.0 113.317 -178.647 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 6.6 t -83.32 -17.56 42.04 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-O 121.896 0.855 . . . . 0.0 109.365 -176.386 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 18.6 t-20 -60.72 -39.24 87.87 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 114.918 -1.037 . . . . 0.0 109.52 177.822 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 67.8 t -56.93 -36.06 49.1 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 CA-C-N 113.714 -1.585 . . . . 0.0 113.33 -176.671 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.415 ' C ' ' HD3' ' A' ' 13' ' ' PRO . 4.7 p-10 -94.43 1.72 55.78 Favored 'General case' 0 C--N 1.312 -1.065 0 C-N-CA 118.581 -1.247 . . . . 0.0 113.449 -175.714 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 91.9 m-70 -116.21 75.23 6.02 Favored Pre-proline 0 N--CA 1.429 -1.489 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 177.538 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.504 ' HA ' ' O ' ' A' ' 16' ' ' CYS . 15.6 Cg_exo -71.43 -10.45 26.95 Favored 'Trans proline' 0 C--N 1.361 1.214 0 C-N-CA 122.396 2.064 . . . . 0.0 111.276 177.905 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.469 ' HG3' HG12 ' A' ' 15' ' ' ILE . 14.8 pt-20 -63.7 -29.24 70.49 Favored 'General case' 0 N--CA 1.434 -1.265 0 C-N-CA 124.314 1.046 . . . . 0.0 110.129 177.801 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.595 ' HB ' ' SG ' ' A' ' 3' ' ' CYS . 35.4 mm -107.85 -58.93 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.169 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 177.308 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.504 ' O ' ' HA ' ' A' ' 13' ' ' PRO . 61.4 m -107.21 92.67 4.17 Favored 'General case' 0 C--N 1.288 -2.106 0 CA-C-N 114.198 -1.364 . . . . 0.0 110.392 -177.049 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.307 -1.27 0 CA-C-N 116.336 -0.393 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.495 -1.173 0 N-CA-C 109.084 -1.607 . . . . 0.0 109.084 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 1.9 m -65.13 -24.06 67.31 Favored 'General case' 0 C--O 1.197 -1.691 0 N-CA-C 114.374 1.25 . . . . 0.0 114.374 -178.548 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 5.8 m -74.58 -32.09 62.27 Favored 'General case' 0 C--N 1.283 -2.29 0 C-N-CA 120.479 -0.488 . . . . 0.0 112.212 176.565 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 10.8 m -69.61 -18.67 63.63 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-O 121.857 0.837 . . . . 0.0 109.404 176.625 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 40.6 m80 -97.51 107.51 39.61 Favored Pre-proline 0 C--N 1.318 -0.767 0 CA-C-N 114.778 -1.101 . . . . 0.0 108.85 176.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_exo -49.33 -36.81 39.08 Favored 'Trans proline' 0 CA--C 1.541 0.843 0 C-N-CA 123.429 2.752 . . . . 0.0 113.636 -178.298 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -72.1 -43.51 64.67 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 111.827 0.306 . . . . 0.0 111.827 -179.467 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 5.7 t -83.49 -10.86 58.07 Favored 'General case' 0 N--CA 1.479 0.978 0 CA-C-O 121.937 0.875 . . . . 0.0 109.815 -174.254 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 -62.31 -44.94 95.34 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 114.786 -1.097 . . . . 0.0 110.498 -179.366 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 49.1 t -61.29 -34.76 62.22 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.116 0 CA-C-N 114.037 -1.438 . . . . 0.0 112.334 -175.875 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -88.53 5.47 42.5 Favored 'General case' 0 C--O 1.245 0.858 0 N-CA-C 112.937 0.718 . . . . 0.0 112.937 -177.773 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 68.9 m80 -119.06 72.73 12.29 Favored Pre-proline 0 N--CA 1.433 -1.288 0 C-N-CA 122.663 0.385 . . . . 0.0 110.329 172.542 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -75.09 -16.03 20.23 Favored 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 122.696 2.264 . . . . 0.0 112.685 -173.554 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -83.37 -19.55 35.87 Favored 'General case' 0 N--CA 1.419 -1.986 0 CA-C-N 115.23 -0.895 . . . . 0.0 111.219 -179.734 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 26.9 mt -103.14 -45.35 10.22 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.004 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 176.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 84.7 m -132.97 87.81 2.44 Favored 'General case' 0 N--CA 1.422 -1.853 0 CA-C-N 114.311 -1.313 . . . . 0.0 110.683 -179.732 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.3 -1.561 0 CA-C-N 116.548 -0.297 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.503 -0.69 0 N-CA-C 110.611 -0.995 . . . . 0.0 110.611 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 6.6 m -65.61 -15.91 63.2 Favored 'General case' 0 CA--C 1.491 -1.309 0 N-CA-C 114.432 1.271 . . . . 0.0 114.432 -177.339 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.441 ' SG ' HG22 ' A' ' 15' ' ' ILE . 86.9 m -66.06 -34.04 77.16 Favored 'General case' 0 C--N 1.276 -2.626 0 CA-C-O 121.481 0.657 . . . . 0.0 111.889 176.975 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 50.5 m -80.32 3.65 20.38 Favored 'General case' 0 C--N 1.279 -2.47 0 CA-C-N 115.303 -0.862 . . . . 0.0 111.069 175.197 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 68.5 m80 -120.95 92.68 48.54 Favored Pre-proline 0 C--N 1.314 -0.949 0 C-N-CA 124.113 0.965 . . . . 0.0 108.624 179.222 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_exo -45.97 -43.19 20.22 Favored 'Trans proline' 0 N--CA 1.486 1.053 0 C-N-CA 123.482 2.788 . . . . 0.0 113.888 -176.17 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -68.03 -24.61 65.11 Favored 'General case' 0 C--O 1.219 -0.552 0 N-CA-C 112.327 0.491 . . . . 0.0 112.327 -178.478 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 18.0 t -97.12 -20.78 17.74 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-O 122.044 0.926 . . . . 0.0 109.048 -179.656 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 45.8 t-20 -77.97 -39.44 42.47 Favored 'General case' 0 C--N 1.301 -1.512 0 CA-C-N 115.125 -0.943 . . . . 0.0 109.481 -176.183 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 11.0 p -60.08 -23.08 26.14 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.157 0 CA-C-N 114.366 -1.288 . . . . 0.0 112.205 -178.158 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -109.96 3.16 20.21 Favored 'General case' 0 CA--C 1.513 -0.443 0 C-N-CA 119.313 -0.955 . . . . 0.0 112.704 178.79 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 76.1 m-70 -118.95 78.25 16.18 Favored Pre-proline 0 N--CA 1.428 -1.542 0 N-CA-C 112.222 0.453 . . . . 0.0 112.222 176.022 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -75.37 -12.98 20.79 Favored 'Trans proline' 0 C--N 1.353 0.774 0 C-N-CA 122.35 2.033 . . . . 0.0 110.191 179.617 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.423 ' HG3' HG12 ' A' ' 15' ' ' ILE . 15.5 pt-20 -71.17 -29.63 65.43 Favored 'General case' 0 N--CA 1.415 -2.194 0 CA-C-N 113.636 -1.62 . . . . 0.0 110.045 178.728 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.441 HG22 ' SG ' ' A' ' 3' ' ' CYS . 32.2 mm -98.82 -54.84 6.54 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.746 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 -178.911 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 70.5 m -132.47 -84.7 0.48 Allowed 'General case' 0 N--CA 1.43 -1.445 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.22 176.68 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.311 -1.09 0 O-C-N 121.721 -0.612 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.506 -0.473 0 N-CA-C 110.413 -1.075 . . . . 0.0 110.413 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 3.4 m -62.69 -19.33 63.78 Favored 'General case' 0 C--O 1.21 -1.0 0 N-CA-C 114.666 1.358 . . . . 0.0 114.666 -177.791 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.468 ' SG ' HG22 ' A' ' 15' ' ' ILE . 52.6 m -70.59 -33.1 70.7 Favored 'General case' 0 C--N 1.281 -2.398 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 177.605 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 18.8 m -81.3 -2.64 49.83 Favored 'General case' 0 C--N 1.284 -2.266 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.015 175.456 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 26.5 m80 -107.43 101.3 38.53 Favored Pre-proline 0 C--N 1.313 -1.0 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.157 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 99.1 Cg_exo -45.56 -44.65 16.96 Favored 'Trans proline' 0 N--CA 1.478 0.615 0 C-N-CA 123.927 3.085 . . . . 0.0 114.408 -175.536 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -72.48 -37.53 68.42 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 112.257 0.465 . . . . 0.0 112.257 -177.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 14.0 t -83.13 -19.97 35.67 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.736 0.779 . . . . 0.0 109.573 -174.837 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -64.12 -45.09 90.1 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.963 -179.515 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 57.7 t -62.06 -39.45 83.84 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.012 0 CA-C-N 114.211 -1.359 . . . . 0.0 112.542 -175.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -86.41 1.37 51.54 Favored 'General case' 0 CA--C 1.512 -0.508 0 C-N-CA 120.079 -0.649 . . . . 0.0 112.647 -177.394 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 49.7 m80 -118.68 73.02 11.23 Favored Pre-proline 0 N--CA 1.425 -1.684 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 172.557 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_exo -71.28 -25.52 21.84 Favored 'Trans proline' 0 C--N 1.353 0.813 0 C-N-CA 122.393 2.062 . . . . 0.0 111.561 -175.898 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -73.8 -26.13 60.47 Favored 'General case' 0 N--CA 1.419 -2.002 0 CA-C-N 114.282 -1.326 . . . . 0.0 110.999 179.56 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.468 HG22 ' SG ' ' A' ' 3' ' ' CYS . 46.2 mt -94.22 -48.36 13.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 178.603 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 32.8 m -138.54 -74.93 0.39 Allowed 'General case' 0 N--CA 1.423 -1.816 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.742 179.046 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.315 -0.934 0 O-C-N 122.206 -0.309 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.493 -1.29 0 N-CA-C 110.249 -1.14 . . . . 0.0 110.249 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 1.7 m -61.56 -34.26 75.27 Favored 'General case' 0 CA--C 1.487 -1.473 0 N-CA-C 114.258 1.207 . . . . 0.0 114.258 -178.737 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 1.6 m -71.0 -22.78 62.12 Favored 'General case' 0 C--N 1.28 -2.439 0 N-CA-C 113.711 1.004 . . . . 0.0 113.711 178.671 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 16.3 m -72.52 -12.45 61.08 Favored 'General case' 0 C--N 1.287 -2.146 0 CA-C-O 121.293 0.568 . . . . 0.0 110.013 173.58 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 62.3 m80 -109.08 122.38 40.02 Favored Pre-proline 0 C--N 1.319 -0.72 0 C-N-CA 123.661 0.784 . . . . 0.0 109.221 178.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -55.55 -33.03 85.24 Favored 'Trans proline' 0 CA--C 1.542 0.921 0 C-N-CA 122.839 2.359 . . . . 0.0 113.825 -177.315 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -72.71 -47.19 49.23 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 112.411 0.523 . . . . 0.0 112.411 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.457 ' HA ' ' OD1' ' A' ' 11' ' ' ASP . 3.9 t -83.24 -14.5 53.11 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-O 121.664 0.745 . . . . 0.0 110.206 -173.168 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 20.1 t-20 -59.75 -42.23 92.76 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 115.334 -0.848 . . . . 0.0 109.838 178.672 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 47.5 t -62.72 -41.28 91.76 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.993 0 CA-C-N 113.847 -1.524 . . . . 0.0 111.684 -177.277 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.457 ' OD1' ' HA ' ' A' ' 8' ' ' CYS . 5.3 p-10 -88.84 14.74 9.66 Favored 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 113.127 0.788 . . . . 0.0 113.127 -176.672 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 18.3 m-70 -118.57 79.53 16.04 Favored Pre-proline 0 N--CA 1.432 -1.343 0 N-CA-C 111.701 0.26 . . . . 0.0 111.701 173.07 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -66.7 -27.23 45.12 Favored 'Trans proline' 0 C--N 1.359 1.107 0 C-N-CA 123.029 2.486 . . . . 0.0 110.95 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.449 ' HG3' HG12 ' A' ' 15' ' ' ILE . 11.0 pt-20 -71.45 -21.35 61.97 Favored 'General case' 0 N--CA 1.419 -2.009 0 CA-C-N 113.729 -1.578 . . . . 0.0 111.853 -178.552 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.449 HG12 ' HG3' ' A' ' 14' ' ' GLU . 30.9 mm -112.24 -49.94 5.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 121.462 0.648 . . . . 0.0 109.54 -178.621 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 84.1 m -124.58 -79.4 0.61 Allowed 'General case' 0 N--CA 1.425 -1.708 0 CA-C-N 115.093 -0.958 . . . . 0.0 111.251 -176.828 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.499 0 O-C-N 122.055 -0.403 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.508 -0.377 0 N-CA-C 111.458 -0.657 . . . . 0.0 111.458 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 32.2 m -60.53 -17.82 48.22 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 116.18 1.918 . . . . 0.0 116.18 -175.678 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 79.6 m -67.05 -33.74 76.16 Favored 'General case' 0 C--N 1.273 -2.748 0 N-CA-C 112.891 0.7 . . . . 0.0 112.891 -179.218 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 24.8 p -86.28 12.6 9.6 Favored 'General case' 0 C--N 1.278 -2.53 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.873 176.399 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 33.7 m-70 -124.35 103.07 32.73 Favored Pre-proline 0 C--N 1.317 -0.822 0 C-N-CA 124.124 0.97 . . . . 0.0 109.036 -178.261 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.408 ' O ' HG23 ' A' ' 10' ' ' VAL . 90.9 Cg_exo -47.46 -45.21 23.46 Favored 'Trans proline' 0 N--CA 1.474 0.349 0 C-N-CA 123.656 2.904 . . . . 0.0 114.186 -176.24 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -68.17 -41.15 81.95 Favored 'General case' 0 C--N 1.317 -0.824 0 C-N-CA 121.337 -0.145 . . . . 0.0 111.282 -177.286 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 8.4 t -83.62 -16.87 43.56 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 121.808 0.813 . . . . 0.0 110.097 -175.694 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 -66.34 -38.25 87.21 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-O 121.751 0.786 . . . . 0.0 108.965 179.526 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.408 HG23 ' O ' ' A' ' 6' ' ' PRO . 97.4 t -60.62 -46.45 95.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 114.011 -1.45 . . . . 0.0 112.679 -178.087 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.412 ' C ' ' HD3' ' A' ' 13' ' ' PRO . 7.5 p-10 -87.01 1.86 51.44 Favored 'General case' 0 CA--C 1.513 -0.45 0 N-CA-C 113.485 0.92 . . . . 0.0 113.485 -173.863 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' HIS . . . . . 0.6 ' HB3' ' HB ' ' A' ' 15' ' ' ILE . 47.3 m80 -116.39 73.0 5.3 Favored Pre-proline 0 N--CA 1.429 -1.479 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 172.318 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.412 ' HD3' ' C ' ' A' ' 11' ' ' ASP . 21.4 Cg_exo -64.95 -27.44 58.4 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 123.079 2.52 . . . . 0.0 114.17 -173.166 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.448 ' H ' ' CD ' ' A' ' 14' ' ' GLU . 0.0 OUTLIER -95.86 -22.06 17.7 Favored 'General case' 0 N--CA 1.408 -2.535 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.209 -178.049 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.6 ' HB ' ' HB3' ' A' ' 12' ' ' HIS . 37.2 mm -89.99 -45.2 15.11 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.665 0 CA-C-O 121.94 0.876 . . . . 0.0 108.66 -177.26 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 62.6 m -116.65 -77.82 0.57 Allowed 'General case' 0 N--CA 1.413 -2.316 0 CA-C-N 114.508 -1.224 . . . . 0.0 110.259 -177.7 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.326 -0.449 0 O-C-N 122.004 -0.435 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.496 -1.103 0 N-CA-C 110.912 -0.875 . . . . 0.0 110.912 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' CYS . . . . . 0.47 ' HA ' ' HB2' ' A' ' 5' ' ' HIS . 19.7 m -66.01 -17.08 64.45 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 115.168 1.544 . . . . 0.0 115.168 -176.334 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.401 ' SG ' HG22 ' A' ' 15' ' ' ILE . 58.4 m -63.15 -31.63 72.81 Favored 'General case' 0 C--N 1.281 -2.373 0 N-CA-C 113.172 0.804 . . . . 0.0 113.172 177.712 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 5.3 p -99.17 18.59 17.1 Favored 'General case' 0 C--N 1.279 -2.487 0 CA-C-O 121.848 0.832 . . . . 0.0 110.118 175.681 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' HIS . . . . . 0.47 ' HB2' ' HA ' ' A' ' 2' ' ' CYS . 67.5 m170 -122.01 93.79 48.43 Favored Pre-proline 0 C--N 1.312 -1.038 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 178.991 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -49.79 -48.68 18.39 Favored 'Trans proline' 0 N--CA 1.484 0.949 0 C-N-CA 123.35 2.7 . . . . 0.0 114.447 -173.958 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -71.34 -19.66 62.27 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.81 -177.113 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 20.8 t -95.07 -22.41 17.92 Favored 'General case' 0 C--O 1.208 -1.128 0 C-N-CA 120.087 -0.645 . . . . 0.0 109.67 179.415 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.412 ' HB2' ' O ' ' A' ' 5' ' ' HIS . 57.3 t30 -85.07 -29.38 24.95 Favored 'General case' 0 C--N 1.28 -2.441 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.93 -167.868 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 7.3 p -56.01 -31.62 31.45 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.126 0 CA-C-N 115.082 -0.963 . . . . 0.0 111.652 178.208 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.407 ' O ' ' HD3' ' A' ' 13' ' ' PRO . 4.3 p30 -97.85 12.56 33.59 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-O 120.894 0.378 . . . . 0.0 111.569 179.425 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' HIS . . . . . 0.407 ' HB3' ' HB ' ' A' ' 15' ' ' ILE . 48.4 m80 -116.94 71.93 5.72 Favored Pre-proline 0 N--CA 1.44 -0.935 0 C-N-CA 122.767 0.427 . . . . 0.0 110.166 174.592 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.407 ' HD3' ' O ' ' A' ' 11' ' ' ASP . 7.5 Cg_exo -72.56 -32.72 9.42 Favored 'Trans proline' 0 C--N 1.356 0.944 0 C-N-CA 122.844 2.363 . . . . 0.0 113.761 -172.593 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -92.4 5.27 51.31 Favored 'General case' 0 N--CA 1.411 -2.376 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.594 -178.549 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.407 ' HB ' ' HB3' ' A' ' 12' ' ' HIS . 37.2 mm -105.33 -65.93 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.952 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 177.565 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 69.2 m -135.56 88.65 2.43 Favored 'General case' 0 C--N 1.288 -2.096 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.458 179.575 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.31 -1.15 0 CA-C-N 116.245 -0.434 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.495 -1.177 0 N-CA-C 110.156 -1.178 . . . . 0.0 110.156 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 14.2 m -68.53 -22.84 64.49 Favored 'General case' 0 N--CA 1.428 -1.528 0 N-CA-C 114.041 1.126 . . . . 0.0 114.041 -177.671 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 65.0 m -75.12 -28.02 60.04 Favored 'General case' 0 C--N 1.294 -1.833 0 CA-C-O 121.697 0.761 . . . . 0.0 111.555 176.411 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 4.1 m -71.54 0.97 7.25 Favored 'General case' 0 C--N 1.297 -1.678 0 CA-C-N 114.495 -1.23 . . . . 0.0 109.781 174.95 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' HIS . . . . . 0.464 ' O ' ' HB2' ' A' ' 9' ' ' ASN . 57.4 m80 -125.91 147.96 60.89 Favored Pre-proline 0 N--CA 1.438 -1.075 0 C-N-CA 124.804 1.241 . . . . 0.0 107.895 178.498 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -77.44 -41.67 0.33 Allowed 'Trans proline' 0 CA--C 1.548 1.217 0 C-N-CA 121.652 1.568 . . . . 0.0 112.865 175.679 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -72.08 -39.86 68.66 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 113.332 0.864 . . . . 0.0 113.332 -174.159 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 10.1 t -87.12 4.21 43.18 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-O 121.932 0.872 . . . . 0.0 109.787 -178.662 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.464 ' HB2' ' O ' ' A' ' 5' ' ' HIS . 1.3 t30 -79.19 -39.78 32.48 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-O 121.702 0.763 . . . . 0.0 109.364 -177.218 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 14.9 p -71.05 -30.59 41.81 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-N 114.46 -1.245 . . . . 0.0 112.752 -174.923 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -87.92 3.43 48.58 Favored 'General case' 0 C--N 1.317 -0.81 0 C-N-CA 119.037 -1.065 . . . . 0.0 112.457 -179.28 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 68.3 m80 -118.67 73.12 11.27 Favored Pre-proline 0 N--CA 1.425 -1.682 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 172.208 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo -72.94 -31.22 10.22 Favored 'Trans proline' 0 C--N 1.359 1.109 0 C-N-CA 122.768 2.312 . . . . 0.0 112.257 -173.446 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -77.51 -10.16 59.33 Favored 'General case' 0 N--CA 1.419 -1.975 0 CA-C-N 114.394 -1.276 . . . . 0.0 111.391 -179.311 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 37.8 mm -104.06 -57.63 4.36 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.007 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 177.496 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 91.7 m -131.4 -83.26 0.52 Allowed 'General case' 0 N--CA 1.426 -1.672 0 CA-C-N 115.074 -0.966 . . . . 0.0 110.761 178.449 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.323 -0.559 0 O-C-N 121.723 -0.611 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.499 -0.919 0 N-CA-C 109.969 -1.253 . . . . 0.0 109.969 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 1.7 m -64.94 -23.2 67.15 Favored 'General case' 0 C--O 1.189 -2.089 0 N-CA-C 113.438 0.903 . . . . 0.0 113.438 179.375 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 19.4 m -77.0 -29.7 55.58 Favored 'General case' 0 C--N 1.277 -2.582 0 CA-C-O 121.213 0.53 . . . . 0.0 112.095 175.974 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 2.7 m -67.44 -28.49 67.93 Favored 'General case' 0 C--N 1.286 -2.16 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 175.016 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' HIS . . . . . 0.4 ' HA ' ' HD2' ' A' ' 6' ' ' PRO . 32.7 m170 -91.04 113.23 57.49 Favored Pre-proline 0 C--N 1.318 -0.8 0 CA-C-N 114.877 -1.056 . . . . 0.0 110.0 -179.674 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.4 ' HD2' ' HA ' ' A' ' 5' ' ' HIS . 7.0 Cg_endo -51.62 -40.97 63.4 Favored 'Trans proline' 0 CA--C 1.539 0.73 0 C-N-CA 123.13 2.553 . . . . 0.0 113.956 -177.901 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -72.41 -39.98 67.52 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 -177.0 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 11.0 t -83.48 -19.83 35.1 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.451 0.644 . . . . 0.0 110.118 -174.506 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 18.4 t-20 -54.08 -44.34 71.09 Favored 'General case' 0 C--N 1.321 -0.673 0 C-N-CA 124.735 1.214 . . . . 0.0 111.162 -178.122 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 36.0 t -62.89 -38.32 81.57 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.184 0 CA-C-N 114.085 -1.416 . . . . 0.0 112.502 -175.072 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.42 ' O ' ' HD3' ' A' ' 13' ' ' PRO . 5.4 p-10 -90.22 13.93 13.94 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 119.795 -0.762 . . . . 0.0 112.93 -176.879 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 22.8 m-70 -114.35 79.17 5.07 Favored Pre-proline 0 N--CA 1.431 -1.425 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 171.809 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.42 ' HD3' ' O ' ' A' ' 11' ' ' ASP . 5.4 Cg_exo -72.31 -27.84 15.86 Favored 'Trans proline' 0 C--N 1.358 1.036 0 C-N-CA 123.36 2.706 . . . . 0.0 112.923 -172.015 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -84.05 -11.46 56.69 Favored 'General case' 0 C--N 1.291 -1.947 0 CA-C-N 115.139 -0.937 . . . . 0.0 111.505 -178.394 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 27.5 mm -107.91 -52.84 6.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 -179.344 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 97.5 m -129.04 -81.69 0.57 Allowed 'General case' 0 N--CA 1.426 -1.641 0 CA-C-N 114.979 -1.009 . . . . 0.0 111.433 -179.088 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.323 -0.571 0 O-C-N 121.809 -0.557 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.502 -0.762 0 N-CA-C 110.801 -0.92 . . . . 0.0 110.801 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' CYS . . . . . 0.476 ' HA ' ' HB2' ' A' ' 5' ' ' HIS . 16.5 m -67.48 -16.27 64.12 Favored 'General case' 0 N--CA 1.435 -1.216 0 N-CA-C 114.765 1.394 . . . . 0.0 114.765 -176.747 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 65.0 m -67.73 -33.98 75.95 Favored 'General case' 0 C--N 1.279 -2.471 0 CA-C-O 121.193 0.521 . . . . 0.0 111.148 176.475 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 20.7 m -85.85 14.53 5.86 Favored 'General case' 0 C--N 1.294 -1.81 0 CA-C-N 115.256 -0.884 . . . . 0.0 110.301 176.037 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' HIS . . . . . 0.476 ' HB2' ' HA ' ' A' ' 2' ' ' CYS . 42.4 m80 -130.76 94.79 27.86 Favored Pre-proline 0 C--N 1.318 -0.785 0 C-N-CA 124.425 1.09 . . . . 0.0 109.727 -178.453 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_exo -48.88 -48.86 16.59 Favored 'Trans proline' 0 N--CA 1.481 0.77 0 C-N-CA 123.537 2.825 . . . . 0.0 113.913 -176.306 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -64.85 -32.63 74.42 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 111.847 0.314 . . . . 0.0 111.847 -178.478 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 34.1 t -84.4 -20.76 31.36 Favored 'General case' 0 C--O 1.203 -1.357 0 CA-C-O 121.601 0.715 . . . . 0.0 109.436 179.838 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 45.6 t-20 -82.73 -48.08 11.26 Favored 'General case' 0 C--N 1.288 -2.105 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.646 -173.321 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 11.8 p -54.04 -39.15 40.17 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.206 0 CA-C-N 114.873 -1.058 . . . . 0.0 113.775 -175.045 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -99.94 5.86 45.23 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 118.557 -1.257 . . . . 0.0 111.905 -179.224 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 20.2 m170 -118.62 76.88 13.84 Favored Pre-proline 0 N--CA 1.438 -1.067 0 N-CA-C 112.789 0.662 . . . . 0.0 112.789 177.174 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_exo -72.56 -21.03 22.79 Favored 'Trans proline' 0 N--CA 1.462 -0.374 0 C-N-CA 121.985 1.79 . . . . 0.0 110.503 178.513 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -74.89 -22.95 58.35 Favored 'General case' 0 N--CA 1.428 -1.556 0 CA-C-N 114.371 -1.286 . . . . 0.0 110.382 179.52 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 50.3 mm -99.8 -50.01 10.96 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.805 0 N-CA-C 108.644 -0.872 . . . . 0.0 108.644 -179.421 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 63.6 m -129.52 -86.58 0.54 Allowed 'General case' 0 N--CA 1.417 -2.101 0 CA-C-N 114.896 -1.047 . . . . 0.0 110.319 -179.848 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.321 -0.655 0 O-C-N 121.665 -0.647 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.807 0 N-CA-C 111.51 -0.636 . . . . 0.0 111.51 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 6.1 m -65.76 -17.97 65.0 Favored 'General case' 0 CA--C 1.491 -1.292 0 N-CA-C 114.747 1.388 . . . . 0.0 114.747 -177.403 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 30.2 m -65.64 -32.86 74.66 Favored 'General case' 0 C--N 1.283 -2.293 0 CA-C-O 121.021 0.439 . . . . 0.0 111.912 177.026 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 19.1 m -82.28 11.61 5.25 Favored 'General case' 0 C--N 1.287 -2.134 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.374 176.06 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 45.2 m-70 -124.56 111.45 27.85 Favored Pre-proline 0 C--N 1.313 -0.983 0 C-N-CA 123.817 0.847 . . . . 0.0 109.361 179.533 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -49.21 -49.31 15.75 Favored 'Trans proline' 0 CA--C 1.539 0.741 0 C-N-CA 123.462 2.774 . . . . 0.0 114.691 -174.485 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -72.75 -37.21 67.75 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 112.621 0.6 . . . . 0.0 112.621 -177.826 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.424 ' HA ' ' OD1' ' A' ' 11' ' ' ASP . 7.3 t -81.65 -19.9 40.76 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 122.019 0.914 . . . . 0.0 108.833 -174.784 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -62.09 -44.19 97.2 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-N 114.837 -1.074 . . . . 0.0 109.704 177.682 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 49.5 t -65.28 -41.96 92.7 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 CA-C-N 113.953 -1.476 . . . . 0.0 111.796 -176.038 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.424 ' OD1' ' HA ' ' A' ' 8' ' ' CYS . 4.5 p-10 -84.9 3.92 35.85 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 113.316 0.858 . . . . 0.0 113.316 -175.283 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' HIS . . . . . 0.459 ' HB3' ' HB ' ' A' ' 15' ' ' ILE . 61.2 m80 -113.72 77.34 3.41 Favored Pre-proline 0 N--CA 1.434 -1.245 0 N-CA-C 109.924 -0.399 . . . . 0.0 109.924 172.462 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_exo -66.54 -32.33 39.52 Favored 'Trans proline' 0 C--N 1.355 0.899 0 C-N-CA 122.728 2.286 . . . . 0.0 112.47 -174.803 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -79.69 -22.69 43.09 Favored 'General case' 0 C--N 1.289 -2.057 0 CA-C-N 114.53 -1.214 . . . . 0.0 111.845 -178.1 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.459 ' HB ' ' HB3' ' A' ' 12' ' ' HIS . 41.2 mm -100.92 -58.71 3.72 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 CA-C-O 121.813 0.816 . . . . 0.0 109.337 -176.757 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 36.8 m -97.78 -71.92 0.67 Allowed 'General case' 0 C--N 1.281 -2.403 0 CA-C-N 114.707 -1.133 . . . . 0.0 110.319 -175.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.321 -0.673 0 O-C-N 122.311 -0.243 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.573 0 N-CA-C 111.958 -0.457 . . . . 0.0 111.958 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' CYS . . . . . 0.464 ' HA ' ' HB2' ' A' ' 5' ' ' HIS . 31.1 m -60.84 -22.04 63.81 Favored 'General case' 0 N--CA 1.438 -1.061 0 N-CA-C 116.358 1.985 . . . . 0.0 116.358 -174.041 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 67.2 m -71.95 -35.91 69.71 Favored 'General case' 0 C--N 1.278 -2.53 0 C-N-CA 120.542 -0.463 . . . . 0.0 112.149 179.247 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 38.4 t -83.64 1.26 43.24 Favored 'General case' 0 C--N 1.281 -2.386 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.931 177.225 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' HIS . . . . . 0.464 ' HB2' ' HA ' ' A' ' 2' ' ' CYS . 39.9 m170 -110.32 111.19 57.85 Favored Pre-proline 0 C--N 1.311 -1.092 0 C-N-CA 123.504 0.721 . . . . 0.0 109.901 -177.788 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.493 ' O ' HG23 ' A' ' 10' ' ' VAL . 52.9 Cg_exo -51.5 -49.62 16.59 Favored 'Trans proline' 0 CA--C 1.542 0.915 0 C-N-CA 123.16 2.573 . . . . 0.0 115.033 -172.587 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -73.09 -33.12 65.42 Favored 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 112.6 0.593 . . . . 0.0 112.6 -176.949 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.523 ' HA ' ' OD2' ' A' ' 11' ' ' ASP . 8.9 t -82.75 -20.33 36.14 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 122.07 0.938 . . . . 0.0 108.906 -177.984 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 -66.21 -40.93 90.71 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 115.057 -0.974 . . . . 0.0 108.484 177.23 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.493 HG23 ' O ' ' A' ' 6' ' ' PRO . 84.3 t -62.34 -36.24 73.62 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 CA-C-N 114.458 -1.247 . . . . 0.0 111.417 -179.921 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.523 ' OD2' ' HA ' ' A' ' 8' ' ' CYS . 3.3 p30 -87.84 0.74 55.42 Favored 'General case' 0 C--N 1.321 -0.664 0 C-N-CA 119.518 -0.873 . . . . 0.0 111.196 179.625 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' HIS . . . . . 0.564 ' HB3' ' HB ' ' A' ' 15' ' ' ILE . 1.0 OUTLIER -118.58 70.59 9.26 Favored Pre-proline 0 C--N 1.312 -1.038 0 C-N-CA 123.071 0.548 . . . . 0.0 110.248 175.378 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -79.19 -17.98 11.43 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 121.696 1.597 . . . . 0.0 111.799 -176.337 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -100.92 0.15 37.84 Favored 'General case' 0 N--CA 1.41 -2.441 0 CA-C-N 114.721 -1.127 . . . . 0.0 111.182 -178.935 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.564 ' HB ' ' HB3' ' A' ' 12' ' ' HIS . 25.3 mm -114.65 -54.95 4.52 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.949 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 -179.797 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 21.6 m -103.9 93.41 4.86 Favored 'General case' 0 C--N 1.284 -2.261 0 CA-C-N 114.089 -1.414 . . . . 0.0 110.077 -174.095 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.31 -1.15 0 CA-C-N 116.39 -0.368 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.946 0 N-CA-C 112.209 -0.357 . . . . 0.0 112.209 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 4.0 m -64.99 -19.95 66.25 Favored 'General case' 0 N--CA 1.433 -1.305 0 N-CA-C 114.158 1.17 . . . . 0.0 114.158 -179.218 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 20.0 m -68.06 -30.81 70.1 Favored 'General case' 0 C--N 1.28 -2.415 0 N-CA-C 112.98 0.733 . . . . 0.0 112.98 178.819 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 16.6 m -72.84 -0.53 13.7 Favored 'General case' 0 C--N 1.291 -1.951 0 CA-C-O 121.369 0.604 . . . . 0.0 110.533 175.742 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 76.6 m80 -125.98 104.21 26.56 Favored Pre-proline 0 C--O 1.216 -0.676 0 C-N-CA 124.322 1.049 . . . . 0.0 108.952 -178.25 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -50.21 -35.19 42.34 Favored 'Trans proline' 0 N--CA 1.483 0.89 0 C-N-CA 123.229 2.619 . . . . 0.0 113.83 -177.217 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -68.98 -32.93 72.85 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 111.577 0.214 . . . . 0.0 111.577 -179.015 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.428 ' HA ' ' OD1' ' A' ' 11' ' ' ASP . 6.4 t -97.11 -18.62 19.22 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.933 0.873 . . . . 0.0 109.593 -177.78 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 19.9 t-20 -60.13 -45.16 93.96 Favored 'General case' 0 C--N 1.314 -0.948 0 C-N-CA 124.21 1.004 . . . . 0.0 110.481 -178.808 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 12.3 p -66.66 -30.56 50.1 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.003 0 CA-C-N 114.156 -1.384 . . . . 0.0 112.322 -176.823 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.428 ' OD1' ' HA ' ' A' ' 8' ' ' CYS 0.252 7.0 p-10 -90.8 5.21 49.32 Favored 'General case' 0 C--O 1.24 0.557 0 C-N-CA 119.649 -0.82 . . . . 0.0 112.137 -179.871 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 69.2 m80 -119.38 72.01 13.45 Favored Pre-proline 0 N--CA 1.431 -1.42 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.702 168.719 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -77.77 -12.02 16.63 Favored 'Trans proline' 0 C--N 1.354 0.856 0 C-N-CA 122.522 2.148 . . . . 0.0 111.955 -176.437 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -80.01 -20.85 44.44 Favored 'General case' 0 N--CA 1.416 -2.125 0 CA-C-N 114.907 -1.042 . . . . 0.0 110.393 177.528 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 38.5 mt -103.37 -54.41 6.58 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.04 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 177.257 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 91.1 m -122.16 -94.65 0.49 Allowed 'General case' 0 N--CA 1.415 -2.212 0 CA-C-N 114.702 -1.136 . . . . 0.0 110.522 178.437 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.322 -0.612 0 O-C-N 121.912 -0.492 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.503 -0.666 0 N-CA-C 110.358 -1.097 . . . . 0.0 110.358 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' CYS . . . . . 0.45 ' HB3' ' O ' ' A' ' 8' ' ' CYS . 8.0 m -72.1 -22.91 61.28 Favored 'General case' 0 N--CA 1.428 -1.536 0 N-CA-C 113.265 0.839 . . . . 0.0 113.265 -178.745 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 1.8 m -74.55 -24.56 58.95 Favored 'General case' 0 C--N 1.294 -1.841 0 CA-C-O 121.205 0.526 . . . . 0.0 111.148 173.792 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 4.0 m -69.77 -26.28 64.21 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 173.638 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' HIS . . . . . 0.555 ' O ' ' HB2' ' A' ' 9' ' ' ASN . 30.5 m80 -90.38 156.2 45.91 Favored Pre-proline 0 N--CA 1.446 -0.666 0 CA-C-N 114.703 -1.135 . . . . 0.0 109.957 178.946 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -84.47 -49.49 0.04 OUTLIER 'Trans proline' 0 CA--C 1.549 1.231 0 C-N-CA 122.03 1.82 . . . . 0.0 114.196 178.59 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -73.26 -38.03 66.11 Favored 'General case' 0 C--N 1.32 -0.706 0 O-C-N 121.703 -0.623 . . . . 0.0 112.299 -177.25 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.45 ' O ' ' HB3' ' A' ' 2' ' ' CYS . 5.9 t -83.3 0.67 44.69 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 122.098 0.951 . . . . 0.0 109.45 -176.837 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.555 ' HB2' ' O ' ' A' ' 5' ' ' HIS . 19.6 t-20 -74.39 -41.19 61.37 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 114.962 -1.017 . . . . 0.0 108.739 -179.73 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 62.1 t -58.82 -35.24 55.05 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-N 113.279 -1.782 . . . . 0.0 112.679 -176.381 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.522 ' O ' ' HD3' ' A' ' 13' ' ' PRO 0.276 7.1 p-10 -82.62 6.35 18.03 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 113.863 1.06 . . . . 0.0 113.863 -177.865 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 12' ' ' HIS . . . . . 0.431 ' HB3' ' HB ' ' A' ' 15' ' ' ILE . 23.5 m-70 -109.75 74.18 0.72 Allowed Pre-proline 0 N--CA 1.441 -0.886 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 168.881 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.522 ' HD3' ' O ' ' A' ' 11' ' ' ASP . 13.6 Cg_exo -66.82 -35.99 25.37 Favored 'Trans proline' 0 CA--C 1.501 -1.14 0 C-N-CA 122.756 2.304 . . . . 0.0 113.439 -168.489 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -86.85 -1.03 57.47 Favored 'General case' 0 C--N 1.282 -2.334 0 CA-C-N 114.926 -1.033 . . . . 0.0 111.946 -177.127 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.431 ' HB ' ' HB3' ' A' ' 12' ' ' HIS . 30.7 mm -114.37 -52.44 5.02 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 -179.661 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 73.5 m -128.24 87.52 2.61 Favored 'General case' 0 C--N 1.288 -2.1 0 CA-C-N 114.625 -1.171 . . . . 0.0 109.945 -179.518 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.304 -1.389 0 CA-C-N 116.223 -0.444 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.13 0 N-CA-C 112.492 -0.243 . . . . 0.0 112.492 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 1.6 m -62.36 -21.65 65.49 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-O 120.963 0.411 . . . . 0.0 111.514 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 3.4 m -65.3 -37.34 86.84 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.155 -179.869 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 50.6 m -64.6 -11.8 38.69 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.37 178.792 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' HIS . . . . . 0.499 ' O ' ' HB2' ' A' ' 9' ' ' ASN . 87.5 m-70 -105.37 150.14 38.58 Favored Pre-proline 0 N--CA 1.452 -0.326 0 CA-C-N 114.922 -1.036 . . . . 0.0 110.273 179.524 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -84.49 -38.51 0.12 Allowed 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.464 2.11 . . . . 0.0 112.928 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -72.29 -44.99 61.94 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 -179.06 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.412 ' HA ' ' OD1' ' A' ' 11' ' ' ASP . 6.9 t -83.59 12.21 6.06 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.664 0.269 . . . . 0.0 111.567 -178.941 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.499 ' HB2' ' O ' ' A' ' 5' ' ' HIS . 54.8 t30 -90.74 -51.45 5.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.192 0.52 . . . . 0.0 111.458 -179.799 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 22.5 t -54.94 -41.69 59.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.201 -0.909 . . . . 0.0 112.598 -178.94 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.412 ' OD1' ' HA ' ' A' ' 8' ' ' CYS . 5.2 p-10 -75.87 1.72 14.33 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 -179.042 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 15.3 m-70 -119.34 71.76 12.97 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.188 179.461 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -76.91 -10.16 18.15 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.321 2.014 . . . . 0.0 112.356 -179.855 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -93.98 -2.77 52.63 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.113 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 25.7 mm -111.8 -71.16 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-O 120.929 0.395 . . . . 0.0 111.098 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 33.6 m -105.23 -77.7 0.58 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.041 179.769 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 116.526 -0.306 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.5 -0.884 0 N-CA-C 110.818 -0.913 . . . . 0.0 110.818 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 20.7 m -62.73 -22.25 66.4 Favored 'General case' 0 N--CA 1.432 -1.366 0 N-CA-C 115.609 1.707 . . . . 0.0 115.609 -175.429 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 24.0 m -70.19 -35.42 73.92 Favored 'General case' 0 C--N 1.283 -2.317 0 C-N-CA 120.543 -0.463 . . . . 0.0 112.194 177.103 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 20.0 m -79.18 -4.38 50.19 Favored 'General case' 0 C--N 1.295 -1.764 0 CA-C-O 121.516 0.674 . . . . 0.0 110.304 177.401 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 10.6 m-70 -104.1 103.71 39.64 Favored Pre-proline 0 C--N 1.317 -0.83 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 176.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_exo -49.57 -38.58 45.16 Favored 'Trans proline' 0 CA--C 1.544 1.025 0 C-N-CA 122.736 2.291 . . . . 0.0 113.302 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -72.46 -41.91 65.55 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 -179.097 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 10.2 t -82.78 -19.99 36.72 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-O 121.742 0.782 . . . . 0.0 109.64 -175.083 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 -58.61 -41.81 86.75 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 115.036 -0.984 . . . . 0.0 109.477 179.093 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 49.1 t -62.7 -34.35 65.01 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 CA-C-N 114.09 -1.414 . . . . 0.0 111.955 -177.724 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -94.25 1.92 55.94 Favored 'General case' 0 C--N 1.316 -0.888 0 C-N-CA 119.199 -1.0 . . . . 0.0 112.971 -175.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 78.6 m-70 -118.73 72.37 10.91 Favored Pre-proline 0 N--CA 1.432 -1.328 0 CA-C-N 116.677 -0.238 . . . . 0.0 110.746 174.06 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -73.49 -13.76 25.04 Favored 'Trans proline' 0 C--N 1.356 0.943 0 C-N-CA 121.795 1.664 . . . . 0.0 111.411 -177.552 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.493 ' HG3' HG12 ' A' ' 15' ' ' ILE . 10.4 pt-20 -81.72 -23.48 36.71 Favored 'General case' 0 N--CA 1.421 -1.922 0 CA-C-N 114.553 -1.203 . . . . 0.0 110.896 179.267 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.493 HG12 ' HG3' ' A' ' 14' ' ' GLU . 35.7 mm -107.54 -50.98 7.54 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.067 0 CA-C-O 121.813 0.816 . . . . 0.0 108.805 -177.606 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 31.1 m . . . . . 0 C--N 1.287 -2.136 0 CA-C-N 114.318 -1.31 . . . . 0.0 109.495 -176.864 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.501 -0.784 0 N-CA-C 110.121 -1.192 . . . . 0.0 110.121 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 9.4 m -66.69 -13.99 61.96 Favored 'General case' 0 CA--C 1.493 -1.217 0 N-CA-C 114.116 1.154 . . . . 0.0 114.116 -178.619 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 96.1 m -68.41 -35.56 77.82 Favored 'General case' 0 C--N 1.28 -2.434 0 CA-C-O 121.766 0.793 . . . . 0.0 110.971 178.111 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 19.2 m -79.72 10.9 3.55 Favored 'General case' 0 C--N 1.281 -2.408 0 CA-C-N 114.772 -1.104 . . . . 0.0 110.308 176.371 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 83.6 m-70 -130.61 95.32 26.85 Favored Pre-proline 0 N--CA 1.444 -0.736 0 C-N-CA 124.274 1.03 . . . . 0.0 109.139 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.454 ' O ' HG23 ' A' ' 10' ' ' VAL . 57.2 Cg_exo -40.87 -47.12 4.87 Favored 'Trans proline' 0 N--CA 1.484 0.969 0 C-N-CA 124.23 3.287 . . . . 0.0 114.744 -176.352 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -65.36 -40.47 93.6 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 -178.407 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 9.4 t -83.41 -20.77 33.55 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 122.143 0.973 . . . . 0.0 109.49 -174.361 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 41.2 t-20 -67.06 -41.54 86.27 Favored 'General case' 0 C--N 1.294 -1.832 0 CA-C-N 114.424 -1.262 . . . . 0.0 109.187 -178.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.454 HG23 ' O ' ' A' ' 6' ' ' PRO . 96.0 t -62.88 -41.72 93.71 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 CA-C-N 113.957 -1.474 . . . . 0.0 111.917 179.672 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -87.14 3.37 46.62 Favored 'General case' 0 C--O 1.24 0.553 0 N-CA-C 113.215 0.82 . . . . 0.0 113.215 -176.207 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . 0.446 ' HB3' ' HB ' ' A' ' 15' ' ' ILE . 88.1 m-70 -119.09 75.1 14.38 Favored Pre-proline 0 N--CA 1.428 -1.567 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.462 171.529 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo -66.43 -24.11 50.02 Favored 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 122.472 2.115 . . . . 0.0 113.997 -174.59 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -93.38 -18.33 22.51 Favored 'General case' 0 N--CA 1.416 -2.145 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.449 -177.225 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.446 ' HB ' ' HB3' ' A' ' 12' ' ' HIS . 22.8 mt -100.14 -40.82 8.67 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 CA-C-O 122.013 0.911 . . . . 0.0 109.196 -178.295 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 62.5 m . . . . . 0 N--CA 1.406 -2.647 0 CA-C-N 114.527 -1.215 . . . . 0.0 110.261 -177.268 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.242 0.645 0 N-CA-C 111.117 -0.793 . . . . 0.0 111.117 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . 0.553 ' HB2' ' NE2' ' A' ' 12' ' ' HIS . 7.9 m -60.79 -18.27 54.2 Favored 'General case' 0 C--O 1.205 -1.286 0 N-CA-C 116.022 1.86 . . . . 0.0 116.022 -176.719 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 4.7 m -65.54 -28.35 69.1 Favored 'General case' 0 C--N 1.277 -2.581 0 N-CA-C 113.947 1.091 . . . . 0.0 113.947 179.021 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 50.6 m -81.6 3.83 23.74 Favored 'General case' 0 C--N 1.282 -2.367 0 CA-C-O 121.501 0.667 . . . . 0.0 110.789 174.236 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 80.1 m-70 -117.63 103.4 50.82 Favored Pre-proline 0 C--N 1.31 -1.128 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 179.01 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_exo -44.56 -43.77 14.04 Favored 'Trans proline' 0 N--CA 1.486 1.037 0 C-N-CA 123.815 3.01 . . . . 0.0 114.245 -176.343 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -72.46 -28.28 62.83 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 112.818 0.673 . . . . 0.0 112.818 -177.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 6.9 t -102.52 4.99 39.17 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-O 122.462 1.125 . . . . 0.0 108.869 -176.53 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 -77.82 -44.97 25.74 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 114.751 -1.113 . . . . 0.0 110.383 -176.528 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 14.6 p -62.83 -25.48 38.46 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.246 0 CA-C-N 113.823 -1.535 . . . . 0.0 112.704 -176.058 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.419 ' O ' ' HD3' ' A' ' 13' ' ' PRO . 4.8 p-10 -91.24 13.15 17.98 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 113.366 0.876 . . . . 0.0 113.366 -177.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . 0.553 ' NE2' ' HB2' ' A' ' 2' ' ' CYS . 36.4 m-70 -110.22 84.18 3.56 Favored Pre-proline 0 N--CA 1.444 -0.731 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 170.342 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.419 ' HD3' ' O ' ' A' ' 11' ' ' ASP . 7.8 Cg_exo -68.74 -26.67 32.54 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.468 2.112 . . . . 0.0 113.934 -173.098 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.402 ' H ' ' CD ' ' A' ' 14' ' ' GLU . 0.2 OUTLIER -95.16 1.62 54.85 Favored 'General case' 0 N--CA 1.409 -2.487 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.561 -177.062 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 30.9 mm -122.93 -62.64 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-O 121.778 0.799 . . . . 0.0 109.166 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 71.3 m . . . . . 0 C--N 1.29 -2.004 0 CA-C-N 115.065 -0.97 . . . . 0.0 111.404 -176.412 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.494 -1.25 0 N-CA-C 110.304 -1.119 . . . . 0.0 110.304 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 3.9 m -61.37 -20.86 63.49 Favored 'General case' 0 C--O 1.2 -1.542 0 N-CA-C 114.773 1.398 . . . . 0.0 114.773 -176.354 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 83.0 m -73.51 -42.08 62.24 Favored 'General case' 0 C--N 1.285 -2.219 0 CA-C-O 121.378 0.608 . . . . 0.0 111.543 177.533 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 11.8 m -73.5 -13.75 61.1 Favored 'General case' 0 C--N 1.286 -2.18 0 CA-C-N 114.726 -1.125 . . . . 0.0 109.851 -179.399 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 9.7 m-70 -96.31 103.82 15.26 Favored Pre-proline 0 N--CA 1.434 -1.267 0 CA-C-N 114.499 -1.228 . . . . 0.0 108.863 175.079 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.537 ' O ' HG23 ' A' ' 10' ' ' VAL . 73.4 Cg_exo -50.46 -38.54 53.9 Favored 'Trans proline' 0 CA--C 1.534 0.505 0 C-N-CA 123.016 2.478 . . . . 0.0 113.679 -175.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -70.79 -40.49 72.52 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.125 0.417 . . . . 0.0 112.125 -177.255 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 11.2 t -83.38 -20.02 34.97 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 121.48 0.657 . . . . 0.0 109.454 -176.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.418 HD21 ' HB2' ' A' ' 16' ' ' CYS . 2.1 t-20 -70.12 -32.8 70.99 Favored 'General case' 0 CA--C 1.501 -0.932 0 CA-C-O 121.206 0.527 . . . . 0.0 109.616 179.418 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.537 HG23 ' O ' ' A' ' 6' ' ' PRO . 89.3 t -53.94 -40.25 44.1 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.11 0 CA-C-N 114.745 -1.116 . . . . 0.0 110.918 175.302 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.476 ' C ' ' HD3' ' A' ' 13' ' ' PRO . 3.9 p30 -94.45 1.97 55.76 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.183 0.516 . . . . 0.0 111.385 179.686 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . 0.426 ' CD2' HG13 ' A' ' 15' ' ' ILE . 6.7 m80 -119.5 67.65 10.23 Favored Pre-proline 0 C--O 1.252 1.215 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.335 173.594 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.476 ' HD3' ' C ' ' A' ' 11' ' ' ASP . 3.4 Cg_exo -84.99 -22.02 2.96 Favored 'Trans proline' 0 C--N 1.357 1.017 0 C-N-CA 121.871 1.714 . . . . 0.0 111.057 -176.605 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.405 ' HG2' ' H ' ' A' ' 14' ' ' GLU . 9.3 pt-20 -84.06 -11.92 55.94 Favored 'General case' 0 N--CA 1.412 -2.363 0 CA-C-N 113.784 -1.553 . . . . 0.0 109.739 179.471 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.426 HG13 ' CD2' ' A' ' 12' ' ' HIS . 38.2 mm -97.31 -52.52 9.08 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.36 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 -177.79 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.418 ' HB2' HD21 ' A' ' 9' ' ' ASN . 69.0 m . . . . . 0 N--CA 1.419 -1.976 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.446 178.397 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.5 -0.885 0 N-CA-C 110.339 -1.104 . . . . 0.0 110.339 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 17.3 m -60.51 -17.33 44.81 Favored 'General case' 0 C--O 1.202 -1.438 0 N-CA-C 115.442 1.645 . . . . 0.0 115.442 -176.2 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 80.8 m -63.64 -38.98 93.19 Favored 'General case' 0 C--N 1.282 -2.351 0 CA-C-O 121.279 0.561 . . . . 0.0 112.105 175.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 17.5 m -79.08 -0.28 30.88 Favored 'General case' 0 C--N 1.281 -2.39 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.668 178.391 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 17.4 m-70 -109.68 105.35 57.09 Favored Pre-proline 0 C--N 1.307 -1.239 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 178.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -54.36 -42.04 71.21 Favored 'Trans proline' 0 CA--C 1.531 0.372 0 C-N-CA 122.301 2.001 . . . . 0.0 112.564 -178.212 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -72.27 -25.23 61.52 Favored 'General case' 0 C--O 1.212 -0.881 0 N-CA-C 112.249 0.463 . . . . 0.0 112.249 -178.227 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 11.2 t -104.22 9.44 36.11 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.908 0.861 . . . . 0.0 109.037 -178.042 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 20.1 t-20 -87.08 -50.69 6.47 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-O 121.355 0.597 . . . . 0.0 110.425 -175.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 8.3 p -58.26 -37.91 65.68 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.145 0 CA-C-N 114.499 -1.228 . . . . 0.0 113.508 -175.108 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -86.97 7.34 27.91 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 113.169 0.803 . . . . 0.0 113.169 -177.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 47.7 m-70 -116.8 73.98 6.44 Favored Pre-proline 0 N--CA 1.433 -1.309 0 O-C-N 122.084 -0.385 . . . . 0.0 111.398 173.705 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_exo -67.9 -25.34 38.95 Favored 'Trans proline' 0 C--N 1.365 1.441 0 C-N-CA 122.374 2.049 . . . . 0.0 109.881 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.471 ' HG3' HG13 ' A' ' 15' ' ' ILE . 4.9 pt-20 -61.89 -34.12 75.46 Favored 'General case' 0 N--CA 1.424 -1.746 0 CA-C-N 112.937 -1.938 . . . . 0.0 112.343 177.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.471 HG13 ' HG3' ' A' ' 14' ' ' GLU . 15.6 mt -108.12 -49.48 7.65 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 C-N-CA 119.608 -0.837 . . . . 0.0 109.777 -177.154 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 84.4 m . . . . . 0 N--CA 1.428 -1.553 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.797 -178.912 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . 0.453 ' O ' ' HD2' ' A' ' 5' ' ' HIS . . . . . . . . 0 CA--C 1.503 -0.716 0 N-CA-C 110.061 -1.216 . . . . 0.0 110.061 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 4.9 m -65.49 -19.86 66.11 Favored 'General case' 0 CA--C 1.489 -1.377 0 N-CA-C 115.49 1.663 . . . . 0.0 115.49 -177.053 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.595 ' SG ' ' HB ' ' A' ' 15' ' ' ILE . 1.6 m -68.19 -25.55 65.29 Favored 'General case' 0 C--N 1.277 -2.559 0 N-CA-C 113.439 0.903 . . . . 0.0 113.439 176.84 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 14.6 m -77.19 0.02 23.37 Favored 'General case' 0 C--N 1.284 -2.241 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.099 173.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . 0.453 ' HD2' ' O ' ' A' ' 1' ' ' GLY . 76.9 m-70 -121.59 109.8 34.22 Favored Pre-proline 0 C--N 1.325 -0.492 0 C-N-CA 123.762 0.825 . . . . 0.0 108.864 -177.338 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_exo -45.74 -49.83 10.34 Favored 'Trans proline' 0 N--CA 1.491 1.333 0 C-N-CA 123.913 3.075 . . . . 0.0 115.929 -172.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -73.55 -34.21 65.06 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 113.317 0.858 . . . . 0.0 113.317 -178.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 6.6 t -83.32 -17.56 42.04 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-O 121.896 0.855 . . . . 0.0 109.365 -176.386 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 18.6 t-20 -60.72 -39.24 87.87 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 114.918 -1.037 . . . . 0.0 109.52 177.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 67.8 t -56.93 -36.06 49.1 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 CA-C-N 113.714 -1.585 . . . . 0.0 113.33 -176.671 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.415 ' C ' ' HD3' ' A' ' 13' ' ' PRO . 4.7 p-10 -94.43 1.72 55.78 Favored 'General case' 0 C--N 1.312 -1.065 0 C-N-CA 118.581 -1.247 . . . . 0.0 113.449 -175.714 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 91.9 m-70 -116.21 75.23 6.02 Favored Pre-proline 0 N--CA 1.429 -1.489 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 177.538 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.504 ' HA ' ' O ' ' A' ' 16' ' ' CYS . 15.6 Cg_exo -71.43 -10.45 26.95 Favored 'Trans proline' 0 C--N 1.361 1.214 0 C-N-CA 122.396 2.064 . . . . 0.0 111.276 177.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.469 ' HG3' HG12 ' A' ' 15' ' ' ILE . 14.8 pt-20 -63.7 -29.24 70.49 Favored 'General case' 0 N--CA 1.434 -1.265 0 C-N-CA 124.314 1.046 . . . . 0.0 110.129 177.801 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.595 ' HB ' ' SG ' ' A' ' 3' ' ' CYS . 35.4 mm -107.85 -58.93 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.169 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 177.308 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.504 ' O ' ' HA ' ' A' ' 13' ' ' PRO . 61.4 m . . . . . 0 C--N 1.288 -2.106 0 CA-C-N 114.198 -1.364 . . . . 0.0 110.392 -177.049 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.495 -1.173 0 N-CA-C 109.084 -1.607 . . . . 0.0 109.084 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 1.9 m -65.13 -24.06 67.31 Favored 'General case' 0 C--O 1.197 -1.691 0 N-CA-C 114.374 1.25 . . . . 0.0 114.374 -178.548 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 5.8 m -74.58 -32.09 62.27 Favored 'General case' 0 C--N 1.283 -2.29 0 C-N-CA 120.479 -0.488 . . . . 0.0 112.212 176.565 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 10.8 m -69.61 -18.67 63.63 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-O 121.857 0.837 . . . . 0.0 109.404 176.625 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 23.3 m-70 -97.51 107.51 39.61 Favored Pre-proline 0 C--N 1.318 -0.767 0 CA-C-N 114.778 -1.101 . . . . 0.0 108.85 176.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_exo -49.33 -36.81 39.08 Favored 'Trans proline' 0 CA--C 1.541 0.843 0 C-N-CA 123.429 2.752 . . . . 0.0 113.636 -178.298 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -72.1 -43.51 64.67 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 111.827 0.306 . . . . 0.0 111.827 -179.467 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 5.7 t -83.49 -10.86 58.07 Favored 'General case' 0 N--CA 1.479 0.978 0 CA-C-O 121.937 0.875 . . . . 0.0 109.815 -174.254 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 -62.31 -44.94 95.34 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 114.786 -1.097 . . . . 0.0 110.498 -179.366 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 49.1 t -61.29 -34.76 62.22 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.116 0 CA-C-N 114.037 -1.438 . . . . 0.0 112.334 -175.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -88.53 5.47 42.5 Favored 'General case' 0 C--O 1.245 0.858 0 N-CA-C 112.937 0.718 . . . . 0.0 112.937 -177.773 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 53.5 m-70 -119.06 72.73 12.29 Favored Pre-proline 0 N--CA 1.433 -1.288 0 C-N-CA 122.663 0.385 . . . . 0.0 110.329 172.542 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -75.09 -16.03 20.23 Favored 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 122.696 2.264 . . . . 0.0 112.685 -173.554 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -83.37 -19.55 35.87 Favored 'General case' 0 N--CA 1.419 -1.986 0 CA-C-N 115.23 -0.895 . . . . 0.0 111.219 -179.734 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 26.9 mt -103.14 -45.35 10.22 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.004 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 176.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 84.7 m . . . . . 0 N--CA 1.422 -1.853 0 CA-C-N 114.311 -1.313 . . . . 0.0 110.683 -179.732 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.503 -0.69 0 N-CA-C 110.611 -0.995 . . . . 0.0 110.611 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 6.6 m -65.61 -15.91 63.2 Favored 'General case' 0 CA--C 1.491 -1.309 0 N-CA-C 114.432 1.271 . . . . 0.0 114.432 -177.339 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.441 ' SG ' HG22 ' A' ' 15' ' ' ILE . 86.9 m -66.06 -34.04 77.16 Favored 'General case' 0 C--N 1.276 -2.626 0 CA-C-O 121.481 0.657 . . . . 0.0 111.889 176.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 50.5 m -80.32 3.65 20.38 Favored 'General case' 0 C--N 1.279 -2.47 0 CA-C-N 115.303 -0.862 . . . . 0.0 111.069 175.197 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 49.4 m-70 -120.95 92.68 48.54 Favored Pre-proline 0 C--N 1.314 -0.949 0 C-N-CA 124.113 0.965 . . . . 0.0 108.624 179.222 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_exo -45.97 -43.19 20.22 Favored 'Trans proline' 0 N--CA 1.486 1.053 0 C-N-CA 123.482 2.788 . . . . 0.0 113.888 -176.17 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -68.03 -24.61 65.11 Favored 'General case' 0 C--O 1.219 -0.552 0 N-CA-C 112.327 0.491 . . . . 0.0 112.327 -178.478 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 18.0 t -97.12 -20.78 17.74 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-O 122.044 0.926 . . . . 0.0 109.048 -179.656 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 45.8 t-20 -77.97 -39.44 42.47 Favored 'General case' 0 C--N 1.301 -1.512 0 CA-C-N 115.125 -0.943 . . . . 0.0 109.481 -176.183 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 11.0 p -60.08 -23.08 26.14 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.157 0 CA-C-N 114.366 -1.288 . . . . 0.0 112.205 -178.158 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -109.96 3.16 20.21 Favored 'General case' 0 CA--C 1.513 -0.443 0 C-N-CA 119.313 -0.955 . . . . 0.0 112.704 178.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 76.1 m-70 -118.95 78.25 16.18 Favored Pre-proline 0 N--CA 1.428 -1.542 0 N-CA-C 112.222 0.453 . . . . 0.0 112.222 176.022 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -75.37 -12.98 20.79 Favored 'Trans proline' 0 C--N 1.353 0.774 0 C-N-CA 122.35 2.033 . . . . 0.0 110.191 179.617 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.423 ' HG3' HG12 ' A' ' 15' ' ' ILE . 15.5 pt-20 -71.17 -29.63 65.43 Favored 'General case' 0 N--CA 1.415 -2.194 0 CA-C-N 113.636 -1.62 . . . . 0.0 110.045 178.728 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.441 HG22 ' SG ' ' A' ' 3' ' ' CYS . 32.2 mm -98.82 -54.84 6.54 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.746 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 -178.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 70.5 m . . . . . 0 N--CA 1.43 -1.445 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.22 176.68 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.506 -0.473 0 N-CA-C 110.413 -1.075 . . . . 0.0 110.413 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 3.4 m -62.69 -19.33 63.78 Favored 'General case' 0 C--O 1.21 -1.0 0 N-CA-C 114.666 1.358 . . . . 0.0 114.666 -177.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.468 ' SG ' HG22 ' A' ' 15' ' ' ILE . 52.6 m -70.59 -33.1 70.7 Favored 'General case' 0 C--N 1.281 -2.398 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 177.605 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 18.8 m -81.3 -2.64 49.83 Favored 'General case' 0 C--N 1.284 -2.266 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.015 175.456 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 17.4 m-70 -107.43 101.3 38.53 Favored Pre-proline 0 C--N 1.313 -1.0 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.157 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 99.1 Cg_exo -45.56 -44.65 16.96 Favored 'Trans proline' 0 N--CA 1.478 0.615 0 C-N-CA 123.927 3.085 . . . . 0.0 114.408 -175.536 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -72.48 -37.53 68.42 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 112.257 0.465 . . . . 0.0 112.257 -177.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 14.0 t -83.13 -19.97 35.67 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.736 0.779 . . . . 0.0 109.573 -174.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.426 HD22 ' HA ' ' A' ' 3' ' ' CYS . 20.5 t-20 -64.12 -45.09 90.1 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.963 -179.515 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 57.7 t -62.06 -39.45 83.84 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.012 0 CA-C-N 114.211 -1.359 . . . . 0.0 112.542 -175.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -86.41 1.37 51.54 Favored 'General case' 0 CA--C 1.512 -0.508 0 C-N-CA 120.079 -0.649 . . . . 0.0 112.647 -177.394 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 83.3 m-70 -118.68 73.02 11.23 Favored Pre-proline 0 N--CA 1.425 -1.684 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 172.557 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_exo -71.28 -25.52 21.84 Favored 'Trans proline' 0 C--N 1.353 0.813 0 C-N-CA 122.393 2.062 . . . . 0.0 111.561 -175.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -73.8 -26.13 60.47 Favored 'General case' 0 N--CA 1.419 -2.002 0 CA-C-N 114.282 -1.326 . . . . 0.0 110.999 179.56 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.468 HG22 ' SG ' ' A' ' 3' ' ' CYS . 46.2 mt -94.22 -48.36 13.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 178.603 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 32.8 m . . . . . 0 N--CA 1.423 -1.816 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.742 179.046 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.493 -1.29 0 N-CA-C 110.249 -1.14 . . . . 0.0 110.249 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 1.7 m -61.56 -34.26 75.27 Favored 'General case' 0 CA--C 1.487 -1.473 0 N-CA-C 114.258 1.207 . . . . 0.0 114.258 -178.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 1.6 m -71.0 -22.78 62.12 Favored 'General case' 0 C--N 1.28 -2.439 0 N-CA-C 113.711 1.004 . . . . 0.0 113.711 178.671 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 16.3 m -72.52 -12.45 61.08 Favored 'General case' 0 C--N 1.287 -2.146 0 CA-C-O 121.293 0.568 . . . . 0.0 110.013 173.58 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 40.0 m-70 -109.08 122.38 40.02 Favored Pre-proline 0 C--N 1.319 -0.72 0 C-N-CA 123.661 0.784 . . . . 0.0 109.221 178.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -55.55 -33.03 85.24 Favored 'Trans proline' 0 CA--C 1.542 0.921 0 C-N-CA 122.839 2.359 . . . . 0.0 113.825 -177.315 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -72.71 -47.19 49.23 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 112.411 0.523 . . . . 0.0 112.411 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.457 ' HA ' ' OD1' ' A' ' 11' ' ' ASP . 3.9 t -83.24 -14.5 53.11 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-O 121.664 0.745 . . . . 0.0 110.206 -173.168 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 20.1 t-20 -59.75 -42.23 92.76 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 115.334 -0.848 . . . . 0.0 109.838 178.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 47.5 t -62.72 -41.28 91.76 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.993 0 CA-C-N 113.847 -1.524 . . . . 0.0 111.684 -177.277 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.457 ' OD1' ' HA ' ' A' ' 8' ' ' CYS . 5.3 p-10 -88.84 14.74 9.66 Favored 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 113.127 0.788 . . . . 0.0 113.127 -176.672 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 18.3 m-70 -118.57 79.53 16.04 Favored Pre-proline 0 N--CA 1.432 -1.343 0 N-CA-C 111.701 0.26 . . . . 0.0 111.701 173.07 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -66.7 -27.23 45.12 Favored 'Trans proline' 0 C--N 1.359 1.107 0 C-N-CA 123.029 2.486 . . . . 0.0 110.95 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.449 ' HG3' HG12 ' A' ' 15' ' ' ILE . 11.0 pt-20 -71.45 -21.35 61.97 Favored 'General case' 0 N--CA 1.419 -2.009 0 CA-C-N 113.729 -1.578 . . . . 0.0 111.853 -178.552 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.449 HG12 ' HG3' ' A' ' 14' ' ' GLU . 30.9 mm -112.24 -49.94 5.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 121.462 0.648 . . . . 0.0 109.54 -178.621 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 84.1 m . . . . . 0 N--CA 1.425 -1.708 0 CA-C-N 115.093 -0.958 . . . . 0.0 111.251 -176.828 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.508 -0.377 0 N-CA-C 111.458 -0.657 . . . . 0.0 111.458 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 32.2 m -60.53 -17.82 48.22 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 116.18 1.918 . . . . 0.0 116.18 -175.678 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 79.6 m -67.05 -33.74 76.16 Favored 'General case' 0 C--N 1.273 -2.748 0 N-CA-C 112.891 0.7 . . . . 0.0 112.891 -179.218 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 24.8 p -86.28 12.6 9.6 Favored 'General case' 0 C--N 1.278 -2.53 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.873 176.399 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 33.7 m-70 -124.35 103.07 32.73 Favored Pre-proline 0 C--N 1.317 -0.822 0 C-N-CA 124.124 0.97 . . . . 0.0 109.036 -178.261 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.408 ' O ' HG23 ' A' ' 10' ' ' VAL . 90.9 Cg_exo -47.46 -45.21 23.46 Favored 'Trans proline' 0 N--CA 1.474 0.349 0 C-N-CA 123.656 2.904 . . . . 0.0 114.186 -176.24 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -68.17 -41.15 81.95 Favored 'General case' 0 C--N 1.317 -0.824 0 C-N-CA 121.337 -0.145 . . . . 0.0 111.282 -177.286 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 8.4 t -83.62 -16.87 43.56 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 121.808 0.813 . . . . 0.0 110.097 -175.694 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 -66.34 -38.25 87.21 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-O 121.751 0.786 . . . . 0.0 108.965 179.526 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.408 HG23 ' O ' ' A' ' 6' ' ' PRO . 97.4 t -60.62 -46.45 95.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 114.011 -1.45 . . . . 0.0 112.679 -178.087 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.412 ' C ' ' HD3' ' A' ' 13' ' ' PRO . 7.5 p-10 -87.01 1.86 51.44 Favored 'General case' 0 CA--C 1.513 -0.45 0 N-CA-C 113.485 0.92 . . . . 0.0 113.485 -173.863 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . 0.6 ' HB3' ' HB ' ' A' ' 15' ' ' ILE . 89.3 m-70 -116.39 73.0 5.3 Favored Pre-proline 0 N--CA 1.429 -1.479 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 172.318 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.412 ' HD3' ' C ' ' A' ' 11' ' ' ASP . 21.4 Cg_exo -64.95 -27.44 58.4 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 123.079 2.52 . . . . 0.0 114.17 -173.166 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.448 ' H ' ' CD ' ' A' ' 14' ' ' GLU . 0.0 OUTLIER -95.86 -22.06 17.7 Favored 'General case' 0 N--CA 1.408 -2.535 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.209 -178.049 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.6 ' HB ' ' HB3' ' A' ' 12' ' ' HIS . 37.2 mm -89.99 -45.2 15.11 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.665 0 CA-C-O 121.94 0.876 . . . . 0.0 108.66 -177.26 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 62.6 m . . . . . 0 N--CA 1.413 -2.316 0 CA-C-N 114.508 -1.224 . . . . 0.0 110.259 -177.7 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.496 -1.103 0 N-CA-C 110.912 -0.875 . . . . 0.0 110.912 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . 0.47 ' HA ' ' HB2' ' A' ' 5' ' ' HIS . 19.7 m -66.01 -17.08 64.45 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 115.168 1.544 . . . . 0.0 115.168 -176.334 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.401 ' SG ' HG22 ' A' ' 15' ' ' ILE . 58.4 m -63.15 -31.63 72.81 Favored 'General case' 0 C--N 1.281 -2.373 0 N-CA-C 113.172 0.804 . . . . 0.0 113.172 177.712 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 5.3 p -99.17 18.59 17.1 Favored 'General case' 0 C--N 1.279 -2.487 0 CA-C-O 121.848 0.832 . . . . 0.0 110.118 175.681 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . 0.47 ' HB2' ' HA ' ' A' ' 2' ' ' CYS . 67.5 m170 -122.01 93.79 48.43 Favored Pre-proline 0 C--N 1.312 -1.038 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 178.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -49.79 -48.68 18.39 Favored 'Trans proline' 0 N--CA 1.484 0.949 0 C-N-CA 123.35 2.7 . . . . 0.0 114.447 -173.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -71.34 -19.66 62.27 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.81 -177.113 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 20.8 t -95.07 -22.41 17.92 Favored 'General case' 0 C--O 1.208 -1.128 0 C-N-CA 120.087 -0.645 . . . . 0.0 109.67 179.415 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.412 ' HB2' ' O ' ' A' ' 5' ' ' HIS . 57.3 t30 -85.07 -29.38 24.95 Favored 'General case' 0 C--N 1.28 -2.441 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.93 -167.868 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 7.3 p -56.01 -31.62 31.45 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.126 0 CA-C-N 115.082 -0.963 . . . . 0.0 111.652 178.208 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.407 ' O ' ' HD3' ' A' ' 13' ' ' PRO . 4.3 p30 -97.85 12.56 33.59 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-O 120.894 0.378 . . . . 0.0 111.569 179.425 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . 0.407 ' HB3' ' HB ' ' A' ' 15' ' ' ILE . 48.4 m80 -116.94 71.93 5.72 Favored Pre-proline 0 N--CA 1.44 -0.935 0 C-N-CA 122.767 0.427 . . . . 0.0 110.166 174.592 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.407 ' HD3' ' O ' ' A' ' 11' ' ' ASP . 7.5 Cg_exo -72.56 -32.72 9.42 Favored 'Trans proline' 0 C--N 1.356 0.944 0 C-N-CA 122.844 2.363 . . . . 0.0 113.761 -172.593 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -92.4 5.27 51.31 Favored 'General case' 0 N--CA 1.411 -2.376 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.594 -178.549 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.407 ' HB ' ' HB3' ' A' ' 12' ' ' HIS . 37.2 mm -105.33 -65.93 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.952 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 177.565 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 69.2 m . . . . . 0 C--N 1.288 -2.096 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.458 179.575 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . 0.413 ' O ' ' HD2' ' A' ' 5' ' ' HIS . . . . . . . . 0 CA--C 1.495 -1.177 0 N-CA-C 110.156 -1.178 . . . . 0.0 110.156 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 14.2 m -68.53 -22.84 64.49 Favored 'General case' 0 N--CA 1.428 -1.528 0 N-CA-C 114.041 1.126 . . . . 0.0 114.041 -177.671 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 65.0 m -75.12 -28.02 60.04 Favored 'General case' 0 C--N 1.294 -1.833 0 CA-C-O 121.697 0.761 . . . . 0.0 111.555 176.411 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 4.1 m -71.54 0.97 7.25 Favored 'General case' 0 C--N 1.297 -1.678 0 CA-C-N 114.495 -1.23 . . . . 0.0 109.781 174.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . 0.464 ' O ' ' HB2' ' A' ' 9' ' ' ASN . 30.7 m-70 -125.91 147.96 60.89 Favored Pre-proline 0 N--CA 1.438 -1.075 0 C-N-CA 124.804 1.241 . . . . 0.0 107.895 178.498 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -77.44 -41.67 0.33 Allowed 'Trans proline' 0 CA--C 1.548 1.217 0 C-N-CA 121.652 1.568 . . . . 0.0 112.865 175.679 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -72.08 -39.86 68.66 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 113.332 0.864 . . . . 0.0 113.332 -174.159 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 10.1 t -87.12 4.21 43.18 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-O 121.932 0.872 . . . . 0.0 109.787 -178.662 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.464 ' HB2' ' O ' ' A' ' 5' ' ' HIS . 9.7 t-20 -79.19 -39.78 32.48 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-O 121.702 0.763 . . . . 0.0 109.364 -177.218 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 14.9 p -71.05 -30.59 41.81 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-N 114.46 -1.245 . . . . 0.0 112.752 -174.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -87.92 3.43 48.58 Favored 'General case' 0 C--N 1.317 -0.81 0 C-N-CA 119.037 -1.065 . . . . 0.0 112.457 -179.28 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 83.8 m-70 -118.67 73.12 11.27 Favored Pre-proline 0 N--CA 1.425 -1.682 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 172.208 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo -72.94 -31.22 10.22 Favored 'Trans proline' 0 C--N 1.359 1.109 0 C-N-CA 122.768 2.312 . . . . 0.0 112.257 -173.446 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -77.51 -10.16 59.33 Favored 'General case' 0 N--CA 1.419 -1.975 0 CA-C-N 114.394 -1.276 . . . . 0.0 111.391 -179.311 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 37.8 mm -104.06 -57.63 4.36 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.007 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 177.496 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 91.7 m . . . . . 0 N--CA 1.426 -1.672 0 CA-C-N 115.074 -0.966 . . . . 0.0 110.761 178.449 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.499 -0.919 0 N-CA-C 109.969 -1.253 . . . . 0.0 109.969 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 1.7 m -64.94 -23.2 67.15 Favored 'General case' 0 C--O 1.189 -2.089 0 N-CA-C 113.438 0.903 . . . . 0.0 113.438 179.375 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 19.4 m -77.0 -29.7 55.58 Favored 'General case' 0 C--N 1.277 -2.582 0 CA-C-O 121.213 0.53 . . . . 0.0 112.095 175.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 2.7 m -67.44 -28.49 67.93 Favored 'General case' 0 C--N 1.286 -2.16 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 175.016 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . 0.4 ' HA ' ' HD2' ' A' ' 6' ' ' PRO . 32.7 m170 -91.04 113.23 57.49 Favored Pre-proline 0 C--N 1.318 -0.8 0 CA-C-N 114.877 -1.056 . . . . 0.0 110.0 -179.674 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.4 ' HD2' ' HA ' ' A' ' 5' ' ' HIS . 7.0 Cg_endo -51.62 -40.97 63.4 Favored 'Trans proline' 0 CA--C 1.539 0.73 0 C-N-CA 123.13 2.553 . . . . 0.0 113.956 -177.901 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -72.41 -39.98 67.52 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 -177.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 11.0 t -83.48 -19.83 35.1 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.451 0.644 . . . . 0.0 110.118 -174.506 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 18.4 t-20 -54.08 -44.34 71.09 Favored 'General case' 0 C--N 1.321 -0.673 0 C-N-CA 124.735 1.214 . . . . 0.0 111.162 -178.122 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 36.0 t -62.89 -38.32 81.57 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.184 0 CA-C-N 114.085 -1.416 . . . . 0.0 112.502 -175.072 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.42 ' O ' ' HD3' ' A' ' 13' ' ' PRO . 5.4 p-10 -90.22 13.93 13.94 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 119.795 -0.762 . . . . 0.0 112.93 -176.879 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 22.8 m-70 -114.35 79.17 5.07 Favored Pre-proline 0 N--CA 1.431 -1.425 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 171.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.42 ' HD3' ' O ' ' A' ' 11' ' ' ASP . 5.4 Cg_exo -72.31 -27.84 15.86 Favored 'Trans proline' 0 C--N 1.358 1.036 0 C-N-CA 123.36 2.706 . . . . 0.0 112.923 -172.015 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -84.05 -11.46 56.69 Favored 'General case' 0 C--N 1.291 -1.947 0 CA-C-N 115.139 -0.937 . . . . 0.0 111.505 -178.394 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 27.5 mm -107.91 -52.84 6.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 -179.344 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 97.5 m . . . . . 0 N--CA 1.426 -1.641 0 CA-C-N 114.979 -1.009 . . . . 0.0 111.433 -179.088 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.502 -0.762 0 N-CA-C 110.801 -0.92 . . . . 0.0 110.801 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . 0.476 ' HA ' ' HB2' ' A' ' 5' ' ' HIS . 16.5 m -67.48 -16.27 64.12 Favored 'General case' 0 N--CA 1.435 -1.216 0 N-CA-C 114.765 1.394 . . . . 0.0 114.765 -176.747 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 65.0 m -67.73 -33.98 75.95 Favored 'General case' 0 C--N 1.279 -2.471 0 CA-C-O 121.193 0.521 . . . . 0.0 111.148 176.475 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 20.7 m -85.85 14.53 5.86 Favored 'General case' 0 C--N 1.294 -1.81 0 CA-C-N 115.256 -0.884 . . . . 0.0 110.301 176.037 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . 0.476 ' HB2' ' HA ' ' A' ' 2' ' ' CYS . 25.0 m-70 -130.76 94.79 27.86 Favored Pre-proline 0 C--N 1.318 -0.785 0 C-N-CA 124.425 1.09 . . . . 0.0 109.727 -178.453 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_exo -48.88 -48.86 16.59 Favored 'Trans proline' 0 N--CA 1.481 0.77 0 C-N-CA 123.537 2.825 . . . . 0.0 113.913 -176.306 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -64.85 -32.63 74.42 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 111.847 0.314 . . . . 0.0 111.847 -178.478 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 34.1 t -84.4 -20.76 31.36 Favored 'General case' 0 C--O 1.203 -1.357 0 CA-C-O 121.601 0.715 . . . . 0.0 109.436 179.838 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 45.6 t-20 -82.73 -48.08 11.26 Favored 'General case' 0 C--N 1.288 -2.105 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.646 -173.321 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 11.8 p -54.04 -39.15 40.17 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.206 0 CA-C-N 114.873 -1.058 . . . . 0.0 113.775 -175.045 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -99.94 5.86 45.23 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 118.557 -1.257 . . . . 0.0 111.905 -179.224 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 31.7 m-70 -118.62 76.88 13.84 Favored Pre-proline 0 N--CA 1.438 -1.067 0 N-CA-C 112.789 0.662 . . . . 0.0 112.789 177.174 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_exo -72.56 -21.03 22.79 Favored 'Trans proline' 0 N--CA 1.462 -0.374 0 C-N-CA 121.985 1.79 . . . . 0.0 110.503 178.513 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -74.89 -22.95 58.35 Favored 'General case' 0 N--CA 1.428 -1.556 0 CA-C-N 114.371 -1.286 . . . . 0.0 110.382 179.52 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 50.3 mm -99.8 -50.01 10.96 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.805 0 N-CA-C 108.644 -0.872 . . . . 0.0 108.644 -179.421 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 63.6 m . . . . . 0 N--CA 1.417 -2.101 0 CA-C-N 114.896 -1.047 . . . . 0.0 110.319 -179.848 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.807 0 N-CA-C 111.51 -0.636 . . . . 0.0 111.51 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 6.1 m -65.76 -17.97 65.0 Favored 'General case' 0 CA--C 1.491 -1.292 0 N-CA-C 114.747 1.388 . . . . 0.0 114.747 -177.403 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 30.2 m -65.64 -32.86 74.66 Favored 'General case' 0 C--N 1.283 -2.293 0 CA-C-O 121.021 0.439 . . . . 0.0 111.912 177.026 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 19.1 m -82.28 11.61 5.25 Favored 'General case' 0 C--N 1.287 -2.134 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.374 176.06 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 45.2 m-70 -124.56 111.45 27.85 Favored Pre-proline 0 C--N 1.313 -0.983 0 C-N-CA 123.817 0.847 . . . . 0.0 109.361 179.533 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -49.21 -49.31 15.75 Favored 'Trans proline' 0 CA--C 1.539 0.741 0 C-N-CA 123.462 2.774 . . . . 0.0 114.691 -174.485 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -72.75 -37.21 67.75 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 112.621 0.6 . . . . 0.0 112.621 -177.826 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.482 ' O ' ' HD2' ' A' ' 12' ' ' HIS . 7.3 t -81.65 -19.9 40.76 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 122.019 0.914 . . . . 0.0 108.833 -174.784 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -62.09 -44.19 97.2 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-N 114.837 -1.074 . . . . 0.0 109.704 177.682 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 49.5 t -65.28 -41.96 92.7 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 CA-C-N 113.953 -1.476 . . . . 0.0 111.796 -176.038 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.424 ' OD1' ' HA ' ' A' ' 8' ' ' CYS . 4.5 p-10 -84.9 3.92 35.85 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 113.316 0.858 . . . . 0.0 113.316 -175.283 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . 0.482 ' HD2' ' O ' ' A' ' 8' ' ' CYS . 66.3 m-70 -113.72 77.34 3.41 Favored Pre-proline 0 N--CA 1.434 -1.245 0 N-CA-C 109.924 -0.399 . . . . 0.0 109.924 172.462 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_exo -66.54 -32.33 39.52 Favored 'Trans proline' 0 C--N 1.355 0.899 0 C-N-CA 122.728 2.286 . . . . 0.0 112.47 -174.803 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -79.69 -22.69 43.09 Favored 'General case' 0 C--N 1.289 -2.057 0 CA-C-N 114.53 -1.214 . . . . 0.0 111.845 -178.1 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.459 ' HB ' ' HB3' ' A' ' 12' ' ' HIS . 41.2 mm -100.92 -58.71 3.72 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 CA-C-O 121.813 0.816 . . . . 0.0 109.337 -176.757 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 36.8 m . . . . . 0 C--N 1.281 -2.403 0 CA-C-N 114.707 -1.133 . . . . 0.0 110.319 -175.975 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.573 0 N-CA-C 111.958 -0.457 . . . . 0.0 111.958 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . 0.464 ' HA ' ' HB2' ' A' ' 5' ' ' HIS . 31.1 m -60.84 -22.04 63.81 Favored 'General case' 0 N--CA 1.438 -1.061 0 N-CA-C 116.358 1.985 . . . . 0.0 116.358 -174.041 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 67.2 m -71.95 -35.91 69.71 Favored 'General case' 0 C--N 1.278 -2.53 0 C-N-CA 120.542 -0.463 . . . . 0.0 112.149 179.247 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 38.4 t -83.64 1.26 43.24 Favored 'General case' 0 C--N 1.281 -2.386 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.931 177.225 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . 0.464 ' HB2' ' HA ' ' A' ' 2' ' ' CYS . 39.9 m170 -110.32 111.19 57.85 Favored Pre-proline 0 C--N 1.311 -1.092 0 C-N-CA 123.504 0.721 . . . . 0.0 109.901 -177.788 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.493 ' O ' HG23 ' A' ' 10' ' ' VAL . 52.9 Cg_exo -51.5 -49.62 16.59 Favored 'Trans proline' 0 CA--C 1.542 0.915 0 C-N-CA 123.16 2.573 . . . . 0.0 115.033 -172.587 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -73.09 -33.12 65.42 Favored 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 112.6 0.593 . . . . 0.0 112.6 -176.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.523 ' HA ' ' OD2' ' A' ' 11' ' ' ASP . 8.9 t -82.75 -20.33 36.14 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 122.07 0.938 . . . . 0.0 108.906 -177.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 -66.21 -40.93 90.71 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 115.057 -0.974 . . . . 0.0 108.484 177.23 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.493 HG23 ' O ' ' A' ' 6' ' ' PRO . 84.3 t -62.34 -36.24 73.62 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 CA-C-N 114.458 -1.247 . . . . 0.0 111.417 -179.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.523 ' OD2' ' HA ' ' A' ' 8' ' ' CYS . 3.3 p30 -87.84 0.74 55.42 Favored 'General case' 0 C--N 1.321 -0.664 0 C-N-CA 119.518 -0.873 . . . . 0.0 111.196 179.625 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . 0.564 ' HB3' ' HB ' ' A' ' 15' ' ' ILE . 1.0 OUTLIER -118.58 70.59 9.26 Favored Pre-proline 0 C--N 1.312 -1.038 0 C-N-CA 123.071 0.548 . . . . 0.0 110.248 175.378 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -79.19 -17.98 11.43 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 121.696 1.597 . . . . 0.0 111.799 -176.337 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -100.92 0.15 37.84 Favored 'General case' 0 N--CA 1.41 -2.441 0 CA-C-N 114.721 -1.127 . . . . 0.0 111.182 -178.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.564 ' HB ' ' HB3' ' A' ' 12' ' ' HIS . 25.3 mm -114.65 -54.95 4.52 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.949 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 -179.797 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 21.6 m . . . . . 0 C--N 1.284 -2.261 0 CA-C-N 114.089 -1.414 . . . . 0.0 110.077 -174.095 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.946 0 N-CA-C 112.209 -0.357 . . . . 0.0 112.209 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 4.0 m -64.99 -19.95 66.25 Favored 'General case' 0 N--CA 1.433 -1.305 0 N-CA-C 114.158 1.17 . . . . 0.0 114.158 -179.218 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 20.0 m -68.06 -30.81 70.1 Favored 'General case' 0 C--N 1.28 -2.415 0 N-CA-C 112.98 0.733 . . . . 0.0 112.98 178.819 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 16.6 m -72.84 -0.53 13.7 Favored 'General case' 0 C--N 1.291 -1.951 0 CA-C-O 121.369 0.604 . . . . 0.0 110.533 175.742 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 67.7 m-70 -125.98 104.21 26.56 Favored Pre-proline 0 C--O 1.216 -0.676 0 C-N-CA 124.322 1.049 . . . . 0.0 108.952 -178.25 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -50.21 -35.19 42.34 Favored 'Trans proline' 0 N--CA 1.483 0.89 0 C-N-CA 123.229 2.619 . . . . 0.0 113.83 -177.217 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -68.98 -32.93 72.85 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 111.577 0.214 . . . . 0.0 111.577 -179.015 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.428 ' HA ' ' OD1' ' A' ' 11' ' ' ASP . 6.4 t -97.11 -18.62 19.22 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.933 0.873 . . . . 0.0 109.593 -177.78 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 19.9 t-20 -60.13 -45.16 93.96 Favored 'General case' 0 C--N 1.314 -0.948 0 C-N-CA 124.21 1.004 . . . . 0.0 110.481 -178.808 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 12.3 p -66.66 -30.56 50.1 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.003 0 CA-C-N 114.156 -1.384 . . . . 0.0 112.322 -176.823 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.428 ' OD1' ' HA ' ' A' ' 8' ' ' CYS 0.252 7.0 p-10 -90.8 5.21 49.32 Favored 'General case' 0 C--O 1.24 0.557 0 C-N-CA 119.649 -0.82 . . . . 0.0 112.137 -179.871 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 57.3 m-70 -119.38 72.01 13.45 Favored Pre-proline 0 N--CA 1.431 -1.42 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.702 168.719 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -77.77 -12.02 16.63 Favored 'Trans proline' 0 C--N 1.354 0.856 0 C-N-CA 122.522 2.148 . . . . 0.0 111.955 -176.437 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -80.01 -20.85 44.44 Favored 'General case' 0 N--CA 1.416 -2.125 0 CA-C-N 114.907 -1.042 . . . . 0.0 110.393 177.528 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 38.5 mt -103.37 -54.41 6.58 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.04 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 177.257 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 91.1 m . . . . . 0 N--CA 1.415 -2.212 0 CA-C-N 114.702 -1.136 . . . . 0.0 110.522 178.437 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.503 -0.666 0 N-CA-C 110.358 -1.097 . . . . 0.0 110.358 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . 0.45 ' HB3' ' O ' ' A' ' 8' ' ' CYS . 8.0 m -72.1 -22.91 61.28 Favored 'General case' 0 N--CA 1.428 -1.536 0 N-CA-C 113.265 0.839 . . . . 0.0 113.265 -178.745 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 1.8 m -74.55 -24.56 58.95 Favored 'General case' 0 C--N 1.294 -1.841 0 CA-C-O 121.205 0.526 . . . . 0.0 111.148 173.792 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 4.0 m -69.77 -26.28 64.21 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 173.638 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . 0.555 ' O ' ' HB2' ' A' ' 9' ' ' ASN . 30.5 m80 -90.38 156.2 45.91 Favored Pre-proline 0 N--CA 1.446 -0.666 0 CA-C-N 114.703 -1.135 . . . . 0.0 109.957 178.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -84.47 -49.49 0.04 OUTLIER 'Trans proline' 0 CA--C 1.549 1.231 0 C-N-CA 122.03 1.82 . . . . 0.0 114.196 178.59 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -73.26 -38.03 66.11 Favored 'General case' 0 C--N 1.32 -0.706 0 O-C-N 121.703 -0.623 . . . . 0.0 112.299 -177.25 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.45 ' O ' ' HB3' ' A' ' 2' ' ' CYS . 5.9 t -83.3 0.67 44.69 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 122.098 0.951 . . . . 0.0 109.45 -176.837 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.555 ' HB2' ' O ' ' A' ' 5' ' ' HIS . 19.6 t-20 -74.39 -41.19 61.37 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 114.962 -1.017 . . . . 0.0 108.739 -179.73 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 62.1 t -58.82 -35.24 55.05 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-N 113.279 -1.782 . . . . 0.0 112.679 -176.381 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.522 ' O ' ' HD3' ' A' ' 13' ' ' PRO 0.276 7.1 p-10 -82.62 6.35 18.03 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 113.863 1.06 . . . . 0.0 113.863 -177.865 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . 0.431 ' HB3' ' HB ' ' A' ' 15' ' ' ILE . 23.5 m-70 -109.75 74.18 0.72 Allowed Pre-proline 0 N--CA 1.441 -0.886 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 168.881 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.522 ' HD3' ' O ' ' A' ' 11' ' ' ASP . 13.6 Cg_exo -66.82 -35.99 25.37 Favored 'Trans proline' 0 CA--C 1.501 -1.14 0 C-N-CA 122.756 2.304 . . . . 0.0 113.439 -168.489 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -86.85 -1.03 57.47 Favored 'General case' 0 C--N 1.282 -2.334 0 CA-C-N 114.926 -1.033 . . . . 0.0 111.946 -177.127 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.431 ' HB ' ' HB3' ' A' ' 12' ' ' HIS . 30.7 mm -114.37 -52.44 5.02 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 -179.661 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 73.5 m . . . . . 0 C--N 1.288 -2.1 0 CA-C-N 114.625 -1.171 . . . . 0.0 109.945 -179.518 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.13 0 N-CA-C 112.492 -0.243 . . . . 0.0 112.492 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 1.6 m -62.36 -21.65 65.49 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-O 120.963 0.411 . . . . 0.0 111.514 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 3.4 m -65.3 -37.34 86.84 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.155 -179.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 50.6 m -64.6 -11.8 38.69 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.37 178.792 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . 0.499 ' O ' ' HB2' ' A' ' 9' ' ' ASN . 87.5 m-70 -105.37 150.14 38.58 Favored Pre-proline 0 N--CA 1.452 -0.326 0 CA-C-N 114.922 -1.036 . . . . 0.0 110.273 179.524 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -84.49 -38.51 0.12 Allowed 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.464 2.11 . . . . 0.0 112.928 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -72.29 -44.99 61.94 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 -179.06 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.412 ' HA ' ' OD1' ' A' ' 11' ' ' ASP . 6.9 t -83.59 12.21 6.06 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.664 0.269 . . . . 0.0 111.567 -178.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.499 ' HB2' ' O ' ' A' ' 5' ' ' HIS . 3.3 t-20 -90.74 -51.45 5.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.192 0.52 . . . . 0.0 111.458 -179.799 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 22.5 t -54.94 -41.69 59.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.201 -0.909 . . . . 0.0 112.598 -178.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.412 ' OD1' ' HA ' ' A' ' 8' ' ' CYS . 5.2 p-10 -75.87 1.72 14.33 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 -179.042 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 15.3 m-70 -119.34 71.76 12.97 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.188 179.461 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -76.91 -10.16 18.15 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.321 2.014 . . . . 0.0 112.356 -179.855 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -93.98 -2.77 52.63 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.113 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 25.7 mm -111.8 -71.16 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-O 120.929 0.395 . . . . 0.0 111.098 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.485 ' HB2' HD21 ' A' ' 9' ' ' ASN . 33.6 m . . . . . 0 C--N 1.323 -0.559 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.041 179.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.5 -0.884 0 N-CA-C 110.818 -0.913 . . . . 0.0 110.818 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 20.7 m -62.73 -22.25 66.4 Favored 'General case' 0 N--CA 1.432 -1.366 0 N-CA-C 115.609 1.707 . . . . 0.0 115.609 -175.429 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 24.0 m -70.19 -35.42 73.92 Favored 'General case' 0 C--N 1.283 -2.317 0 C-N-CA 120.543 -0.463 . . . . 0.0 112.194 177.103 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 20.0 m -79.18 -4.38 50.19 Favored 'General case' 0 C--N 1.295 -1.764 0 CA-C-O 121.516 0.674 . . . . 0.0 110.304 177.401 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 10.6 m-70 -104.1 103.71 39.64 Favored Pre-proline 0 C--N 1.317 -0.83 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 176.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_exo -49.57 -38.58 45.16 Favored 'Trans proline' 0 CA--C 1.544 1.025 0 C-N-CA 122.736 2.291 . . . . 0.0 113.302 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -72.46 -41.91 65.55 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 -179.097 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 10.2 t -82.78 -19.99 36.72 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-O 121.742 0.782 . . . . 0.0 109.64 -175.083 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 -58.61 -41.81 86.75 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 115.036 -0.984 . . . . 0.0 109.477 179.093 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 49.1 t -62.7 -34.35 65.01 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 CA-C-N 114.09 -1.414 . . . . 0.0 111.955 -177.724 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -94.25 1.92 55.94 Favored 'General case' 0 C--N 1.316 -0.888 0 C-N-CA 119.199 -1.0 . . . . 0.0 112.971 -175.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 78.6 m-70 -118.73 72.37 10.91 Favored Pre-proline 0 N--CA 1.432 -1.328 0 CA-C-N 116.677 -0.238 . . . . 0.0 110.746 174.06 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -73.49 -13.76 25.04 Favored 'Trans proline' 0 C--N 1.356 0.943 0 C-N-CA 121.795 1.664 . . . . 0.0 111.411 -177.552 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.493 ' HG3' HG12 ' A' ' 15' ' ' ILE . 10.4 pt-20 -81.72 -23.48 36.71 Favored 'General case' 0 N--CA 1.421 -1.922 0 CA-C-N 114.553 -1.203 . . . . 0.0 110.896 179.267 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.493 HG12 ' HG3' ' A' ' 14' ' ' GLU . 35.7 mm -107.54 -50.98 7.54 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.067 0 CA-C-O 121.813 0.816 . . . . 0.0 108.805 -177.606 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 31.1 m -98.74 95.41 7.21 Favored 'General case' 0 C--N 1.287 -2.136 0 CA-C-N 114.318 -1.31 . . . . 0.0 109.495 -176.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.306 -1.293 0 CA-C-N 116.463 -0.335 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.501 -0.784 0 N-CA-C 110.121 -1.192 . . . . 0.0 110.121 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 9.4 m -66.69 -13.99 61.96 Favored 'General case' 0 CA--C 1.493 -1.217 0 N-CA-C 114.116 1.154 . . . . 0.0 114.116 -178.619 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 96.1 m -68.41 -35.56 77.82 Favored 'General case' 0 C--N 1.28 -2.434 0 CA-C-O 121.766 0.793 . . . . 0.0 110.971 178.111 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 19.2 m -79.72 10.9 3.55 Favored 'General case' 0 C--N 1.281 -2.408 0 CA-C-N 114.772 -1.104 . . . . 0.0 110.308 176.371 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 83.6 m-70 -130.61 95.32 26.85 Favored Pre-proline 0 N--CA 1.444 -0.736 0 C-N-CA 124.274 1.03 . . . . 0.0 109.139 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.454 ' O ' HG23 ' A' ' 10' ' ' VAL . 57.2 Cg_exo -40.87 -47.12 4.87 Favored 'Trans proline' 0 N--CA 1.484 0.969 0 C-N-CA 124.23 3.287 . . . . 0.0 114.744 -176.352 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -65.36 -40.47 93.6 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 -178.407 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 9.4 t -83.41 -20.77 33.55 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 122.143 0.973 . . . . 0.0 109.49 -174.361 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 41.2 t-20 -67.06 -41.54 86.27 Favored 'General case' 0 C--N 1.294 -1.832 0 CA-C-N 114.424 -1.262 . . . . 0.0 109.187 -178.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.454 HG23 ' O ' ' A' ' 6' ' ' PRO . 96.0 t -62.88 -41.72 93.71 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 CA-C-N 113.957 -1.474 . . . . 0.0 111.917 179.672 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -87.14 3.37 46.62 Favored 'General case' 0 C--O 1.24 0.553 0 N-CA-C 113.215 0.82 . . . . 0.0 113.215 -176.207 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . 0.446 ' HB3' ' HB ' ' A' ' 15' ' ' ILE . 88.1 m-70 -119.09 75.1 14.38 Favored Pre-proline 0 N--CA 1.428 -1.567 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.462 171.529 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo -66.43 -24.11 50.02 Favored 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 122.472 2.115 . . . . 0.0 113.997 -174.59 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -93.38 -18.33 22.51 Favored 'General case' 0 N--CA 1.416 -2.145 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.449 -177.225 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.446 ' HB ' ' HB3' ' A' ' 12' ' ' HIS . 22.8 mt -100.14 -40.82 8.67 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 CA-C-O 122.013 0.911 . . . . 0.0 109.196 -178.295 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 62.5 m -125.16 -75.31 0.59 Allowed 'General case' 0 N--CA 1.406 -2.647 0 CA-C-N 114.527 -1.215 . . . . 0.0 110.261 -177.268 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.314 -0.942 0 O-C-N 122.014 -0.429 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.242 0.645 0 N-CA-C 111.117 -0.793 . . . . 0.0 111.117 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . 0.553 ' HB2' ' NE2' ' A' ' 12' ' ' HIS . 7.9 m -60.79 -18.27 54.2 Favored 'General case' 0 C--O 1.205 -1.286 0 N-CA-C 116.022 1.86 . . . . 0.0 116.022 -176.719 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 4.7 m -65.54 -28.35 69.1 Favored 'General case' 0 C--N 1.277 -2.581 0 N-CA-C 113.947 1.091 . . . . 0.0 113.947 179.021 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 50.6 m -81.6 3.83 23.74 Favored 'General case' 0 C--N 1.282 -2.367 0 CA-C-O 121.501 0.667 . . . . 0.0 110.789 174.236 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 80.1 m-70 -117.63 103.4 50.82 Favored Pre-proline 0 C--N 1.31 -1.128 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 179.01 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_exo -44.56 -43.77 14.04 Favored 'Trans proline' 0 N--CA 1.486 1.037 0 C-N-CA 123.815 3.01 . . . . 0.0 114.245 -176.343 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -72.46 -28.28 62.83 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 112.818 0.673 . . . . 0.0 112.818 -177.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 6.9 t -102.52 4.99 39.17 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-O 122.462 1.125 . . . . 0.0 108.869 -176.53 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 -77.82 -44.97 25.74 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 114.751 -1.113 . . . . 0.0 110.383 -176.528 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 14.6 p -62.83 -25.48 38.46 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.246 0 CA-C-N 113.823 -1.535 . . . . 0.0 112.704 -176.058 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.419 ' O ' ' HD3' ' A' ' 13' ' ' PRO . 4.8 p-10 -91.24 13.15 17.98 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 113.366 0.876 . . . . 0.0 113.366 -177.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . 0.553 ' NE2' ' HB2' ' A' ' 2' ' ' CYS . 36.4 m-70 -110.22 84.18 3.56 Favored Pre-proline 0 N--CA 1.444 -0.731 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 170.342 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.419 ' HD3' ' O ' ' A' ' 11' ' ' ASP . 7.8 Cg_exo -68.74 -26.67 32.54 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.468 2.112 . . . . 0.0 113.934 -173.098 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.402 ' H ' ' CD ' ' A' ' 14' ' ' GLU . 0.2 OUTLIER -95.16 1.62 54.85 Favored 'General case' 0 N--CA 1.409 -2.487 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.561 -177.062 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 30.9 mm -122.93 -62.64 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-O 121.778 0.799 . . . . 0.0 109.166 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 71.3 m -119.71 -88.0 0.63 Allowed 'General case' 0 C--N 1.29 -2.004 0 CA-C-N 115.065 -0.97 . . . . 0.0 111.404 -176.412 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.538 0 O-C-N 121.94 -0.475 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.494 -1.25 0 N-CA-C 110.304 -1.119 . . . . 0.0 110.304 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 3.9 m -61.37 -20.86 63.49 Favored 'General case' 0 C--O 1.2 -1.542 0 N-CA-C 114.773 1.398 . . . . 0.0 114.773 -176.354 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 83.0 m -73.51 -42.08 62.24 Favored 'General case' 0 C--N 1.285 -2.219 0 CA-C-O 121.378 0.608 . . . . 0.0 111.543 177.533 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 11.8 m -73.5 -13.75 61.1 Favored 'General case' 0 C--N 1.286 -2.18 0 CA-C-N 114.726 -1.125 . . . . 0.0 109.851 -179.399 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 9.7 m-70 -96.31 103.82 15.26 Favored Pre-proline 0 N--CA 1.434 -1.267 0 CA-C-N 114.499 -1.228 . . . . 0.0 108.863 175.079 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.537 ' O ' HG23 ' A' ' 10' ' ' VAL . 73.4 Cg_exo -50.46 -38.54 53.9 Favored 'Trans proline' 0 CA--C 1.534 0.505 0 C-N-CA 123.016 2.478 . . . . 0.0 113.679 -175.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -70.79 -40.49 72.52 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.125 0.417 . . . . 0.0 112.125 -177.255 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 11.2 t -83.38 -20.02 34.97 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 121.48 0.657 . . . . 0.0 109.454 -176.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.418 HD21 ' HB2' ' A' ' 16' ' ' CYS . 2.1 t-20 -70.12 -32.8 70.99 Favored 'General case' 0 CA--C 1.501 -0.932 0 CA-C-O 121.206 0.527 . . . . 0.0 109.616 179.418 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.537 HG23 ' O ' ' A' ' 6' ' ' PRO . 89.3 t -53.94 -40.25 44.1 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.11 0 CA-C-N 114.745 -1.116 . . . . 0.0 110.918 175.302 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.476 ' C ' ' HD3' ' A' ' 13' ' ' PRO . 3.9 p30 -94.45 1.97 55.76 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.183 0.516 . . . . 0.0 111.385 179.686 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . 0.426 ' CD2' HG13 ' A' ' 15' ' ' ILE . 6.7 m80 -119.5 67.65 10.23 Favored Pre-proline 0 C--O 1.252 1.215 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.335 173.594 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.476 ' HD3' ' C ' ' A' ' 11' ' ' ASP . 3.4 Cg_exo -84.99 -22.02 2.96 Favored 'Trans proline' 0 C--N 1.357 1.017 0 C-N-CA 121.871 1.714 . . . . 0.0 111.057 -176.605 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.405 ' HG2' ' H ' ' A' ' 14' ' ' GLU . 9.3 pt-20 -84.06 -11.92 55.94 Favored 'General case' 0 N--CA 1.412 -2.363 0 CA-C-N 113.784 -1.553 . . . . 0.0 109.739 179.471 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.426 HG13 ' CD2' ' A' ' 12' ' ' HIS . 38.2 mm -97.31 -52.52 9.08 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.36 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 -177.79 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.418 ' HB2' HD21 ' A' ' 9' ' ' ASN . 69.0 m -140.94 89.4 2.25 Favored 'General case' 0 N--CA 1.419 -1.976 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.446 178.397 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.307 -1.272 0 CA-C-N 116.441 -0.345 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.5 -0.885 0 N-CA-C 110.339 -1.104 . . . . 0.0 110.339 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 17.3 m -60.51 -17.33 44.81 Favored 'General case' 0 C--O 1.202 -1.438 0 N-CA-C 115.442 1.645 . . . . 0.0 115.442 -176.2 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 80.8 m -63.64 -38.98 93.19 Favored 'General case' 0 C--N 1.282 -2.351 0 CA-C-O 121.279 0.561 . . . . 0.0 112.105 175.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 17.5 m -79.08 -0.28 30.88 Favored 'General case' 0 C--N 1.281 -2.39 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.668 178.391 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 17.4 m-70 -109.68 105.35 57.09 Favored Pre-proline 0 C--N 1.307 -1.239 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 178.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -54.36 -42.04 71.21 Favored 'Trans proline' 0 CA--C 1.531 0.372 0 C-N-CA 122.301 2.001 . . . . 0.0 112.564 -178.212 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -72.27 -25.23 61.52 Favored 'General case' 0 C--O 1.212 -0.881 0 N-CA-C 112.249 0.463 . . . . 0.0 112.249 -178.227 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 11.2 t -104.22 9.44 36.11 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.908 0.861 . . . . 0.0 109.037 -178.042 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 20.1 t-20 -87.08 -50.69 6.47 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-O 121.355 0.597 . . . . 0.0 110.425 -175.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 8.3 p -58.26 -37.91 65.68 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.145 0 CA-C-N 114.499 -1.228 . . . . 0.0 113.508 -175.108 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -86.97 7.34 27.91 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 113.169 0.803 . . . . 0.0 113.169 -177.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 47.7 m-70 -116.8 73.98 6.44 Favored Pre-proline 0 N--CA 1.433 -1.309 0 O-C-N 122.084 -0.385 . . . . 0.0 111.398 173.705 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_exo -67.9 -25.34 38.95 Favored 'Trans proline' 0 C--N 1.365 1.441 0 C-N-CA 122.374 2.049 . . . . 0.0 109.881 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.471 ' HG3' HG13 ' A' ' 15' ' ' ILE . 4.9 pt-20 -61.89 -34.12 75.46 Favored 'General case' 0 N--CA 1.424 -1.746 0 CA-C-N 112.937 -1.938 . . . . 0.0 112.343 177.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.471 HG13 ' HG3' ' A' ' 14' ' ' GLU . 15.6 mt -108.12 -49.48 7.65 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 C-N-CA 119.608 -0.837 . . . . 0.0 109.777 -177.154 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 84.4 m -143.88 -89.72 0.12 Allowed 'General case' 0 N--CA 1.428 -1.553 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.797 -178.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.318 -0.798 0 O-C-N 121.663 -0.648 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.453 ' O ' ' HD2' ' A' ' 5' ' ' HIS . . . . . . . . 0 CA--C 1.503 -0.716 0 N-CA-C 110.061 -1.216 . . . . 0.0 110.061 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 4.9 m -65.49 -19.86 66.11 Favored 'General case' 0 CA--C 1.489 -1.377 0 N-CA-C 115.49 1.663 . . . . 0.0 115.49 -177.053 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.595 ' SG ' ' HB ' ' A' ' 15' ' ' ILE . 1.6 m -68.19 -25.55 65.29 Favored 'General case' 0 C--N 1.277 -2.559 0 N-CA-C 113.439 0.903 . . . . 0.0 113.439 176.84 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 14.6 m -77.19 0.02 23.37 Favored 'General case' 0 C--N 1.284 -2.241 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.099 173.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . 0.453 ' HD2' ' O ' ' A' ' 1' ' ' GLY . 76.9 m-70 -121.59 109.8 34.22 Favored Pre-proline 0 C--N 1.325 -0.492 0 C-N-CA 123.762 0.825 . . . . 0.0 108.864 -177.338 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_exo -45.74 -49.83 10.34 Favored 'Trans proline' 0 N--CA 1.491 1.333 0 C-N-CA 123.913 3.075 . . . . 0.0 115.929 -172.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -73.55 -34.21 65.06 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 113.317 0.858 . . . . 0.0 113.317 -178.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 6.6 t -83.32 -17.56 42.04 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-O 121.896 0.855 . . . . 0.0 109.365 -176.386 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 18.6 t-20 -60.72 -39.24 87.87 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 114.918 -1.037 . . . . 0.0 109.52 177.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 67.8 t -56.93 -36.06 49.1 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 CA-C-N 113.714 -1.585 . . . . 0.0 113.33 -176.671 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.415 ' C ' ' HD3' ' A' ' 13' ' ' PRO . 4.7 p-10 -94.43 1.72 55.78 Favored 'General case' 0 C--N 1.312 -1.065 0 C-N-CA 118.581 -1.247 . . . . 0.0 113.449 -175.714 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 91.9 m-70 -116.21 75.23 6.02 Favored Pre-proline 0 N--CA 1.429 -1.489 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 177.538 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.504 ' HA ' ' O ' ' A' ' 16' ' ' CYS . 15.6 Cg_exo -71.43 -10.45 26.95 Favored 'Trans proline' 0 C--N 1.361 1.214 0 C-N-CA 122.396 2.064 . . . . 0.0 111.276 177.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.469 ' HG3' HG12 ' A' ' 15' ' ' ILE . 14.8 pt-20 -63.7 -29.24 70.49 Favored 'General case' 0 N--CA 1.434 -1.265 0 C-N-CA 124.314 1.046 . . . . 0.0 110.129 177.801 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.595 ' HB ' ' SG ' ' A' ' 3' ' ' CYS . 35.4 mm -107.85 -58.93 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.169 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 177.308 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.504 ' O ' ' HA ' ' A' ' 13' ' ' PRO . 61.4 m -107.21 92.67 4.17 Favored 'General case' 0 C--N 1.288 -2.106 0 CA-C-N 114.198 -1.364 . . . . 0.0 110.392 -177.049 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.307 -1.27 0 CA-C-N 116.336 -0.393 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.495 -1.173 0 N-CA-C 109.084 -1.607 . . . . 0.0 109.084 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 1.9 m -65.13 -24.06 67.31 Favored 'General case' 0 C--O 1.197 -1.691 0 N-CA-C 114.374 1.25 . . . . 0.0 114.374 -178.548 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 5.8 m -74.58 -32.09 62.27 Favored 'General case' 0 C--N 1.283 -2.29 0 C-N-CA 120.479 -0.488 . . . . 0.0 112.212 176.565 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 10.8 m -69.61 -18.67 63.63 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-O 121.857 0.837 . . . . 0.0 109.404 176.625 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 23.3 m-70 -97.51 107.51 39.61 Favored Pre-proline 0 C--N 1.318 -0.767 0 CA-C-N 114.778 -1.101 . . . . 0.0 108.85 176.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_exo -49.33 -36.81 39.08 Favored 'Trans proline' 0 CA--C 1.541 0.843 0 C-N-CA 123.429 2.752 . . . . 0.0 113.636 -178.298 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -72.1 -43.51 64.67 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 111.827 0.306 . . . . 0.0 111.827 -179.467 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 5.7 t -83.49 -10.86 58.07 Favored 'General case' 0 N--CA 1.479 0.978 0 CA-C-O 121.937 0.875 . . . . 0.0 109.815 -174.254 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 -62.31 -44.94 95.34 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 114.786 -1.097 . . . . 0.0 110.498 -179.366 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 49.1 t -61.29 -34.76 62.22 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.116 0 CA-C-N 114.037 -1.438 . . . . 0.0 112.334 -175.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -88.53 5.47 42.5 Favored 'General case' 0 C--O 1.245 0.858 0 N-CA-C 112.937 0.718 . . . . 0.0 112.937 -177.773 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 53.5 m-70 -119.06 72.73 12.29 Favored Pre-proline 0 N--CA 1.433 -1.288 0 C-N-CA 122.663 0.385 . . . . 0.0 110.329 172.542 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -75.09 -16.03 20.23 Favored 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 122.696 2.264 . . . . 0.0 112.685 -173.554 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -83.37 -19.55 35.87 Favored 'General case' 0 N--CA 1.419 -1.986 0 CA-C-N 115.23 -0.895 . . . . 0.0 111.219 -179.734 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 26.9 mt -103.14 -45.35 10.22 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.004 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 176.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 84.7 m -132.97 87.81 2.44 Favored 'General case' 0 N--CA 1.422 -1.853 0 CA-C-N 114.311 -1.313 . . . . 0.0 110.683 -179.732 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.3 -1.561 0 CA-C-N 116.548 -0.297 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.503 -0.69 0 N-CA-C 110.611 -0.995 . . . . 0.0 110.611 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 6.6 m -65.61 -15.91 63.2 Favored 'General case' 0 CA--C 1.491 -1.309 0 N-CA-C 114.432 1.271 . . . . 0.0 114.432 -177.339 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.441 ' SG ' HG22 ' A' ' 15' ' ' ILE . 86.9 m -66.06 -34.04 77.16 Favored 'General case' 0 C--N 1.276 -2.626 0 CA-C-O 121.481 0.657 . . . . 0.0 111.889 176.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 50.5 m -80.32 3.65 20.38 Favored 'General case' 0 C--N 1.279 -2.47 0 CA-C-N 115.303 -0.862 . . . . 0.0 111.069 175.197 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 49.4 m-70 -120.95 92.68 48.54 Favored Pre-proline 0 C--N 1.314 -0.949 0 C-N-CA 124.113 0.965 . . . . 0.0 108.624 179.222 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_exo -45.97 -43.19 20.22 Favored 'Trans proline' 0 N--CA 1.486 1.053 0 C-N-CA 123.482 2.788 . . . . 0.0 113.888 -176.17 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -68.03 -24.61 65.11 Favored 'General case' 0 C--O 1.219 -0.552 0 N-CA-C 112.327 0.491 . . . . 0.0 112.327 -178.478 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 18.0 t -97.12 -20.78 17.74 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-O 122.044 0.926 . . . . 0.0 109.048 -179.656 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 45.8 t-20 -77.97 -39.44 42.47 Favored 'General case' 0 C--N 1.301 -1.512 0 CA-C-N 115.125 -0.943 . . . . 0.0 109.481 -176.183 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 11.0 p -60.08 -23.08 26.14 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.157 0 CA-C-N 114.366 -1.288 . . . . 0.0 112.205 -178.158 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -109.96 3.16 20.21 Favored 'General case' 0 CA--C 1.513 -0.443 0 C-N-CA 119.313 -0.955 . . . . 0.0 112.704 178.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 76.1 m-70 -118.95 78.25 16.18 Favored Pre-proline 0 N--CA 1.428 -1.542 0 N-CA-C 112.222 0.453 . . . . 0.0 112.222 176.022 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -75.37 -12.98 20.79 Favored 'Trans proline' 0 C--N 1.353 0.774 0 C-N-CA 122.35 2.033 . . . . 0.0 110.191 179.617 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.423 ' HG3' HG12 ' A' ' 15' ' ' ILE . 15.5 pt-20 -71.17 -29.63 65.43 Favored 'General case' 0 N--CA 1.415 -2.194 0 CA-C-N 113.636 -1.62 . . . . 0.0 110.045 178.728 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.441 HG22 ' SG ' ' A' ' 3' ' ' CYS . 32.2 mm -98.82 -54.84 6.54 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.746 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 -178.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 70.5 m -132.47 -84.7 0.48 Allowed 'General case' 0 N--CA 1.43 -1.445 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.22 176.68 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.311 -1.09 0 O-C-N 121.721 -0.612 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.506 -0.473 0 N-CA-C 110.413 -1.075 . . . . 0.0 110.413 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 3.4 m -62.69 -19.33 63.78 Favored 'General case' 0 C--O 1.21 -1.0 0 N-CA-C 114.666 1.358 . . . . 0.0 114.666 -177.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.468 ' SG ' HG22 ' A' ' 15' ' ' ILE . 52.6 m -70.59 -33.1 70.7 Favored 'General case' 0 C--N 1.281 -2.398 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 177.605 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 18.8 m -81.3 -2.64 49.83 Favored 'General case' 0 C--N 1.284 -2.266 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.015 175.456 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 17.4 m-70 -107.43 101.3 38.53 Favored Pre-proline 0 C--N 1.313 -1.0 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.157 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 99.1 Cg_exo -45.56 -44.65 16.96 Favored 'Trans proline' 0 N--CA 1.478 0.615 0 C-N-CA 123.927 3.085 . . . . 0.0 114.408 -175.536 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -72.48 -37.53 68.42 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 112.257 0.465 . . . . 0.0 112.257 -177.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 14.0 t -83.13 -19.97 35.67 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.736 0.779 . . . . 0.0 109.573 -174.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.426 HD22 ' HA ' ' A' ' 3' ' ' CYS . 20.5 t-20 -64.12 -45.09 90.1 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.963 -179.515 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 57.7 t -62.06 -39.45 83.84 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.012 0 CA-C-N 114.211 -1.359 . . . . 0.0 112.542 -175.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -86.41 1.37 51.54 Favored 'General case' 0 CA--C 1.512 -0.508 0 C-N-CA 120.079 -0.649 . . . . 0.0 112.647 -177.394 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 83.3 m-70 -118.68 73.02 11.23 Favored Pre-proline 0 N--CA 1.425 -1.684 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 172.557 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_exo -71.28 -25.52 21.84 Favored 'Trans proline' 0 C--N 1.353 0.813 0 C-N-CA 122.393 2.062 . . . . 0.0 111.561 -175.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -73.8 -26.13 60.47 Favored 'General case' 0 N--CA 1.419 -2.002 0 CA-C-N 114.282 -1.326 . . . . 0.0 110.999 179.56 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.468 HG22 ' SG ' ' A' ' 3' ' ' CYS . 46.2 mt -94.22 -48.36 13.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 178.603 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 32.8 m -138.54 -74.93 0.39 Allowed 'General case' 0 N--CA 1.423 -1.816 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.742 179.046 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.315 -0.934 0 O-C-N 122.206 -0.309 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.493 -1.29 0 N-CA-C 110.249 -1.14 . . . . 0.0 110.249 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 1.7 m -61.56 -34.26 75.27 Favored 'General case' 0 CA--C 1.487 -1.473 0 N-CA-C 114.258 1.207 . . . . 0.0 114.258 -178.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 1.6 m -71.0 -22.78 62.12 Favored 'General case' 0 C--N 1.28 -2.439 0 N-CA-C 113.711 1.004 . . . . 0.0 113.711 178.671 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 16.3 m -72.52 -12.45 61.08 Favored 'General case' 0 C--N 1.287 -2.146 0 CA-C-O 121.293 0.568 . . . . 0.0 110.013 173.58 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 40.0 m-70 -109.08 122.38 40.02 Favored Pre-proline 0 C--N 1.319 -0.72 0 C-N-CA 123.661 0.784 . . . . 0.0 109.221 178.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -55.55 -33.03 85.24 Favored 'Trans proline' 0 CA--C 1.542 0.921 0 C-N-CA 122.839 2.359 . . . . 0.0 113.825 -177.315 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -72.71 -47.19 49.23 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 112.411 0.523 . . . . 0.0 112.411 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.457 ' HA ' ' OD1' ' A' ' 11' ' ' ASP . 3.9 t -83.24 -14.5 53.11 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-O 121.664 0.745 . . . . 0.0 110.206 -173.168 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 20.1 t-20 -59.75 -42.23 92.76 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 115.334 -0.848 . . . . 0.0 109.838 178.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 47.5 t -62.72 -41.28 91.76 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.993 0 CA-C-N 113.847 -1.524 . . . . 0.0 111.684 -177.277 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.457 ' OD1' ' HA ' ' A' ' 8' ' ' CYS . 5.3 p-10 -88.84 14.74 9.66 Favored 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 113.127 0.788 . . . . 0.0 113.127 -176.672 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 18.3 m-70 -118.57 79.53 16.04 Favored Pre-proline 0 N--CA 1.432 -1.343 0 N-CA-C 111.701 0.26 . . . . 0.0 111.701 173.07 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -66.7 -27.23 45.12 Favored 'Trans proline' 0 C--N 1.359 1.107 0 C-N-CA 123.029 2.486 . . . . 0.0 110.95 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.449 ' HG3' HG12 ' A' ' 15' ' ' ILE . 11.0 pt-20 -71.45 -21.35 61.97 Favored 'General case' 0 N--CA 1.419 -2.009 0 CA-C-N 113.729 -1.578 . . . . 0.0 111.853 -178.552 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.449 HG12 ' HG3' ' A' ' 14' ' ' GLU . 30.9 mm -112.24 -49.94 5.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 121.462 0.648 . . . . 0.0 109.54 -178.621 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 84.1 m -124.58 -79.4 0.61 Allowed 'General case' 0 N--CA 1.425 -1.708 0 CA-C-N 115.093 -0.958 . . . . 0.0 111.251 -176.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.499 0 O-C-N 122.055 -0.403 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.508 -0.377 0 N-CA-C 111.458 -0.657 . . . . 0.0 111.458 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 32.2 m -60.53 -17.82 48.22 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 116.18 1.918 . . . . 0.0 116.18 -175.678 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 79.6 m -67.05 -33.74 76.16 Favored 'General case' 0 C--N 1.273 -2.748 0 N-CA-C 112.891 0.7 . . . . 0.0 112.891 -179.218 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 24.8 p -86.28 12.6 9.6 Favored 'General case' 0 C--N 1.278 -2.53 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.873 176.399 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 33.7 m-70 -124.35 103.07 32.73 Favored Pre-proline 0 C--N 1.317 -0.822 0 C-N-CA 124.124 0.97 . . . . 0.0 109.036 -178.261 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.408 ' O ' HG23 ' A' ' 10' ' ' VAL . 90.9 Cg_exo -47.46 -45.21 23.46 Favored 'Trans proline' 0 N--CA 1.474 0.349 0 C-N-CA 123.656 2.904 . . . . 0.0 114.186 -176.24 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -68.17 -41.15 81.95 Favored 'General case' 0 C--N 1.317 -0.824 0 C-N-CA 121.337 -0.145 . . . . 0.0 111.282 -177.286 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 8.4 t -83.62 -16.87 43.56 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 121.808 0.813 . . . . 0.0 110.097 -175.694 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 -66.34 -38.25 87.21 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-O 121.751 0.786 . . . . 0.0 108.965 179.526 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.408 HG23 ' O ' ' A' ' 6' ' ' PRO . 97.4 t -60.62 -46.45 95.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 114.011 -1.45 . . . . 0.0 112.679 -178.087 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.412 ' C ' ' HD3' ' A' ' 13' ' ' PRO . 7.5 p-10 -87.01 1.86 51.44 Favored 'General case' 0 CA--C 1.513 -0.45 0 N-CA-C 113.485 0.92 . . . . 0.0 113.485 -173.863 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . 0.6 ' HB3' ' HB ' ' A' ' 15' ' ' ILE . 89.3 m-70 -116.39 73.0 5.3 Favored Pre-proline 0 N--CA 1.429 -1.479 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 172.318 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.412 ' HD3' ' C ' ' A' ' 11' ' ' ASP . 21.4 Cg_exo -64.95 -27.44 58.4 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 123.079 2.52 . . . . 0.0 114.17 -173.166 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.448 ' H ' ' CD ' ' A' ' 14' ' ' GLU . 0.0 OUTLIER -95.86 -22.06 17.7 Favored 'General case' 0 N--CA 1.408 -2.535 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.209 -178.049 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.6 ' HB ' ' HB3' ' A' ' 12' ' ' HIS . 37.2 mm -89.99 -45.2 15.11 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.665 0 CA-C-O 121.94 0.876 . . . . 0.0 108.66 -177.26 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 62.6 m -116.65 -77.82 0.57 Allowed 'General case' 0 N--CA 1.413 -2.316 0 CA-C-N 114.508 -1.224 . . . . 0.0 110.259 -177.7 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.326 -0.449 0 O-C-N 122.004 -0.435 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.496 -1.103 0 N-CA-C 110.912 -0.875 . . . . 0.0 110.912 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . 0.47 ' HA ' ' HB2' ' A' ' 5' ' ' HIS . 19.7 m -66.01 -17.08 64.45 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 115.168 1.544 . . . . 0.0 115.168 -176.334 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.401 ' SG ' HG22 ' A' ' 15' ' ' ILE . 58.4 m -63.15 -31.63 72.81 Favored 'General case' 0 C--N 1.281 -2.373 0 N-CA-C 113.172 0.804 . . . . 0.0 113.172 177.712 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 5.3 p -99.17 18.59 17.1 Favored 'General case' 0 C--N 1.279 -2.487 0 CA-C-O 121.848 0.832 . . . . 0.0 110.118 175.681 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . 0.47 ' HB2' ' HA ' ' A' ' 2' ' ' CYS . 67.5 m170 -122.01 93.79 48.43 Favored Pre-proline 0 C--N 1.312 -1.038 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 178.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -49.79 -48.68 18.39 Favored 'Trans proline' 0 N--CA 1.484 0.949 0 C-N-CA 123.35 2.7 . . . . 0.0 114.447 -173.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -71.34 -19.66 62.27 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.81 -177.113 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 20.8 t -95.07 -22.41 17.92 Favored 'General case' 0 C--O 1.208 -1.128 0 C-N-CA 120.087 -0.645 . . . . 0.0 109.67 179.415 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.412 ' HB2' ' O ' ' A' ' 5' ' ' HIS . 57.3 t30 -85.07 -29.38 24.95 Favored 'General case' 0 C--N 1.28 -2.441 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.93 -167.868 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 7.3 p -56.01 -31.62 31.45 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.126 0 CA-C-N 115.082 -0.963 . . . . 0.0 111.652 178.208 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.407 ' O ' ' HD3' ' A' ' 13' ' ' PRO . 4.3 p30 -97.85 12.56 33.59 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-O 120.894 0.378 . . . . 0.0 111.569 179.425 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . 0.407 ' HB3' ' HB ' ' A' ' 15' ' ' ILE . 48.4 m80 -116.94 71.93 5.72 Favored Pre-proline 0 N--CA 1.44 -0.935 0 C-N-CA 122.767 0.427 . . . . 0.0 110.166 174.592 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.407 ' HD3' ' O ' ' A' ' 11' ' ' ASP . 7.5 Cg_exo -72.56 -32.72 9.42 Favored 'Trans proline' 0 C--N 1.356 0.944 0 C-N-CA 122.844 2.363 . . . . 0.0 113.761 -172.593 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -92.4 5.27 51.31 Favored 'General case' 0 N--CA 1.411 -2.376 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.594 -178.549 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.407 ' HB ' ' HB3' ' A' ' 12' ' ' HIS . 37.2 mm -105.33 -65.93 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.952 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 177.565 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 69.2 m -135.56 88.65 2.43 Favored 'General case' 0 C--N 1.288 -2.096 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.458 179.575 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.31 -1.15 0 CA-C-N 116.245 -0.434 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.413 ' O ' ' HD2' ' A' ' 5' ' ' HIS . . . . . . . . 0 CA--C 1.495 -1.177 0 N-CA-C 110.156 -1.178 . . . . 0.0 110.156 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 14.2 m -68.53 -22.84 64.49 Favored 'General case' 0 N--CA 1.428 -1.528 0 N-CA-C 114.041 1.126 . . . . 0.0 114.041 -177.671 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 65.0 m -75.12 -28.02 60.04 Favored 'General case' 0 C--N 1.294 -1.833 0 CA-C-O 121.697 0.761 . . . . 0.0 111.555 176.411 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 4.1 m -71.54 0.97 7.25 Favored 'General case' 0 C--N 1.297 -1.678 0 CA-C-N 114.495 -1.23 . . . . 0.0 109.781 174.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . 0.464 ' O ' ' HB2' ' A' ' 9' ' ' ASN . 30.7 m-70 -125.91 147.96 60.89 Favored Pre-proline 0 N--CA 1.438 -1.075 0 C-N-CA 124.804 1.241 . . . . 0.0 107.895 178.498 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -77.44 -41.67 0.33 Allowed 'Trans proline' 0 CA--C 1.548 1.217 0 C-N-CA 121.652 1.568 . . . . 0.0 112.865 175.679 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -72.08 -39.86 68.66 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 113.332 0.864 . . . . 0.0 113.332 -174.159 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 10.1 t -87.12 4.21 43.18 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-O 121.932 0.872 . . . . 0.0 109.787 -178.662 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.464 ' HB2' ' O ' ' A' ' 5' ' ' HIS . 9.7 t-20 -79.19 -39.78 32.48 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-O 121.702 0.763 . . . . 0.0 109.364 -177.218 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 14.9 p -71.05 -30.59 41.81 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-N 114.46 -1.245 . . . . 0.0 112.752 -174.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -87.92 3.43 48.58 Favored 'General case' 0 C--N 1.317 -0.81 0 C-N-CA 119.037 -1.065 . . . . 0.0 112.457 -179.28 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 83.8 m-70 -118.67 73.12 11.27 Favored Pre-proline 0 N--CA 1.425 -1.682 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 172.208 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo -72.94 -31.22 10.22 Favored 'Trans proline' 0 C--N 1.359 1.109 0 C-N-CA 122.768 2.312 . . . . 0.0 112.257 -173.446 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -77.51 -10.16 59.33 Favored 'General case' 0 N--CA 1.419 -1.975 0 CA-C-N 114.394 -1.276 . . . . 0.0 111.391 -179.311 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 37.8 mm -104.06 -57.63 4.36 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.007 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 177.496 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 91.7 m -131.4 -83.26 0.52 Allowed 'General case' 0 N--CA 1.426 -1.672 0 CA-C-N 115.074 -0.966 . . . . 0.0 110.761 178.449 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.323 -0.559 0 O-C-N 121.723 -0.611 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.499 -0.919 0 N-CA-C 109.969 -1.253 . . . . 0.0 109.969 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 1.7 m -64.94 -23.2 67.15 Favored 'General case' 0 C--O 1.189 -2.089 0 N-CA-C 113.438 0.903 . . . . 0.0 113.438 179.375 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 19.4 m -77.0 -29.7 55.58 Favored 'General case' 0 C--N 1.277 -2.582 0 CA-C-O 121.213 0.53 . . . . 0.0 112.095 175.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 2.7 m -67.44 -28.49 67.93 Favored 'General case' 0 C--N 1.286 -2.16 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 175.016 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . 0.4 ' HA ' ' HD2' ' A' ' 6' ' ' PRO . 32.7 m170 -91.04 113.23 57.49 Favored Pre-proline 0 C--N 1.318 -0.8 0 CA-C-N 114.877 -1.056 . . . . 0.0 110.0 -179.674 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.4 ' HD2' ' HA ' ' A' ' 5' ' ' HIS . 7.0 Cg_endo -51.62 -40.97 63.4 Favored 'Trans proline' 0 CA--C 1.539 0.73 0 C-N-CA 123.13 2.553 . . . . 0.0 113.956 -177.901 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -72.41 -39.98 67.52 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 -177.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 11.0 t -83.48 -19.83 35.1 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.451 0.644 . . . . 0.0 110.118 -174.506 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 18.4 t-20 -54.08 -44.34 71.09 Favored 'General case' 0 C--N 1.321 -0.673 0 C-N-CA 124.735 1.214 . . . . 0.0 111.162 -178.122 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 36.0 t -62.89 -38.32 81.57 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.184 0 CA-C-N 114.085 -1.416 . . . . 0.0 112.502 -175.072 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.42 ' O ' ' HD3' ' A' ' 13' ' ' PRO . 5.4 p-10 -90.22 13.93 13.94 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 119.795 -0.762 . . . . 0.0 112.93 -176.879 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 22.8 m-70 -114.35 79.17 5.07 Favored Pre-proline 0 N--CA 1.431 -1.425 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 171.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.42 ' HD3' ' O ' ' A' ' 11' ' ' ASP . 5.4 Cg_exo -72.31 -27.84 15.86 Favored 'Trans proline' 0 C--N 1.358 1.036 0 C-N-CA 123.36 2.706 . . . . 0.0 112.923 -172.015 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -84.05 -11.46 56.69 Favored 'General case' 0 C--N 1.291 -1.947 0 CA-C-N 115.139 -0.937 . . . . 0.0 111.505 -178.394 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 27.5 mm -107.91 -52.84 6.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 -179.344 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 97.5 m -129.04 -81.69 0.57 Allowed 'General case' 0 N--CA 1.426 -1.641 0 CA-C-N 114.979 -1.009 . . . . 0.0 111.433 -179.088 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.323 -0.571 0 O-C-N 121.809 -0.557 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.502 -0.762 0 N-CA-C 110.801 -0.92 . . . . 0.0 110.801 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . 0.476 ' HA ' ' HB2' ' A' ' 5' ' ' HIS . 16.5 m -67.48 -16.27 64.12 Favored 'General case' 0 N--CA 1.435 -1.216 0 N-CA-C 114.765 1.394 . . . . 0.0 114.765 -176.747 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 65.0 m -67.73 -33.98 75.95 Favored 'General case' 0 C--N 1.279 -2.471 0 CA-C-O 121.193 0.521 . . . . 0.0 111.148 176.475 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 20.7 m -85.85 14.53 5.86 Favored 'General case' 0 C--N 1.294 -1.81 0 CA-C-N 115.256 -0.884 . . . . 0.0 110.301 176.037 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . 0.476 ' HB2' ' HA ' ' A' ' 2' ' ' CYS . 25.0 m-70 -130.76 94.79 27.86 Favored Pre-proline 0 C--N 1.318 -0.785 0 C-N-CA 124.425 1.09 . . . . 0.0 109.727 -178.453 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_exo -48.88 -48.86 16.59 Favored 'Trans proline' 0 N--CA 1.481 0.77 0 C-N-CA 123.537 2.825 . . . . 0.0 113.913 -176.306 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -64.85 -32.63 74.42 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 111.847 0.314 . . . . 0.0 111.847 -178.478 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 34.1 t -84.4 -20.76 31.36 Favored 'General case' 0 C--O 1.203 -1.357 0 CA-C-O 121.601 0.715 . . . . 0.0 109.436 179.838 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 45.6 t-20 -82.73 -48.08 11.26 Favored 'General case' 0 C--N 1.288 -2.105 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.646 -173.321 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 11.8 p -54.04 -39.15 40.17 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.206 0 CA-C-N 114.873 -1.058 . . . . 0.0 113.775 -175.045 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -99.94 5.86 45.23 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 118.557 -1.257 . . . . 0.0 111.905 -179.224 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 31.7 m-70 -118.62 76.88 13.84 Favored Pre-proline 0 N--CA 1.438 -1.067 0 N-CA-C 112.789 0.662 . . . . 0.0 112.789 177.174 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_exo -72.56 -21.03 22.79 Favored 'Trans proline' 0 N--CA 1.462 -0.374 0 C-N-CA 121.985 1.79 . . . . 0.0 110.503 178.513 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -74.89 -22.95 58.35 Favored 'General case' 0 N--CA 1.428 -1.556 0 CA-C-N 114.371 -1.286 . . . . 0.0 110.382 179.52 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 50.3 mm -99.8 -50.01 10.96 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.805 0 N-CA-C 108.644 -0.872 . . . . 0.0 108.644 -179.421 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 63.6 m -129.52 -86.58 0.54 Allowed 'General case' 0 N--CA 1.417 -2.101 0 CA-C-N 114.896 -1.047 . . . . 0.0 110.319 -179.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.321 -0.655 0 O-C-N 121.665 -0.647 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.807 0 N-CA-C 111.51 -0.636 . . . . 0.0 111.51 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 6.1 m -65.76 -17.97 65.0 Favored 'General case' 0 CA--C 1.491 -1.292 0 N-CA-C 114.747 1.388 . . . . 0.0 114.747 -177.403 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 30.2 m -65.64 -32.86 74.66 Favored 'General case' 0 C--N 1.283 -2.293 0 CA-C-O 121.021 0.439 . . . . 0.0 111.912 177.026 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 19.1 m -82.28 11.61 5.25 Favored 'General case' 0 C--N 1.287 -2.134 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.374 176.06 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 45.2 m-70 -124.56 111.45 27.85 Favored Pre-proline 0 C--N 1.313 -0.983 0 C-N-CA 123.817 0.847 . . . . 0.0 109.361 179.533 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -49.21 -49.31 15.75 Favored 'Trans proline' 0 CA--C 1.539 0.741 0 C-N-CA 123.462 2.774 . . . . 0.0 114.691 -174.485 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -72.75 -37.21 67.75 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 112.621 0.6 . . . . 0.0 112.621 -177.826 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.482 ' O ' ' HD2' ' A' ' 12' ' ' HIS . 7.3 t -81.65 -19.9 40.76 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 122.019 0.914 . . . . 0.0 108.833 -174.784 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -62.09 -44.19 97.2 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-N 114.837 -1.074 . . . . 0.0 109.704 177.682 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 49.5 t -65.28 -41.96 92.7 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 CA-C-N 113.953 -1.476 . . . . 0.0 111.796 -176.038 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.424 ' OD1' ' HA ' ' A' ' 8' ' ' CYS . 4.5 p-10 -84.9 3.92 35.85 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 113.316 0.858 . . . . 0.0 113.316 -175.283 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . 0.482 ' HD2' ' O ' ' A' ' 8' ' ' CYS . 66.3 m-70 -113.72 77.34 3.41 Favored Pre-proline 0 N--CA 1.434 -1.245 0 N-CA-C 109.924 -0.399 . . . . 0.0 109.924 172.462 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_exo -66.54 -32.33 39.52 Favored 'Trans proline' 0 C--N 1.355 0.899 0 C-N-CA 122.728 2.286 . . . . 0.0 112.47 -174.803 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -79.69 -22.69 43.09 Favored 'General case' 0 C--N 1.289 -2.057 0 CA-C-N 114.53 -1.214 . . . . 0.0 111.845 -178.1 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.459 ' HB ' ' HB3' ' A' ' 12' ' ' HIS . 41.2 mm -100.92 -58.71 3.72 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 CA-C-O 121.813 0.816 . . . . 0.0 109.337 -176.757 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 36.8 m -97.78 -71.92 0.67 Allowed 'General case' 0 C--N 1.281 -2.403 0 CA-C-N 114.707 -1.133 . . . . 0.0 110.319 -175.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.321 -0.673 0 O-C-N 122.311 -0.243 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.573 0 N-CA-C 111.958 -0.457 . . . . 0.0 111.958 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . 0.464 ' HA ' ' HB2' ' A' ' 5' ' ' HIS . 31.1 m -60.84 -22.04 63.81 Favored 'General case' 0 N--CA 1.438 -1.061 0 N-CA-C 116.358 1.985 . . . . 0.0 116.358 -174.041 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 67.2 m -71.95 -35.91 69.71 Favored 'General case' 0 C--N 1.278 -2.53 0 C-N-CA 120.542 -0.463 . . . . 0.0 112.149 179.247 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 38.4 t -83.64 1.26 43.24 Favored 'General case' 0 C--N 1.281 -2.386 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.931 177.225 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . 0.464 ' HB2' ' HA ' ' A' ' 2' ' ' CYS . 39.9 m170 -110.32 111.19 57.85 Favored Pre-proline 0 C--N 1.311 -1.092 0 C-N-CA 123.504 0.721 . . . . 0.0 109.901 -177.788 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.493 ' O ' HG23 ' A' ' 10' ' ' VAL . 52.9 Cg_exo -51.5 -49.62 16.59 Favored 'Trans proline' 0 CA--C 1.542 0.915 0 C-N-CA 123.16 2.573 . . . . 0.0 115.033 -172.587 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -73.09 -33.12 65.42 Favored 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 112.6 0.593 . . . . 0.0 112.6 -176.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.523 ' HA ' ' OD2' ' A' ' 11' ' ' ASP . 8.9 t -82.75 -20.33 36.14 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 122.07 0.938 . . . . 0.0 108.906 -177.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 -66.21 -40.93 90.71 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 115.057 -0.974 . . . . 0.0 108.484 177.23 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.493 HG23 ' O ' ' A' ' 6' ' ' PRO . 84.3 t -62.34 -36.24 73.62 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 CA-C-N 114.458 -1.247 . . . . 0.0 111.417 -179.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.523 ' OD2' ' HA ' ' A' ' 8' ' ' CYS . 3.3 p30 -87.84 0.74 55.42 Favored 'General case' 0 C--N 1.321 -0.664 0 C-N-CA 119.518 -0.873 . . . . 0.0 111.196 179.625 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . 0.564 ' HB3' ' HB ' ' A' ' 15' ' ' ILE . 1.0 OUTLIER -118.58 70.59 9.26 Favored Pre-proline 0 C--N 1.312 -1.038 0 C-N-CA 123.071 0.548 . . . . 0.0 110.248 175.378 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -79.19 -17.98 11.43 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 121.696 1.597 . . . . 0.0 111.799 -176.337 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -100.92 0.15 37.84 Favored 'General case' 0 N--CA 1.41 -2.441 0 CA-C-N 114.721 -1.127 . . . . 0.0 111.182 -178.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.564 ' HB ' ' HB3' ' A' ' 12' ' ' HIS . 25.3 mm -114.65 -54.95 4.52 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.949 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 -179.797 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 21.6 m -103.9 93.41 4.86 Favored 'General case' 0 C--N 1.284 -2.261 0 CA-C-N 114.089 -1.414 . . . . 0.0 110.077 -174.095 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.31 -1.15 0 CA-C-N 116.39 -0.368 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.946 0 N-CA-C 112.209 -0.357 . . . . 0.0 112.209 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 4.0 m -64.99 -19.95 66.25 Favored 'General case' 0 N--CA 1.433 -1.305 0 N-CA-C 114.158 1.17 . . . . 0.0 114.158 -179.218 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 20.0 m -68.06 -30.81 70.1 Favored 'General case' 0 C--N 1.28 -2.415 0 N-CA-C 112.98 0.733 . . . . 0.0 112.98 178.819 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 16.6 m -72.84 -0.53 13.7 Favored 'General case' 0 C--N 1.291 -1.951 0 CA-C-O 121.369 0.604 . . . . 0.0 110.533 175.742 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 67.7 m-70 -125.98 104.21 26.56 Favored Pre-proline 0 C--O 1.216 -0.676 0 C-N-CA 124.322 1.049 . . . . 0.0 108.952 -178.25 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -50.21 -35.19 42.34 Favored 'Trans proline' 0 N--CA 1.483 0.89 0 C-N-CA 123.229 2.619 . . . . 0.0 113.83 -177.217 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -68.98 -32.93 72.85 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 111.577 0.214 . . . . 0.0 111.577 -179.015 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.428 ' HA ' ' OD1' ' A' ' 11' ' ' ASP . 6.4 t -97.11 -18.62 19.22 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.933 0.873 . . . . 0.0 109.593 -177.78 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 19.9 t-20 -60.13 -45.16 93.96 Favored 'General case' 0 C--N 1.314 -0.948 0 C-N-CA 124.21 1.004 . . . . 0.0 110.481 -178.808 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 12.3 p -66.66 -30.56 50.1 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.003 0 CA-C-N 114.156 -1.384 . . . . 0.0 112.322 -176.823 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.428 ' OD1' ' HA ' ' A' ' 8' ' ' CYS 0.252 7.0 p-10 -90.8 5.21 49.32 Favored 'General case' 0 C--O 1.24 0.557 0 C-N-CA 119.649 -0.82 . . . . 0.0 112.137 -179.871 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 57.3 m-70 -119.38 72.01 13.45 Favored Pre-proline 0 N--CA 1.431 -1.42 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.702 168.719 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -77.77 -12.02 16.63 Favored 'Trans proline' 0 C--N 1.354 0.856 0 C-N-CA 122.522 2.148 . . . . 0.0 111.955 -176.437 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -80.01 -20.85 44.44 Favored 'General case' 0 N--CA 1.416 -2.125 0 CA-C-N 114.907 -1.042 . . . . 0.0 110.393 177.528 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 38.5 mt -103.37 -54.41 6.58 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.04 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 177.257 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 91.1 m -122.16 -94.65 0.49 Allowed 'General case' 0 N--CA 1.415 -2.212 0 CA-C-N 114.702 -1.136 . . . . 0.0 110.522 178.437 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.322 -0.612 0 O-C-N 121.912 -0.492 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.503 -0.666 0 N-CA-C 110.358 -1.097 . . . . 0.0 110.358 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . 0.45 ' HB3' ' O ' ' A' ' 8' ' ' CYS . 8.0 m -72.1 -22.91 61.28 Favored 'General case' 0 N--CA 1.428 -1.536 0 N-CA-C 113.265 0.839 . . . . 0.0 113.265 -178.745 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 1.8 m -74.55 -24.56 58.95 Favored 'General case' 0 C--N 1.294 -1.841 0 CA-C-O 121.205 0.526 . . . . 0.0 111.148 173.792 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 4.0 m -69.77 -26.28 64.21 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 173.638 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . 0.555 ' O ' ' HB2' ' A' ' 9' ' ' ASN . 30.5 m80 -90.38 156.2 45.91 Favored Pre-proline 0 N--CA 1.446 -0.666 0 CA-C-N 114.703 -1.135 . . . . 0.0 109.957 178.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -84.47 -49.49 0.04 OUTLIER 'Trans proline' 0 CA--C 1.549 1.231 0 C-N-CA 122.03 1.82 . . . . 0.0 114.196 178.59 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -73.26 -38.03 66.11 Favored 'General case' 0 C--N 1.32 -0.706 0 O-C-N 121.703 -0.623 . . . . 0.0 112.299 -177.25 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.45 ' O ' ' HB3' ' A' ' 2' ' ' CYS . 5.9 t -83.3 0.67 44.69 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 122.098 0.951 . . . . 0.0 109.45 -176.837 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.555 ' HB2' ' O ' ' A' ' 5' ' ' HIS . 19.6 t-20 -74.39 -41.19 61.37 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 114.962 -1.017 . . . . 0.0 108.739 -179.73 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 62.1 t -58.82 -35.24 55.05 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-N 113.279 -1.782 . . . . 0.0 112.679 -176.381 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.522 ' O ' ' HD3' ' A' ' 13' ' ' PRO 0.276 7.1 p-10 -82.62 6.35 18.03 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 113.863 1.06 . . . . 0.0 113.863 -177.865 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . 0.431 ' HB3' ' HB ' ' A' ' 15' ' ' ILE . 23.5 m-70 -109.75 74.18 0.72 Allowed Pre-proline 0 N--CA 1.441 -0.886 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 168.881 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.522 ' HD3' ' O ' ' A' ' 11' ' ' ASP . 13.6 Cg_exo -66.82 -35.99 25.37 Favored 'Trans proline' 0 CA--C 1.501 -1.14 0 C-N-CA 122.756 2.304 . . . . 0.0 113.439 -168.489 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -86.85 -1.03 57.47 Favored 'General case' 0 C--N 1.282 -2.334 0 CA-C-N 114.926 -1.033 . . . . 0.0 111.946 -177.127 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.431 ' HB ' ' HB3' ' A' ' 12' ' ' HIS . 30.7 mm -114.37 -52.44 5.02 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 -179.661 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 73.5 m -128.24 87.52 2.61 Favored 'General case' 0 C--N 1.288 -2.1 0 CA-C-N 114.625 -1.171 . . . . 0.0 109.945 -179.518 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.304 -1.389 0 CA-C-N 116.223 -0.444 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.13 0 N-CA-C 112.492 -0.243 . . . . 0.0 112.492 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 1.6 m -62.36 -21.65 65.49 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-O 120.963 0.411 . . . . 0.0 111.514 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 3.4 m -65.3 -37.34 86.84 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.155 -179.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 50.6 m -64.6 -11.8 38.69 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.37 178.792 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . 0.499 ' O ' ' HB2' ' A' ' 9' ' ' ASN . 87.5 m-70 -105.37 150.14 38.58 Favored Pre-proline 0 N--CA 1.452 -0.326 0 CA-C-N 114.922 -1.036 . . . . 0.0 110.273 179.524 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -84.49 -38.51 0.12 Allowed 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.464 2.11 . . . . 0.0 112.928 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -72.29 -44.99 61.94 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 -179.06 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.412 ' HA ' ' OD1' ' A' ' 11' ' ' ASP . 6.9 t -83.59 12.21 6.06 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.664 0.269 . . . . 0.0 111.567 -178.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.499 ' HB2' ' O ' ' A' ' 5' ' ' HIS . 3.3 t-20 -90.74 -51.45 5.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.192 0.52 . . . . 0.0 111.458 -179.799 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 22.5 t -54.94 -41.69 59.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.201 -0.909 . . . . 0.0 112.598 -178.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.412 ' OD1' ' HA ' ' A' ' 8' ' ' CYS . 5.2 p-10 -75.87 1.72 14.33 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 -179.042 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 15.3 m-70 -119.34 71.76 12.97 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.188 179.461 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -76.91 -10.16 18.15 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.321 2.014 . . . . 0.0 112.356 -179.855 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -93.98 -2.77 52.63 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.113 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 25.7 mm -111.8 -71.16 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-O 120.929 0.395 . . . . 0.0 111.098 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.485 ' HB2' HD21 ' A' ' 9' ' ' ASN . 33.6 m -105.23 -77.7 0.58 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.041 179.769 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 116.526 -0.306 . . . . 0.0 . . . . . . . . . . 0 0 . 1 stop_ save_